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ABSTRACT 
The main purpose of this thesis is the presentation of the complete process 
of development and validation of four multi-class and multi-detection screening 
methods of antibiotics in milk, fish muscle, bovine muscle and bovine liver. 
Applying the currently analytical tool of choice, ultra-high performance liquid 
chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS), all 
methods were validated according the European Commission requirements 
stated in the Commission Decision 2002/657/EC and can be applied in routine 
analysis of official samples of the target food products. 
In chapter one, a review on the last developments on the detection of 
antibiotics in food-producing animals by liquid-chromatography is presented. This 
chapter highlights the use of liquid chromatography combined with tandem mass 
spectrometry detection as the preferred technique in the field of veterinary 
residues analysis in complex biological samples due to the possibility of fulfil the 
European Commission criteria. Methods for the individual families of antibiotics 
are described and emphasized the advantages of using multi-detection and multi-
class screening methods in routine analysis. However, the most important 
problems found while developing those methods are also emphasized. 
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The second chapter presented the developed UHPLC-MS/MS methods for 
determining sulphonamides, trimethoprim, tetracyclines, macrolides, quinolones, 
penicillins and chloramphenicol in milk, fish muscle, bovine muscle and bovine 
liver. For all matrices it is described the process of optimizing sample preparation 
and detection of target compounds followed by the validation procedure. One of 
the main goals, successful achieved, of validation is to provided evidence that the 
methods are suitable for application in routine analysis. With that being proved, 
the developed screening methods for antibiotics in the target matrices, became 
important tools in the Food Safety field. Thus the referred methods could be 
applied by Official Laboratories in the National Residue Monitoring Plan for 
veterinary medicines, pesticides and contaminants in food of animal origin. 
Finally, in the third and last chapter, regarding the principal drawback 
observed when using chromatography coupled with mass spectrometry 
detection, studies of the real impact of matrix effect in the detection and 
quantification of the target compounds, were performed. The developed methods 
can detect, simultaneously, several compounds from different families 
representing a multitude of diverse physic-chemical properties and, considering 
that, the specificity of sample preparation had to be minimized. In mass 
spectrometry that situation can lead to ion suppression or enhancement of signal, 
owing to interferences coming from the matrices and present in the sample 
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extract to be analysed by mass spectrometry. Such phenomenon was studied in 
order to understand the real impact in routine analysis. It was concluded that, 
although multi-detection and multi-class methods can be successfully used for 
screening purposes, when it comes to quantitation more selective methods 
should be applied. Despite that, the advantages achieved with the multi-detection 
UHPC-MS/MS methods turn them in important tools to be used in Food Safety. 
The capability of detection at residual concentrations, the cost-effectiveness, 
reduced time of analysis and the specificity to identify the presence of antibiotic 
in the sample are the features that guarantee the usefulness of the developed 
methods. 
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RESUMO 
O objetivo central desta tese é o de apresentar detalhadamente todo o 
processo de desenvolvimento e validação de quatro métodos, multi-classe e 
multi-deteção, para a triagem de antibióticos em leite, músculo de peixe e 
músculo e fígado de bovino. Recorrendo à ferramenta analítica mais actual, a 
cromatografia líquida de alta resolução acoplada a um detetor de massa 
sequencial (UHPLC-MS/MS), os métodos desenvolvidos foram validados de 
acordo com as especificações da Comissão Europeia, definidas na Decisão da 
Comissão 2002/657/EC, e destinam-se a ser aplicados na análise de amostras de 
rotina para o controlo oficial dos produtos alimentares descritos. 
 No primeiro capítulo é apresentada uma revisão bibliográfica sobre os 
desenvolvimentos analíticos, para a deteção de antibióticos em produtos 
alimentares de origem animal, por cromatografia liquida. Neste capítulo é 
salientada a utilização de cromatografia liquida acoplada a espectrometria de 
massa sequencial como sendo a principal técnica na área da pesquisa de resíduos 
veterinários em amostras biológicas complexas, devido ao facto de garantir que 
sejam cumpridos todos os critérios estabelecidos pela Comissão Europeia. São 
ainda descritos os métodos utilizados para a determinação dos grupos de 
antibióticos isoladamente, assim como são destacadas as vantagens da utilização 
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de métodos multi-deteção e multi-classe na triagem de antibióticos em amostras 
de rotina. No entanto, não deixam de ser também referidos os problemas mais 
relevantes encontrados durante o desenvolvimento dessas metodologias. 
 O segundo capítulo centra-se na descrição dos métodos desenvolvidos, por 
UHPLC-MS/MS, para leite, músculo de peixe e músculo e fígado de bovino. Entre 
os antimicrobianos determinados encontram-se sulfonamidas, trimetoprim, 
tetraciclinas, macrólidos, quinolonas, penicilinas e cloranfenicol. Para todas as 
matrizes é descrito o processo de otimização da preparação das amostras e 
deteção dos compostos de interesse, assim como o procedimento de validação de 
acordo com as diretivas da Comissão Europeia. Um dos principais objetivos da 
validação dos métodos analíticos é o de demonstrar que os mesmos são de uso 
apropriado em análises de rotina, o que no presente caso ficou claramente 
demonstrado. Deste modo, os métodos apresentados, para as matrizes 
selecionadas, poderão tornar-se ferramentas importantes de utilização na área da 
Segurança Alimentar com aplicação no plano de monitorização oficial.   
Finalmente, no terceiro e último capítulo, e tendo em conta os principais 
problemas encontrados durante a análise de amostras por cromatografia líquida 
acoplada a espectrometria de massa, foram feitos estudos sobre o real impacto 
do efeito da matriz. Visto que nos métodos desenvolvidos são analisados, 
simultaneamente, diferentes grupos de compostos, com diferentes propriedades 
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físico-químicas, a especificidade da preparação da amostra tem de ser 
minimizada. Em espectrometria de massa, esta situação pode levar a que 
interferentes provenientes da matriz provoquem efeitos de supressão iónica ou 
aumento do sinal detetado. Estes fenómenos foram estudados por forma a 
conhecer os reais impactos dos mesmos durante a análise de amostras de rotina. 
Foi possível concluir que, apesar dos métodos de multi-deteção e multi-classe 
terem a eficiência necessária para a sua aplicação em triagem, no que respeita à 
quantificação de compostos detetados, devem ser aplicadas metodologias mais 
específicas. No entanto, a capacidade de deteção observada para cada método 
desenvolvido por UHPLC-MS/MS, o baixo custo e curto período de tempo de 
resposta por amostra, bem como a especificidade para identificar 
inequivocamente o antimicrobiano presente, são características que comprovam 
que as metodologias desenvolvidas são ferramentas essenciais a aplicar em 
Segurança Alimentar. 
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INTRODUCTION 
The use of antibiotics in intensive livestock production systems has 
become a common practice to treat infected animals and also as a preventive 
measure. The possible and irresponsible use of those compounds as growth 
promoters triggered the requirement for monitoring programs within the 
European Union. Nowadays, analytical methods for determining the presence of 
veterinary drugs in food products of animal origin are essential to fulfil those 
control plans. A complete legal framework is in constant updating to cover the 
whole food chain.  
The topics discussed in the introduction section are related with the use of 
antibiotics in food producing animals, the impact in terms of human health, the 
European legislation, the current analytical methods employed to fulfil the 
legislation requirements and the validation process according to the Commission 
Decision 2002/657/EC [1]. 
 
ANTIBIOTICS IN FOOD-PRODUCING ANIMALS 
Veterinary medicines are generally administrated to food-producing 
animals for therapeutic and/or prophylactic and metaphylactic purposes. A large 
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number of different types of compounds can be included in such treatments being 
feed and drinking water their principal route of administration. In the case of 
antibiotics, they can be used to treat infected animals and as a preventive measure 
(i.e. preventing epidemics), keeping welfare of the animals, or to promote animal 
growth. Growth promoting effects are achieved by continuously using antibiotics 
at sub-therapeutic doses, making its use economically advantageous. The effect 
of antibiotics as growth promoters were first discovered in the 1950s, as described 
by Stokestad and Jukes [2]. It was observed that small sub-therapeutic quantities 
of antibiotics, particularly penicillin and tetracyclines added to feed could enhance 
the feed conversion ratio for poultry, swine and cattle. Although, nowadays, it is 
not completely clear the mechanism on how antibiotics can promote animal 
growth, it is believed that the continuous administration of those compounds can 
reduce the incidence and the severity of subclinical infections and also can 
improve the absorption of nutrients by thinning the intestinal wall thus increasing 
feed efficiency [3, 4]. 
The inappropriate and abusive use of veterinary drugs as described can 
lead to the presence of residues of these compounds or their metabolites in edible 
tissues and, in the particular case of antibiotics, can be responsible for toxic effects 
to the consumers, allergic reactions in individuals with hypersensitivity and for the 
development of resistant strains of bacteria. Another important negative effect is 
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related with processed food and to the fact that the final products can have their 
quality compromised and, as an example of that situation are products obtained 
by fermentation in which antibiotics can inhibit the action of bacteria responsible 
for the process. Kemper [5] summarized those described potential side effects 
arising from the presence of the different types of antibiotics, usually 
administrated in human and animals, in food products. The referred author also 
studied the effects observed by the excessive use of antibiotics in livestock 
production giving rise to concerns related with the fate of antibiotics, their 
metabolites and degradation products, excreted by animal husbandry. Their 
persistence in the terrestrial and aquatic environmental are highlighted along with 
the possibility of occurrence of resistant bacteria in soil and water [5].  
Nevertheless, the major concern at global level is related with the occurrence of 
resistant bacteria [6] that can be disseminated from animals through the food chain 
[7, 8] and to the environment [9] and, finally, transferred to humans. Each animal 
continuously treated with antibiotics can become a potential source for the 
production and subsequent dispersion of antibiotic resistant bacteria [10, 11].  
Several studies described by Cogliani, Goossens and Greko [12] established a direct 
relation between the low-doses and non-therapeutic administration of antibiotics 
in farm animals and the emergence and spread of resistance genes. It is also 
proved that the antibiotic resistance patterns in humans is determined by the 
same mechanism as in animals and that the dissemination of the resistance genes 
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occurs from the food chain to the intestinal flora of humans but also via direct 
contact with animals [5]. Furthermore, it is important to enhance that many 
antibiotics applied in veterinary medicine are the same used to treat humans, 
confirming that the occurrence of bacterial resistance is a serious public health 
concern, both for animals and for humans. The emergence and dissemination of 
multiple antibiotic resistant bacteria has special attention in public and scientific 
population worldwide justifying why in 2006 EU completely banned the use of 
antibiotics as growth promoters [13]. Antimicrobial resistance has been nowadays 
recognized as a serious public health concern that has already reached worldwide 
dimensions. The Regulation (EC) 1831/2003 [14] stated that antibiotics, other than 
coccidiostats and histomonostats, cannot be used after 2005 as feed additive. This 
prohibition, considered as an effort to restore the microbial flora of animals when 
no resistant bacteria are present, was the final step to end the permissive use of 
antibiotics to increase food production. Historically, the first prohibition occurred 
in a follow up of an epidemic of resistance Salmonella typhimurium in UK from 
1963 until 1965 [12]. It was discovered that oxytetracycline resistant bacteria was 
transferred from food animals to Salmonella typhimurium. As a consequence, 
from 1972 and 1974, EU banned the use, as growth promoters, of tetracyclines, 
penicillins and streptomycin [12]. 
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Another problem caused by the presence of antibiotic residues in food 
products is the consequent difficulties observed during food processing, 
particularly in fermentation [15]. The presence of inhibitory substances as 
antibiotics can slow or destroy the growth of fermentation bacteria responsible 
for the transformation in fermented products. At the end of the process it can be 
observed a significant loss of quality or even in achieving the final product. A 
perfect example of that situation is described by Chandan and Kilara [16] and by 
Hummel, Hertel, Holzapfel and Franz [17] for dairy products during the production 
of cheese and yogurts and the negative effects of inhibitory compounds such as 
antibiotics. 
 
EUROPEAN REGULATION  
“Assuring that the EU has the highest standards of food safety is a key policy 
priority for the Commission.” 
EU Commission, White paper on food safety, 2000 [18] 
 
The use of antibiotics in modern animal-food producing industry is 
essential and, being aware of the potential negative effects for the consumers and 
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their protection, the European Community settled strict regulations for their use. 
Food safety is one of the top priorities assumed by the European Commission, as 
well explained in the White Paper on Food Safety [18], meaning that legislation has 
to be continuously modernized and implemented in order to control food from 
the farm to the table along with constant developments in the scientific 
capabilities. 
Several regulatory documents to regulate the control of veterinary drugs 
in foodstuff of animal origin have been set along the years. Directive 96/23/EC [19] 
turned mandatory the control of food producing animals as well as their primary 
products by monitoring the presence of residues of veterinary medicines before 
marketing authorization. In the same Directive the compounds used in veterinary 
medicine are divided in two groups in which group A comprises prohibited 
substances and the allowed compounds are in the group B with established 
maximum residue level (MRL) and compounds for which no MRL has been set as 
no hazard for consumers has been proved. The MRL concentrations were 
determined after toxicological studies and with the purpose of minimizing human 
exposure. In practice all food products of animal origin should be free of forbidden 
or non-authorized substances or contain quantities below the MRL for allowed 
compounds. When this situation is not observed it is considered that the product 
is not suitable for human consumption. Although for non-authorized substances 
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there is no tolerance level, in some cases, to harmonize the analytical 
performance of the methods within official member states laboratories, a 
minimum required performance limit (MRPL) had been set [1, 20]. The MRPL is not 
a concentration obtained from toxicological data, but is only related with 
analytical performance. 
As allowed substances to be used in veterinary practice, antibiotics are 
included in group B and for many of them the MRL are available. But they are 
completely forbidden, as animal growth promoters, since 2006 [14]. Substances 
belonging to groups A and B are briefly described in table 1. The procedures for 
the establishment of residue limits on pharmacologically active substances and 
their classification regarding MRL are defined in the EU Council Regulation 
470/2009/EC [21] which repealed the previous Council Regulation (EEC) 
No 2377/90 [22]. The EU Commission Regulation 37/2010 [23], also repealing the 
same regulation [22], presents a complete list of the pharmacologically active 
substances and their MRLs in foodstuffs of animal origin. 
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Table 1: Substances of Group A and Group B, according to Directive 96/23/EC [19] 
Group A 
Substances with anabolic effects and 
unauthorized substances 
Group B 
Veterinary drugs and contaminants 
Stilbenes, stilbene derivatives, and their 
salts and esters 
Antithyroid agents 
Steroids 
Resorcylic acid lactones including zeranol 
β-Agonists 
Compounds included in Annex IV to Council 
Regulation 2377/90/EC 
Antibacterial substances 
Anthelmintics 
Anticoccidiostats, including nitroimidazoles 
Carbamates and pyrethroids 
Carbadox and olaquindox 
Sedatives 
Non-steroidal anti-inflammatory drugs 
Other pharmacologically active substances 
Other substances and environmental 
contaminants 
Organochlorine compounds including PCBs 
Organophosphorus compounds 
Chemical elements 
Mycotoxins 
Dyes 
Others 
 
The surveillance plan designed to ensure that the legislation is being 
respected is the National Residue Monitoring Plan, mandatory in each one of the 
member states as stated by the Directive 96/23/EC [19]. In Portugal, such control is 
performed in the Instituto Nacional de Investigação Agrária e Veterinária (INIAV) 
where the Portuguese National Reference Laboratory for Residues is located. This 
monitoring plan covers the living animals (analytical determinations in biological 
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fluids, feed and water for drinking) and also samples collected in the 
slaughterhouse (edible tissues). Analysis should also be performed in other food 
products obtained from animals, such as milk, eggs or honey. 
The performance criteria that have to be fulfilled for the analytical 
methods employed in the official residues control are described in the EU Decision 
2002/657/EC [1]. 
 
ANALYTICAL STRATEGIES 
The widespread use of antibiotics for therapeutic reasons and as growth-
promoters, turned the development of analytical methods for the determination 
of such compounds in food, a mandatory issue in Food Safety policy. Usually, the 
target matrices for antibiotic residue determination were muscle, liver, kidney and 
milk but in the current days, due to the changes in food habits, worldwide, fish 
muscle, eggs and honey are also matrices of interest in this field of residue 
analysis. Equally important are the control of feed and water for drinking, since 
those are the principal ways of administration of antibiotics and other veterinary 
drugs often used in food producing animals. The control of feed has to be in 
accordance with the EU Regulation 1831/2003/EC [14] that settled down the 
banned antibiotics. 
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In terms of analytical strategies, three categories of methods can be used 
to detect antibiotics in edible tissues: microbiological, immunochemical and 
physic-chemical.  
Screening of antibiotics has been commonly performed by microbiological 
methods. These tests are performed by incubating a susceptible organism in the 
presence of the sample to be analysed, and are based in the inhibition of bacterial 
growth caused by the presence of antibiotics in the samples, which can be very 
unspecific. Although microbiological methods are capable of detecting active 
antibiotics at trace levels having the potential to cover a wide antibiotic spectrum 
within one test, they are not specific in the identification of the drug responsible 
for the inhibition or even of the group of antibiotic present in the sample [24]. 
Another drawback is the fact that the microorganisms used in the test are not 
equally sensitive to all types of antibiotics and, for that reason, some antibiotics 
are better detected than others. Although these methods can give limited 
information, they are characterized by giving rapid results allowing the analysis of 
a large volume of samples in a short period of time. Also another important 
attribute is the fact that no sample extraction is needed [25]. 
The immunochemical techniques, based on the reaction between antigen 
and antibody, are highly selective and sensitive for a particular drug or a group of 
structurally related compounds since the interaction established between the 
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antigen and the antibody is very specific. The most common immunological 
technique is in the enzyme-linked-immuno-sorbent assay, ELISA [15]. The main 
advantages associated to this type of methods are the fact that they can be used 
for screening of a large number of samples in one kit, easy to perform in a short 
time period, with high sensitivity and selectivity along with reduced cost, though 
more expensive than the microbiological methods [26]. Immunoassays are 
especially suitable for the analysis of compounds at residual concentration and in 
samples with simple or even no preparation, due to their low detection limits. 
Another advantage is the possibility to use those kits in the field without the need 
to transport the sample to the laboratory. Nevertheless the high selectivity of such 
assays is the principal restriction since it makes impossible to use as multi-residue 
methods [27]. 
The most recent and continuous improvements are in physic-chemical 
methods allowing the development of reliable, specific and sensitive methods 
able to fulfil the criteria stated in the Decision 2002/657/EC [1], that regulates the 
performance conditions for methods to be used in the official residues control. 
The accurate identification of veterinary drugs in products from animal origin is 
one of the main requirements when choosing the right analytical method. For that 
reason the use of liquid chromatography (LC) with tandem mass spectrometry has 
been the analytical tool of choice. The main advantage of LC in relation with gas 
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chromatography (GC) is the fact that the majority of the analysed compounds is 
polar and with reduced volatility. The use of UHPLC gives the possibility of having 
short running times together with higher resolution and sensitivity. 
In terms of detection, mass spectrometry, as triple quadrupole coupled to 
LC (LC-MS/MS or UHPLC-MS/MS) represents a huge advantage to guarantee the 
required criteria, specially the unequivocal identification. Mass spectrometry 
detection performed by a triple quadrupole allows recording full mass spectra 
(scan mode) or, more specific, selected ion monitoring (SIM) and multiple reaction 
monitoring (MRM). Nevertheless, the application of Time-of-Flight (ToF) or High 
Resolution Mass Spectrometry (HR-MS) is growing in residue analysis. The high 
cost associated with those equipments along with the fact that it is not completely 
clear how to apply the performance and validation in those methods, according 
to legislation, are the principal drawbacks for their use.  
One of the identification criteria introduced by the Decision 2002/657/EC 
[1] is the identification points (IP). Compounds listed in group A should have at least 
four IPs, in the case of antibiotics, listed in group B, an accurate confirmation of 
their presence requires a minimum of three IPs. The number of IPs earned 
depends on the specificity of the MS technique used as presented in table 2. 
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Table 2: Identification points (IP) for each mass spectrometry (MS) technique 
MS Technique IPs per ion 
LR(1) - MSn precursor ion 1.0 
LR - MSn transition products 1.5 
HR(2)  - MSn precursor ion 2.0 
HR - MSn transition products 2.5 
In the table: (1) means Low Resolution and (2) High Resolution. 
 
Nevertheless, for screening purposes a single signal can be accepted for a 
first identification. After that, a complete confirmation has to be performed. In 
that case, along with the IPs, other specific criteria like relative retention time and 
ion ratio has to be verified. The ratio between the chromatographic retention time 
of the target compound and its internal standard, named relative retention time 
(RRT), should not exceed 2.5%. The ion ration tolerances are presented in the table 
3. 
Table 3: Maximum permitted tolerances for relative ion intensities using LC-MS/MS 
Relative Intensity Ion Ratio Tolerance  
> 50 % ± 20% 
> 20 – 50 % ± 25% 
> 10 – 20% ± 30% 
≤ 10% ± 50% 
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The increasing interest in improving cost-effectiveness of analytical 
procedures has become an important issue in the field of residues analysis. Such 
improvement can be achieved by maximizing the number of substances 
determined in one assay. Developing reliable screening methods, able to detect, 
at the same time and in a single run, the maximum number of analytes as possible 
is the nowadays challenge. These methodologies can provide rapid results by 
reducing the number of samples to be confirmed and, consequently, decreasing 
the cost associated with more methods. The UHPLC-MS/MS has been proved to 
be a powerful tool that allows multi-class and multi-compound detection of 
antibiotics in complex biological samples even present at residual concentrations.   
However, when simultaneously analysing different groups of compounds 
with different physic-chemical properties, the specificity of sample preparation 
has to be minimized in order to avoid losses of the analytes during the process. In 
mass spectrometry, this situation can be responsible for ion suppression or 
enhancement of signals due to interferences coming from the matrices, 
compounds released from the samples or reagents used during the process of 
sample preparation [28, 29]. The interferences present in the sample extract can co-
elute with the target compounds and lead to modifications in the spray droplet 
solution changing the evaporation process and, consequently, interfering with 
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ionization process leading to either decrease or enhancement of the detected 
signal. To overcome such situation the measurement tool has achieve detection 
at very low concentrations to guarantee detection even when higher suppression 
is observed. 
 
VALIDATION OF ANALYTICAL METHODS 
The actual legislation settled by the European Commission, concerning 
residues control of veterinary drugs in food products of animal origin, does not 
include the requirement of using normalized methods for the official control. 
However the analytical results developed by different laboratories across Europe, 
should be comparable, and the quality control has to be equally ensured. For that 
reason all the methods used must be validated using common procedures and the 
relevant performance characteristics should be fulfilled. Commission Decision 
2002/657/EC [1] lays down rules for the performance of analytical methods and 
their validation and specifies common criteria for the interpretation of analytical 
results.  
The analytical methods used, depending of their classification as screening, 
confirmatory, quantitative or qualitative, have different parameters to be 
controlled. A qualitative method is an analytical method that identifies a 
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substance on the basis of its chemical, biological or physical properties. The result 
obtained is the presence or absence of the target compound. A quantitative 
method determines the amount or mass fraction of a substance expressing the 
result as a numerical value of appropriate units. On the other hand a screening 
method is used to detect the presence of a substance or class of substances at the 
level of interest. A confirmatory methodology provides the necessary information 
in order to have an unequivocal identification of the substance and, when 
necessary, quantify it at the level of interest. 
In the table 4 the classification of the methods and the correspondent 
performance characteristics are summarized. 
Table 4: Parameters that have to be determined in the validation of the different analytical methods 
  
Decision 
limit (CCα) 
Detection 
limit (CCβ) 
Recovery Precision 
Selectivity 
Specificity 
Applicability 
Ruggedness 
Screening 
Qualitative  √   √ √ 
Quantitative  √  √ √ √ 
Confirmatory 
Qualitative √ √   √ √ 
Quantitative √ √ √ √ √ √ 
 
The validation concept proposed apply to new parameters replacing the 
traditional limit of detection (LOD) and limit of quantification (LOQ) by two critical 
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concentrations: decision limit (CCα) and detection capability (CCβ). The statistical 
definitions, the calculations associated with the determination of those 
parameters and the interpretation of the results obtained are well described by 
Freitas and co-workers [30]. The decision limit, CCα, refers to the “limit at and 
above which it can be concluded with an error probability of α that a sample is 
non-compliant” [1]. The α error is related with the probability of having a compliant 
sample despite the non-compliant result obtained – “false non-compliant 
decision”. Statistically, CCα introduces the uncertainty of the method in the result. 
Detection capability, CCβ, is “the smallest content of the substance that may be 
detected, identified and/or quantified with an error probability of β” [1]. The β 
error happens when a compliant result is obtained when in fact is non-compliant 
– “false compliant decision”. These new concepts were not contemplated in the 
LOD and LOQ determination.    
According to Commission Decision 2002/657/EC [1] the calculation of CCα 
and CCβ can be performed by the determination of signal-to-noise ratio (S/N) 
observed when analysing representative blank samples from the routine 
(equation 1) and by the construction of calibration curves (equation 2) in 
accordance with the described in the ISO 11843 [31]. 
𝐶𝐶𝛼 = 3 × 𝑆 𝑁20 𝑏𝑙𝑎𝑛𝑘 𝑠𝑎𝑚𝑝𝑙𝑒𝑠⁄  (Equation 1) 
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𝐶𝐶𝛼 = 𝐵𝑙𝑎𝑛𝑘 + 2.33 × 𝑆𝐷20 𝑏𝑙𝑎𝑛𝑘 𝑠𝑎𝑚𝑝𝑙𝑒𝑠  (Equation 2) 
Where S/N20 blank samples is the mean of signal-to-noise ratio of 20 blank samples and 
SD20 blank samples represents the standard deviation of the signal obtained in the 20 
blank samples. Twenty blank samples spiked at the determined CCα and the 
corresponding standard deviation (SD20 spiked blank samples at CCα) will allow the 
determination of CCβ. 
𝐶𝐶𝛽 = 𝐶𝐶𝛼 + 1.64 × 𝑆𝐷20 𝑠𝑝𝑖𝑘𝑒𝑑 𝑏𝑙𝑎𝑛𝑘 𝑠𝑎𝑚𝑝𝑙𝑒𝑠 𝑎𝑡 CCα  (Equation 3) 
When dealing with compounds with established MRL this concentration has to be 
taken into account when calculating the analytical limits that will decide on the 
compliance of the samples. 
𝐶𝐶𝛼 = 𝐶𝑀𝑅𝐿 + 1.64 × 𝑆𝐷20 𝑠𝑝𝑖𝑘𝑒𝑑 𝑠𝑎𝑚𝑝𝑙𝑒𝑠 𝑎𝑡 𝑀𝑅𝐿 (Equation 4) 
𝐶𝐶𝛽 = 𝐶𝐶𝛼 + 1.64 × 𝑆𝐷20 𝑠𝑝𝑖𝑘𝑒𝑑 𝑠𝑎𝑚𝑝𝑙𝑒𝑠 𝑎𝑡 CCα (Equation 5) 
In equation 4, the SD20 spiked blank samples at MRL represents the standard 
deviation observed in 20 blank samples spiked at the MRL level.  
Recovery has to be determined for confirmatory quantitative methods and 
is the percentage of the true concentration of a substance obtained in the end of 
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the analytical procedure. If certified reference material is available the deviation 
of recoveries should be in the range of values presented in table 5. 
Table 5: Acceptable recovery range depending on the concentration 
Mass fraction  Recovery range 
≤ 1 µg/kg 50% to 120% 
> 1 until 10 µg/kg 70% to 110% 
≥ 10 µg/kg 80% to 110% 
 
Precision, only mandatory for quantitative methods, measures the 
coefficient variation (CV) between repeated analyses. Under reproducibility 
conditions, the CV should not exceed the calculated by the Horwitz equation. In 
conditions of repeatability the CV should be between one half and two thirds of 
the calculated by the equation 6.  
𝐶𝑉 =  2(1−0.5 log 𝐶) (Equation 6) 
The concentration (C) is expressed as exponent of 10, for example 1mg g-1 = 10-3. 
Selectivity and specificity measure the ability of the method to distinguish 
between the target analyte and other substances present in the sample and has 
to be monitored for all types of methods. These parameters are dependent on the 
matrix, compound and analytical procedure used. 
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Applicability and ruggedness should also be studied for the different 
analytical methods by observing the consequences of variation in experimental 
conditions. All possible changes and conditions that can be subject to fluctuations 
and may affect final the results (i.e. storage conditions; stability of reagents; pH; 
temperature; among others depending on the procedure) should be tested. 
Decision 657/2002/EC [1] also describes the identification criteria, which 
should be fulfilled in all the validation samples, as already presented above: IPs, 
RRT and ion ratio. 
Although not demanded in any legislation, it is consensual in the scientific 
community working in the residues analysis that, a complete matrix effect study 
should be performed to complement the validation and to understand the real 
impact in the final results especially concerning the official control [32, 33]. 
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THESIS OUTLINE 
The continuous administration of antibiotics in farm animals has the 
principal consequence of enhancing the exposure of humans to these compounds 
by the presence of their residues in food products coming from treated animals. 
This situation can be responsible for the development and spread of resistant 
strains of bacteria and severe allergic reactions in hypersensitive individuals to 
those compounds or even to their metabolites or degradation products. On the 
other hand, the presence of antibiotics in food products can contribute to 
difficulties in food processing, in particular in the industry of fermented products 
resulting, in the end of the process, in loss of quality. The presence of inhibitory 
substances such as antibiotics, can slow or destroy the growth of fermentation 
bacteria responsible for the transformation of fermented products. 
Baring in mind the described situations, the public health concerns and the 
economical losses arising from inappropriate utilization of antibiotics in veterinary 
field, the current research had the following specific objectives: 
- Optimization of extractive procedures for the determination of several 
antibiotics as possible in different matrices of animal origin: milk, fish 
muscle, bovine muscle and liver; 
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- Development of multi-class multi-detection methods, to be applied in 
routine analysis of samples of the national plan of residues control in 
Portugal, by UHPLC-MS/MS, for the semi-quantitative screening of 
sulphonamides, trimethoprim, tetracyclines, macrolides, quinolones, 
penicillins and chloramphenicol; 
- Validation of the developed methods in accordance with the 
requirements of the EU Decision 2002/657/EC [1] in order to apply them 
to the official national monitoring plan for veterinary medicine 
residues. 
- Evaluation of the possible matrix effects in terms of suppression or 
enhancement of the detected signal, caused by interferences present 
in the sample extract. 
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ABSTRACT 
In modern agricultural practice antibiotics are widely implemented and 
administrated as feed additives or in drinking water with the main purpose of treat 
and prevent diseases and/or to promote growth. The use of antibiotics as growth 
promoters is considered inappropriate and the abusive utilization of these 
compounds can lead to residues in edible tissues. For the consumers, the presence 
of such residues can be responsible for toxic effects, allergic reactions in 
individuals with hypersensitivity and can result in the development of resistant 
strains of bacteria. 
In order to control these abuse situations, the European Union settled 
down several important official documents which regulate the control of 
veterinary drugs in products from animal origin. The Council Directive 96/23/EC 
determines the control of food producing animals as well as their primary 
products by monitoring residues of veterinary medicines while EU Council 
Regulation 37/2010/EC lays down community procedures for the establishment 
of residue limits on pharmacologically active substances and their classification 
regarding maximum residue limits (MRL), repealing Council regulation (EEC) 
2377/90. Also important is Decision 2002/657/EC that describes the performance 
criteria for the analytical methods employed in the official residues control. 
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The principal methods used for analysing antibiotics in edible tissues can 
be divided in: microbiological tests, immunochemical assays and physic-chemical 
methods. The most recent improvements refer to the last ones, with 
special emphasis on Liquid Chromatography (LC) mainly due the polarity of 
compounds and the lack of volatility, which makes the use of Gas-
Chromatography (GC) more difficult and time consuming. Also, a physical-
chemical analytical approach allows the development of reliable, robust, specific 
and sensitive methods important in quantification. In terms of detection, the use 
of mass spectrometry, such as triple quadrupole coupled with LC (LC-QqQ-MS), 
represented a huge improvement in terms of analytical strategies. This powerful 
tool allows multi-class and multi-compound detection of antibiotics in complex 
biological samples with high levels of specificity and robustness. Additionally, the 
choice, in terms of detection, is growing in recent years and Time-of-Flight (ToF) 
or High Resolution Mass Spectrometry (HR-MS) benchtop instruments are much 
more laboratory reachable. 
This review has the main intent of making an analysis of how veterinary 
drugs, in the particular case of antibiotics, are being monitored in food producing 
animals in the last years, and how the development of new analytical strategies in 
the Liquid Chromatography field influenced the improvement of antibiotic 
residues detection.  
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INTRODUCTION 
In modern agriculture the use of antibiotics is a widely implemented 
practice with the main purpose of treating and preventing diseases but also to 
stimulate animal growth [1-4]. Nonetheless, the resort to antibiotics as growth 
promoters is considered inappropriate and the mechanisms that explain how 
antibiotics can induce growth are still not completely understood [5, 6]. Moreover, 
the abusive use of these compounds can lead to the presence of residues in edible 
tissues that can be responsible for toxic effects to the consumers, allergic 
reactions in individuals with hypersensitivity and can also result in the 
development of resistant strains of bacteria [7-12]. 
In order to control such situations, the European Community settled down 
several official documents to regulate the control of veterinary drugs in products 
of animal origin. One important regulation is Council Directive 96/23/EC [13] that 
determines the control of food producing animals as well as their primary 
products by monitoring residues of veterinary medicines. According to this 
directive veterinary compounds are divided in two groups with group A including 
prohibited substances and group B comprising permitted compounds with 
established maximum residue levels (MRL) as well as compounds for which no 
MRL has been set because no hazard for public health has been observed. Many 
organizations, such as Codex Alimentarius, European Union (EU) and US Food and 
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Drug Administration work together to establish MRL’s in order to minimize human 
exposure.  
Antibiotics, as allowed veterinary drugs, are included in group B and for 
many of them MRL are available. EU Council Regulation 470/2009/EC [14] lays 
down community procedures for the establishment of residue limits on 
pharmacologically active substances and their classification regarding MRL, 
repealing Council regulation (EEC) 2377/90 [15] while EU Commission Regulation 
37/2010 [16] lists the pharmacologically active substances and their classification 
regarding maximum residue limits in foodstuffs of animal origin. Also important is 
the EU Decision 2002/657/EC [17] that describes the performance criteria for the 
analytical methods employed in the official residues control. In 2009, Companyó 
and colleagues [18] made a complete historical review on legislation and validation 
of analytical methodologies for determination of antibiotics in food. Previously, 
other reviews were also published on analytical methods for the determination of 
residues in food producing animals [19-22]. An overview of some selected methods 
for residues extraction from biological matrices is discussed in detail by Kinsella et 
al. [23]. 
The main intent for the present review is to analyse how veterinary drugs, 
in the particular case of antibiotics, have been monitored in food producing 
60 
animals for the last years, and how the development of new analytical strategies 
in the LC field have influenced the improvement of antibiotic residues detection. 
 
ANTIBIOTICS AND ANALYTICAL STRATEGIES  
Antibiotics are a diverse range of compounds, both natural and semi-
synthetic, which possess the ability to inhibit the growth of micro-organisms. The 
term antibiotic was originally applied to describe compounds derived from living 
organisms, but presently also encompasses synthetic substances. Another 
common designation to antibiotics is antibacterials due to their use in the 
treatment of infections caused by bacteria. 
In the past the preferred matrixes for antibiotic residue determination 
were muscle, liver, kidney and milk. Nowadays, the changes in consumption habits 
have increased the importance of fish, eggs and honey in the field of residues 
analysis [21, 24-42]. Animal feeds are also important matrixes that need to be 
controlled since the administration of antibiotics is allowed for therapeutic 
purposes but prohibited when used for growth promotion. The EU Regulation 
1831/2003/EC [43] settled down the banned antibiotics that might be used with 
this aim. Within this view, the main methods used for analysing antibiotics in 
edible tissues can be divided in: microbiological tests, immunochemical assays and 
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physic-chemical methods. Microbiological tests are based in the inhibition of 
bacterial growth, being the 4-plate test one example. These tests are capable of 
detecting active antibiotics at trace levels but they are not specific in the 
identification of the drug responsible for the inhibition or even the group of 
antibiotic present in the sample [44-48].  
Considering the immunochemical assays they have the advantage of being 
highly selective and sensitive for a particular drug and can be used for screening a 
large number of samples within a short time at low cost. Basically, a specific target 
antibiotic is captured by immobilized antibodies or by a broader-spectrum 
receptor such as a bacterial cell. The main restriction is imposed by the fact that 
immunochemical assays are single analyte methods hindering multi-residue 
methods and preventing the detection of non-target drugs [44, 49-53]. As for the 
physic-chemical methods that allow the development of reliable, robust, specific 
and sensitive methods important to quantification, the most recent 
improvements were registered with special emphasis to liquid chromatography 
(LC), mainly due to the polarity of compounds and the lack of volatility which 
makes the use of gas chromatography (GC) more difficult and time consuming.  
The LC usually consists of reverse-phase with an alkyl-bonded silica column 
(C8 or C18) and involves a mobile phase gradient, with main part of aqueous 
solution. It separates the compounds based on the hydrophobic interactions 
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between the non-polar stationary phase and the organic components of typical 
analytes. The retention of polar analytes often requires a highly aqueous mobile 
phase to achieve retention and this situation can lead to the stationary phase 
collapse thus decreasing the retention of very polar analytes. This phenomenon is 
well described by Przybyciel et al. [55]. Some specialized packings were developed 
to prevent this situations [55] including polar embedded phases or hydrophilically 
end-capped reversed phase bonded silica, among others. However, it is also 
increasing the use of hydrophilic interaction liquid chromatography (HILIC) which 
consists of an alternative technique for the separation of highly polar analytes, 
solving the problems associated with column collapse and retention that would 
not be achieved by reversed-phase chromatography. HILIC requires a high 
percentage of a non-polar mobile phase and the elution order is reversed when 
compared to reversed-phase liquid chromatography.  
In terms of detection, the use of mass spectrometry, as triple quadrupole 
coupled with LC (LC-QqQ-MS or more often used LC-MS/MS), represented a great 
improvement in terms of analytical strategies. This powerful tool allows multi-
class and multi-compound detection of antibiotics in complex biological samples 
with high levels of specificity and robustness. Additionally, the choice, in terms of 
detection, is growing in recent years and Time-of-Flight (ToF) or High Resolution 
Mass Spectrometry (HR-MS) benchtop instruments are much more laboratory 
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reachable. Also, the combination of ultra-high performance liquid 
chromatography (UHPLC) with ToF, for screening purposes, is nowadays 
presented as the most powerful measurement tool in terms of selectivity, 
sensitivity and speed [30, 35, 36, 44]. For confirmatory quantification QqQ-MS is still 
the technique of preference. The identity of veterinary drugs in products from 
animal origin has to fulfill the criteria described in European guidelines 
2002/657/EC [17]. The unequivocal confirmation is based on identification points 
(IP) and the number of IP depends on the analytical technique used being 
mandatory the minimum of 4 IP in case of unauthorized substances and 3 IP for 
confirmation of MRL substances. Although it is possible to obtain the required IP 
in low-resolution with a triple-quadrupole mass spectrometer by MRM and also 
by high-resolution mass spectrometer such as ToF-MS, these approaches are not 
yet included in the regulation accepted for confirmation purposes [17]. In several 
publications it is possible to observe the use of ToF for multi-detection screening 
methods in which the suspected samples follow confirmation by LC-QqQ-MS [21, 
30, 38, 44, 56-59].  
Kaufmann and colleagues [59] developed a study in which a comparison of 
quantitative and confirmative performance was evaluated in two different mass 
spectrometry techniques: high‐resolution mass spectrometry (HRMS) in an 
Orbitrap MS and a ToF-MS versus a tandem mass spectrometry (MS/MS) of 
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quadrupole technology. The comparison was carried out in 36 analytes residues 
present at trace level in a difficult food matrix, honey. The authors based their 
experiences on the fact that there has never been a real scientific reason why 
MS/MS should be the only confirmatory and quantitative MS technology 
accepted. According to the authors, the principal reason why MS/MS is still the 
analytical tool of choice is the advantage in terms of sensitivity and selectivity, 
when compared with current HRMS technology, in case of a limited number of 
monitored analytes. However, when working with real multi-residue methods, 
where a large number of compounds has to be detected and quantified, HRMS 
gives interesting possibilities. The same study [59] concluded that HRMS, as 
provided by a single‐stage Orbitrap instrument, gives the precision and accuracy 
necessary for confirmation and quantification purposes. Nevertheless they also 
agree that MS/MS should still be the choice in cases of extremely toxic or banned 
compounds which have to be confirmed at very low levels. 
There are many different groups of antibiotics and their use depends on 
the type of infection and animals that need to be treated, the majority belonging 
to the following families: aminoglycosides, amphenicols, beta-lactams, 
macrolides, nitrofurans, quinolones, sulphonamides and tetracyclines. 
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AMINOGLYCOSIDES 
Aminoglycosides are broad-spectrum antibiotics, active against most 
Gram-positive and negative bacteria [60]. They are potent bactericidal substances 
that act by creating fissures in the outer membrane of the bacterial cell and by 
binding to the 30S ribosome inhibiting bacterial protein synthesis. The chemical 
structure of aminoglycosides is based on an aminocyclitol ring (2-
deoxystreptamine in most case) coupled to two or more amino sugars in a 
glycoside linkage. Structures of selected compounds representing the group are 
presented in figure 1. 
 
Figure 1: Chemical structures of representative aminoglycosides 
Streptomycin Amikacin 
Gentamicin 
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Their physic-chemical properties difficult the development of sample 
extraction as they are scarcely soluble in organic solvents, basic compounds, very 
hydrophobic and thermally labile [61]. The challenging advantages in developing 
analytical methods for aminoglycosides determination, until 2008, were 
presented by McGlincheya et al. [62]. The fact that these compounds do not contain 
any chromophores or fluorophores made the use of derivatization step a 
procedure of choice for fluorescence detection. However, the analytical 
procedure become more time consuming and the derivatives themselves showed 
to be unstable by degrading within a few hours after formation [62, 63]. To overcome 
these difficulties the use of mass spectrometry became the preferred detection 
method for aminoglycosides offering the advantages of sensitivity and the 
unequivocal confirmation of identity [46, 62-67]. In addition, as the amino groups of 
these drugs ionize well with electrospray, the need for derivatization has 
diminished and these analytical techniques are widely selected for confirmatory 
methods. However, the fact that aminoglycosides are not adequately retained on 
reversed-phase columns still presents an analytical challenge. One way to 
overcome this difficulty is through the use of HILIC but this method presents the 
disadvantage of requiring high ionic strength buffers and special chromatographic 
columns. Turnipseed and colleagues [66] demonstrated that the derivatization of 
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aminoglycosides with phenyl isocyante provided derivatives that could be easily 
synthesized, retained and separated on a common reversed-phase column 
avoiding the need of ion-pair reagents or HILIC LC columns. The confirmation and 
quantification, in samples of milk, was performed with detection in an ion trap 
mass spectrometer, using positive ion electrospray where the product ion spectra 
were generated from the derivatized protonated molecules. In the extraction 
procedure, adapted from existing methodologies [68, 70], aminoglycoside residues 
were extracted with acid and isolated from the matrix with a weak cation 
exchange solid-phase extraction cartridge. 
Kaufmann et al. [67] presented a method that detects and quantifies 13 
commonly used aminoglycosides in a variety of food matrices (pork muscle, fish, 
veal livers and kidneys). The method described was based on an earlier work from 
the same authors [69], but unlike the previous approach, relied on a simple clean-
up procedure based on a strong cation-exchange solid-phase cartridge that 
permitted high sample extract loading volumes. The elution was based on a 
volatile buffer at intermediately high pH value in combination with an organic 
solvent allowing the quantitative elution of the various aminoglycosides. In terms 
of chromatography the authors presented the use of ion pair modifiers and 
reversed-phase LC instead of HILIC LC. The observations showed that the ion pair 
system was very stable after some two to three injections and produced higher 
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sensitivities for late-eluting aminoglycosides than HILIC. For the compounds 
separation a C18 column was used with two solutions for mobile phase: 
acetonitrile and water with heptafluorobutyric acid. It was concluded that the use 
of a neutralized eluate guaranteed sufficient weak ion strength not compromising 
the separation of compounds in the column. 
 
AMPHENICOLS 
Chloramphenicol, figure 2, is the principal compound of this group being a 
broad spectrum antibiotic active against aerobic and anaerobic Gram-positive and 
negative bacteria acting as a bacteriostatic drug preventing bacterial growth 
by inhibiting protein synthesis. After the reported toxicity indicating that 
chloramphenicol can cause plastic anaemia in humans the compound was banned 
in animal production in USA and EU in 1994. As a result of this interdiction very 
sensitive methods for the detection and quantification of chloramphenicol are 
needed and, at least, should be able to detect the presence of the compound at 
the minimum required performance limit (MRPL) level (0,3 μg kg-1, in all food of 
animal origin) [17, 71]. Other compounds with similar chemical structure, 
thiamphenicol and florfenicol can be used instead. 
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Figure 2: Chloramphenicol chemical structure 
Several analytical methods have been developed and reviewed for the 
detection and quantification of chloramphenicol in biological matrices. The use of 
GC coupled with MS is one of the options most frequently applied coupled to 
ionization techniques such as chemical ionization (CI) and electron impact (EI) [19, 
20, 22, 72-77]. However, GC-MS requires a derivatization step in order to improve the 
chromatographic properties, usually a sylilation reaction catalysed by acids or 
bases, which is possible due the presence of polar functional groups in the 
chloramphenicol molecule.  
On the other hand, liquid chromatography coupled with mass 
spectrometry (LC-MS) does not require the derivatization step as a result of a 
pronounced electron affinity of the compound that is responsible for an efficient 
detection in negative ionization mode [19, 20, 22, 78-85]. A full MS scan of 
chloramphenicol shows a typical isotopic pattern due to the presence of two 
atoms of chloride in the molecule. The most abundant ion is m/z 321, with two 
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35Cl-atoms, and the most intense fragment ions from this molecule are m/z 152, 
m/z 257 and m/z 194 (Fig. 3). 
 
Figure 3: Most intense fragment ions from chloramphenicol molecule 
 
Bononi et al. [80] presented a method for the determination of 
chloramphenicol in propolis, a natural honeybee product, using thiamphenicol as 
the internal standard for quantification. Analytically, LC-MS/MS interfaced with 
electrospray in negative ionization mode was used and the acquisition was 
achieved with selected reaction monitoring (SRM) mode. The hydroalcoholic and 
glycolic extracts were simply diluted with ethyl acetate and analysed. For LC, a C18 
column was used and the mobile phases were water and methanol. This simple 
procedure showed to be suitable for the analysis of the compound in the matrix 
presented, with a limit of detection (LOD) = 0.05 μg kg-1 and recoveries ranging 
from 80% to 99%. 
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Rønning et al. [81] developed an LC-MS/MS method for the determination 
of chloramphenicol residues in several food matrices: meat, seafood, egg, honey, 
milk, plasma and urine. The method presented a very simple sample preparation 
for most matrices consisting of extraction in acetonitrile while using deutered 
chloramphenicol (d5- chloramphenicol) as internal standard. However, for plasma 
and urine a SPE procedure was required in order to obtain cleaner extracts, using 
a C18 column for chromatographic separation and acidified water with formic acid 
and methanol as mobile phases. As for MS/MS detection ions were monitored in 
negative multiple reaction monitoring mode (MRM). The method was fully 
validated in accordance with EU [17] for all matrices with reproducibility values 
always below 25%. The critical concentrations were also determined with decision 
limit (CCα) of 0.02 μg kg-1 and a detection capability (CCβ) of 0.04 μg kg-1. 
 
BETA-LACTAMS 
Beta-lactams (ß-lactams) antibiotics are probably the most widely used in 
veterinary medicine for treatment and prevention of bacterial infections [20]. 
These antibiotics work by inhibiting bacterial cell wall biosynthesis which has a 
lethal effect on bacteria. The ß-lactams family holds two main groups: penicillins 
and cephalosporins that have in common a four member cyclic amine (Fig. 4). The 
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basic structure of penicillin is a 6-aminopenicillanic acid while cephalosporins 
present a 7-aminocephalosporanic acid nucleus. In both cases the presence of the 
four membered ß-lactam ring, unstable and thermally labile, makes these 
compounds easily degraded by heat and in presence of alcohols as long as it is 
possible to occur isomerization of penicillins in acid conditions [19, 20, 22, 86, 87]. 
Tyczkowska et al [87] reported a study where the degradation of cloxacillin was 
analysed and it was observed that penicillins degraded during exposure to 
chemicals and solvents in sample preparation and that storage of stock solutions 
had the same result. The authors concluded that cloxacillin was rapidly degraded 
when stored in methanol or in methanol-water solutions probably due to 
reactions leading to methyl ester formation. 
 
Figure 4: Structure of: β-lactam ring (A); basic structure of penicillin (B), and basic structure of 
cephalosporin (C) 
More recently, de Baere et al [92] and also Freitas et al. [93], studied the 
degradation of amoxicillin in muscle and in solution, in different conditions of 
A B C 
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temperature and pH. The use of LC-MS/MS offered the possibility to characterize 
amoxicillin’s degradation products even when present at trace levels. 
All the aspects concerning the stability of these antibiotics oblige several 
precautions, concerning temperature and pH during sample preparation. It is also 
important to refer that several authors have reported multi-residue methods for 
the determination of β-lactams in animal tissues or milk [86-91], but only some of 
these methods included cephalosporins [86, 90, 91]. 
One example of that is given by Martínez-Huelamo and colleagues [89], 
which optimized a simple and efficient clean-up extraction of penicillins in milk 
through LC-MS/MS. The recoveries were higher than 70%, except for amoxicillin. 
The method involved the addition of a phosphate buffer solution in order to 
provide a pH between 7 and 8 that was found to be the ideal for penicillin 
extraction. The resulting extracts were then subjected to SPE clean-up with a 
polymeric poly (divinylbenzene-co-N-vinylpyrrolidone) before being analysed by 
LC-MS/MS. In this process, a C18 column was used with a mobile phase consisting 
of acetonitrile and water acidified with formic acid. Multiple reaction monitoring 
(MRM) experiments in the positive ionization mode were performed for penicillin 
detection. After validation it was concluded that the method was suitable for 
routine analysis as the limits of quantification (LOQ) were found to be lower 
enough to determine residues in milk below the permissible MRL established [16]. 
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For the determination of both penicillins and cephalosporins, Mastovska 
et al. [86] developed an analytical method for multi-residue analysis in bovine 
kidney using LC-MS/MS. In this case pH was not taken under consideration and 
sample preparation was performed with a simple liquid-phase extraction with 
water and acetonitrile followed by an extraction with C18 sorbent. The 
chromatographic conditions, similar to all β-lactams analyses [86-91], consisted in a 
C18 column working with water and acetonitrile, both containing formic acid. The 
authors referred the use of methanol instead of acetonitrile could lead to the 
degradation of some compounds and also reported that acetonitrile provided 
better sensitivity for the tested β-lactams. 
A recent publication by Pérez-Burgos et al. [90] presented the advantages 
of cephalosporins analysis in muscle with new dispersive solid phase extraction 
procedures based on QuEChERS (quick, easy, cheap, effective, rugged and safe) 
methodologies in comparison with conventional SPE. These procedures are 
characterized by fewer and simpler steps for an effective clean-up in complex 
matrices such as biological tissues. A minimal amount of organic solvent and 
various salts or buffers are added to the organic phase for clean-up by dispersive 
solid-phase extraction. In this particular case a water:acetonitrile solution was 
added to the sample and after centrifugation a primary-secondary amine sorbent, 
C18 sorbent and MgSO4 were introduced into the organic layer for clean-up 
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resulting in a purified final extract to be analysed by LC-MS/MS. The method was 
validated [17] and the authors concluded that the use of this procedure provides 
lower solvent consumption and it is faster and more straightforward than 
conventional SPE.  
 
QUINOLONES 
The quinolones are a family of synthetic broad-spectrum antibiotics 
synthesized from 3-quinolonecarboxylic acid, used in the treatment of livestock 
and in aquaculture and characterized by an excellent activity against both Gram-
positive and Gram-negative organisms. These drugs are widely used to treat 
respiratory, urinary and digestive bacterial infections. The representative 
chemical structure is shown in figure 5. The majority of quinolones are called 
fluoroquinolones possessing a fluorine atom attached to the central ring system, 
typically at the C-6 or C-7 positions. 
The earlier methods used for the determination of these compounds 
involved ultraviolet detection (UV) [94-96, 109, 110] and, more frequently, fluorescence 
detection [95-108, 110] since most of the quinolones are fluorescent. One of the 
restrictions of such processes is the limited number of quinolones that can be 
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detected. Nowadays LC, coupled with MS detection, has become the preferred 
analytical tool for quantification and confirmatory analysis [109-115].  
 
 
Figure 5: Structure of fluoroquinolone antibiotics, as a fluorine atom is present in the quinolone basic 
structure 
Van Hoof et al. [112] developed and validated a LC–MS method with ion-trap 
for the simultaneous quantification of eight quinolones at the MRL level in 
matrices including bovine muscle, milk and aquaculture products. The compounds 
were extracted from the tissue using ultrapure water followed by SPE with a C18 
cartridge. In the case of milk, an additional step for the precipitation of proteins 
was added with trichloroacetic acid, before SPE. Full scan MS2 mass spectrum of 
each quinolone was obtained, giving the possibility of getting structural 
information. In all the obtained spectra the precursor ion was presented and the 
product ions were the result of the loss of water molecules (m/z=18) and COO- 
(m/z=44). The method was fully validated according to the legislation [13] proving 
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the ability to be used in routine analysis for the confirmation of eight quinolones 
in bovine muscle, shrimp and milk. 
Bogialli et al. [116] presented a simple and rapid method to determine the 
residues of seven quinolones in eggs. Sample preparation consisted of matrix 
solid-phase dispersion technique with hot water acidified with formic acid acting 
as an extracting solvent, followed by liquid chromatography–tandem mass 
spectrometry. The chromatographic separation was achieved with a C18 column 
and mobile phase with acetonitrile and water acidified with formic acid. The MS 
data acquisition was performed in MRM mode. In conclusion, the results proved 
that hot water worked as an efficient extracting medium, since absolute 
recoveries of the analyte in egg at the level of 20 μg kg-1 were 89–103%. Also, the 
limits of quantification ranged between 0.2–0.6 μg kg-1 and, depending on the 
analyte, CCα ranged between 0.41 and 2.6 μg kg-1 while CCβ were 0.64–3.7 μg kg-
1. A similar work was previously described by the same authors, Bogialli et al. [113], 
successfully applied to bovine tissues. 
Being milk one of the new target matrixes, in recent years publications 
about quinolones determination in this product have been increasing. 
Herrera-Herrera et al. [108] described the use of 1-ethyl-3-
methylimidazolium tetrafluoroborate (EMIm-BF4) as mobile phase additive for the 
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analysis with LC coupled to fluorescence detection of seven basic fluoroquinolone 
antibiotics in bovine, caprine and ovine milk samples. The additive provided a 
perfect chromatographic separation of the compounds in a C18 column. The 
sample extraction involved an acidic deproteination followed by a solid-phase 
extraction procedure. As for the applicability of the method it was demonstrated 
during the validation with recovery values ranging from 73% to 113% obtained for 
all three types of samples. Also, reproducibility was below 16% in all the cases. 
However the method was not fully validated according to the EU guideline 
2002/657/EC [17] and was only applied for screening purposes. More recently, in 
2011, the same authors [109], described a UHPLC-MS/MS method for the 
determination of 15 quinolones in powdered milk for children. The same sample 
preparation principle was followed: milk deproteination followed by a solid-phase 
extraction, achieving recoveries higher than 84% and reproducibility lower than 
13% for all analytes. The main advantage of this method was the possibility of 
analysing a sample extract in less than 10 minutes for all compounds 
accomplishing limits of detection between 0.04 and 0.52 μg kg-1. 
Another method by Zhang and colleagues [115] based on UHPLC-MS/MS 
analysed a 22 quinolones in milk. The extraction of the analytes was achieved 
using McIlvaine buffer by ultrasonic bath and clean-up with SPE while detection 
was operated in positive mode with MRM acquisition. The chromatographic 
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separation was optimized to allow the best separation of all 22 compounds using 
a C18 column and acidified mobile phase with formic acid, which was found to be 
the best solvent for enhanced ionization efficiency. Good recoveries and 
reproducibilities for 19 of the 22 quinolones were obtained and the LOQ were 
found to be low enough to determine these compounds at the MRL established 
[16] ranging between 0.008 and 0.339 μg kg-1.  
 
NITROFURANS 
Nitrofurans are a group of highly effective antibiotic drugs with broad 
antimicrobial activity in the treatment of infections caused mainly by Escherichia 
coli and Salmonella sp. In the past this class was widely administered in the food 
animal production sector, especially in swine, poultry and fish husbandries, but 
due to the concerns related to the potential induction of carcinogenicity and 
mutagenicity, well described by McCalla [117] and Van Koten-Vermeulen [118] their 
use in livestock has been banned in the EU [119-121] and other countries. Nitrofurans 
are rapidly metabolized and distributed after administration which indicates that 
only their metabolites are likely to be detected as tissue-bound marker residues 
[122-125]. This rapid metabolism coupled to the fact that these drugs are prohibited, 
makes the development of analytical strategies more challenging.  
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Regarding the chemical structure this class of drugs is characterized by a 
nitro group in position 5 of the nitrofuran ring. Examples of the most used 
nitrofurans are furazolidone, furaltadone, nifursol, nitrofurantoin and 
nitrofurazone with the respective metabolites being AOZ (3-amino-2-
oxazolidinone), AMOZ (3-amino-5-morpholino-methyl-1,3-oxa-zolidinone), 
DNSAH (3,5-dinitrosalicylic acid hydrazide), AHD (1-aminohydantoin) and SEM 
(semicarbazide) [128]. Figure 6 shows the structure of furazolidone and its 
metabolites as an example. 
For the detection of nitrofuran tissue-bound side-chain metabolites, LC-
MS/MS methods are now used throughout the world in animal tissues and other 
matrices. These methods are based on those described by Leitner et al. [126] and 
Connelly et al. [127] in which the nitrofuran metabolites as their nitrophenyl 
derivatives are detected. Although several methods are now published for 
different matrices it can be easily concluded that, in terms of sample preparation, 
the basis remains the same: homogenization, acid hydrolysis, derivatisation with 
ortho-nitrobenzaldehyde (o-NBA) and extraction with polar organic solvent 
(usually ethyl acetate). 
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Figure 6: Structure of the nitrofuran furazolidone, its marker metabolite and the corresponding 
nitrophenyl derivative 
With some improvements, and following the ban on nitrofurans, Verdon 
et al. [128] validated an analytical method with LC coupled to electrospray tandem 
mass spectrometry for the monitoring of 5 metabolites of nitrofurans in turkey 
muscle. The authors proved the applicability of the method since it is able to 
detect all metabolites above the established minimum required performance limit 
(MRPL) of 1μg kg-1 [71].  
Lopez et al. [129] presented an analytical method for the determination and 
confirmation of nitrofuran metabolites in honey by LC-MS/MS. In this method a 
solid-phase clean-up of the sample, using a sorbent composed of a hydrophilic-
lipophilic copolymer, was useful before hydrolysis and derivatization to obtain 
cleaner final extracts. Chromatographic separation was achieved with a C18 
column and mobile phase composed by an ammonium acetate solution and 
methanol. The protonated ions, [M + H]+, for the derivatives were obtained and 
acquisition was performed by MRM transitions. The method was validated 
O
NHN
+
O
-
O
N
O
O
NH2
N
O
O
N
O
O
NH
N
+O
-
O
Nitrofuran: 
Furazolidone
Marker metabolite: 
AOZ
Nitrophenyl derivative: 
NPAOZ
82 
proving that it can be used for regulatory purposes and to monitor the presence 
of nitrofuran side chains in honey. For the nitrofuran side-chain residues, the 
reproducibility was lower than 10% and the accuracies between 92 and 103%. 
Limits of quantification were found to be below 0.25 μg kg-1, due to their good 
response in the LC-MS/MS analysis. 
Previously, Tribalat et al. [130] published an article where the advantages of 
the use of LC-MS/MS compared to LC-MS were presented for the determination 
of nitrofurans in honey. In sample preparation a clean-up step was also added 
before derivatization, using SPE cartridge composed by hydrophilic-lipophilic 
copolymer. In terms of chromatography, a C18 column was chosen with mobile 
phases composed of ammonium formate solution and methanol for LC-MS and 
acetonitrile for LC-MS/MS. LC-MS ionization was achieved with electrospray and 
compounds detected in positive mode (selective ion monitoring, SIM). One of the 
limitations found in this technique was that it does not lead just to the selection 
of ions characteristic to the derivatized metabolites. A large number of molecules 
contained in the sample that have the same mass of the derivatized metabolites 
also appear on the chromatograms, causing interferences.  
As for LC-MS/MS the mass spectrometric detection was in positive mode 
using MRM. The selectivity achieved by this technique allowed the development 
of a faster and simpler chromatographic method without any risk of co-elution.  
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For that reason, only the last technique was validated to be used in routine 
analysis.  
In 2010, Tsai and colleagues [131] validated a method based on the 
European Union regulations [17] to determine the presence of furazolidone, 
furaltadone, nitrofurazone, nitrofurantoin and their corresponding metabolites 
AOZ, AMOZ, SEM and AHD in fish muscle. Samples were acid-hydrolyzed, 
derivatized with 2-nitrobenzaldehyde, extracted with ethyl acetate and analysed 
by LC-MS/MS. Chromatography analysis was developed on a C18 reversed-phase 
column and the mobile phase was composed of a mixture of ammonium acetate 
and methanol. The method was fully validated and the critical concentrations 
were determined. The CCα were 2.93-5.01 μg kg-1 for nitrofurans and 0.19-0.43 
μg kg-1 for metabolites while the CCβ ranged between 3.62-6.20 μg kg-1 for 
nitrofurans and 0.23-0.54 μg kg-1 for metabolites. Based on the calculated limits it 
was concluded that the method is suitable for the analysis of the four nitrofurans 
since the metabolites could be determined at concentrations below the MRPL set 
at 1 μg kg-1 by the EU [71].  
The same method can also be applied to the determination of side-chain 
metabolites in eggs, as described by Block et al. [132], McCracken et al. [133] and 
Barbosa et al. [134]. However, in the case of eggs, it is also possible to find not just 
the metabolites but also the nitrofuran parent compounds. McCracken et al. [133] 
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and Barbosa et al. [134] described the possibility of detecting nitrofurans in eggs as 
their parent drugs using a simpler procedure, as no hydrolysis and derivatization 
step are needed. The parent compounds are first extracted into ethyl acetate, fats 
are removed by partition between acetonitrile and hexane, and after 
concentration the sample is analysed by LC–MS/MS. The validation, in accordance 
with European guidelines [17], proved that the method is suitable for routine 
analysis fulfilling all the legislated criteria. 
 
SULPHONAMIDES 
Sulphonamides are synthetic bacteriostatic antibiotics structurally based 
on a p-aminobenzenesulphonamide functional group (figure 7). These broad-
spectrum antimicrobials act by inhibiting the conversion of p-amino benzoic acid 
to dihydropteroate, which is fundamental for folic acid synthesis in both Gram-
positive and negative bacteria, as well as some protozoa, such as coccidia. 
Sulphonamides have been widely used in animal feed as growth promoters as well 
as to prevent and treat a series of diseases such as infections on the digestive and 
respiratory tracts. Trimethoprim is a potentiator often administered together with 
sulphonamides and, in many cases, also detected through the same method [135-
138]. 
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Figure 7: Structure of the p-aminobenzenesulphonamide functional group 
For the detection of sulphonamides, GC-MS methods are considered to be 
an inappropriate option as this method requires derivatization due the high 
polarity and low volatility of these compounds. Several methods, based on HPLC 
with diode array detector [139-144] and fluorescence [145-148], have been reported for 
their analysis in different biological matrices.  
Nowadays these methods are being replaced by MS/MSn methods with the 
advantage of achieving more sensibility and specificity [135, 137-139, 149-157] as already 
discussed for other groups of antibiotics. The methods reported usually present 
detection through positive electrospray and acquisition with MRM mode. In all of 
them the protonated precursor ion is presented, [M+H]+ and by fragmentation 
produces the following product ions: p-aminobenzene sulphonic acid [M−RNH2]+ 
(m/z=156), [M−RNH2–SO]+ (m/z=108), [M−RNH2 −SO2]+ (m/z=92), and ions from 
the various amino substituent R-NH3 [MH−155]+.  
Nebot et al. [156] developed a LC-MS/MS method for the determination and 
quantification of nine sulphonamides in muscle samples, at concentrations below 
the established MRL. To minimize the matrix interferences the authors proposed 
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a sample size reduction, which also allowed the reduction in the amount of 
solvents required and avoided the use of SPE cartridges for purification. These 
adjustments led to a rapid and easy extraction protocol with organic solvent. The 
chromatographic separation was assured with a C18 column with acetonitrile and 
a solution of ammonium acetate as mobile phase. The validation was carried out 
in accordance with EU Commission Decision 2002/657/EC [17] and for all the target 
compounds the recoveries obtained were above 88% which demonstrate the 
applicability of the new protocol for extraction. 
In 2011, Won and colleagues [139] presented a method for sulphonamides 
determination in fish and shrimp using HPLC with photodiode array detector (PDA) 
for screening and UHPLC-MS/MS for confirmatory and unequivocal identification. 
Sample preparation involved a liquid-phase extraction with acetonitrile followed 
by a solid phase extraction adding to the organic layer a C18 powder. For HPLC-
PDA screening, a C18 column was used for chromatographic separation along with 
a solution of potassium dihydrogen phosphate (pH 3.25) and methanol as mobile 
phases. For confirmation with UHPLC, water and acetonitrile both acidified with 
formic acid, were the chosen eluents. Authors concluded that a more reliable 
method for confirmation was needed as some false-positive results could be 
obtained with HPLC-PDA method. 
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The use of sulphonamides to protect honey bees against bacterial diseases 
is a frequent practice in beekeeping [159]. A recent method for the determination 
of these antibiotics was published by Economou et al. [135] that was able to identify 
and quantify seven sulphonamides, trimethoprim and dapsone in honey. As no 
MRL is established for sulphonamides and trimethoprim in honey the authors 
considered the target compounds as banned substances while developing the 
method and the requirements of higher selectivity and sensitivity were the main 
purpose. The analysis, by LC-MS/MS, was performed with positive electrospray 
and acquisition in MRM mode. The chromatographic separation was fulfilled on a 
C18 column in combination with two mobile phases: water and acetonitrile both 
containing 0.1% (v/v) of formic acid. In terms of sample extraction it is important 
to consider that sulphonamides can bind to honey sugars and an acidic hydrolysis 
is needed to liberate the target compounds [135, 147, 148, 160]. After the hydrolysis 
step, the authors used a SPE clean-up with a cartridge composed by a hydrophilic-
lipophilic copolymer. The method was successfully validated, according European 
guides [17], achieving recoveries ranging from 70% to 106% and reproducibility 
from 6 to 18 %. CCα and CCβ values were also calculated ranging between 0.4-0.9 
and 0.7-1.4 μg kg-1, respectively. 
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TETRACYCLINES 
Tetracyclines are a group of antibiotics widely used in veterinary medicine 
being active against a broad range of Gram-positive and Gram-negative organisms 
by inhibiting protein biosynthesis through binding to the 30S ribosome. 
Tetracyclines are used for the treatment of gastrointestinal, respiratory and skin 
bacterial infections [161,162] and present a common structure with four six member 
rings where five radical chains can be modified, as seen in figure 8.  
 
Figure 8: Basic tetracycline structure 
These compounds are relatively stable in acids but not in bases, and can be 
photodegraded forming reversible epimers. It is also important to observe that 
tetracyclines are strong chelating agents being chelation of a divalent metal ion 
essential for their antimicrobial activity. All these factors, well described by 
Anderson et al. [165] and Kinsella et al. [23], are responsible for the difficulties found 
when extracting tetracyclines from biological tissues leading to low and variable 
recoveries. To overcome these problems sample extraction, in almost of the 
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reported cases, leads to a primary step of aqueous extraction with solution 
containing EDTA (ethylenediamine tetraacetic acid), since tetracyclines show low 
affinity to organic solvents. The use of EDTA, as a chelating agent, minimizes the 
interaction of tetracyclines with chelating complexes. Also, the aqueous solution 
used for the first step is normally mildly acidic in order to promote 
deproteinization and minimize the presence of cations normally binded to 
proteins.  
Although a wide range of analytical methods have been developed for the 
determination of tetracyclines in products of animal origin, such as immunoassays 
and capillary electrophoretic, LC methods in the recent years have been the most 
applied. Önal et al. [163] described in detail some of the recently advances in the LC 
methods. As referred by the authors, LC-MS/MS methods were developed to 
improve sensitivity and accuracy in tetracyclines quantification obtained by UV 
and fluorescence methods, which nevertheless, are still used [163-168]. Several LC-
MS/MS methods are currently available in the literature [20-22, 163, 171-177] having the 
main advantage of providing the possibility of detection not just for tetracyclines 
but also for their epimers. In all of them it is observed that the full scan mass 
spectrum shows the [M+H]+ ions, as precursor ions, and the most intense products 
obtained after their fragmentation correspond to [M+H–H2O]+, [M+H–NH3]+ and 
[M+H–H2O–NH3]+.  
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De Ruyck and co-authors [173] developed a LC-MS/MS method for the 
determination of 4 tetracyclines and respective epimers in milk. As no MRL is 
available for doxycycline in milk the principal goal was to develop a sensitive 
analytical method with acceptable extraction recoveries. A liquid extraction with 
an aqueous solution with trichloroacetic to precipitate proteins was performed. 
The extract was then applied to SPE cartridge, a hydrophobic-lipophilic-copolymer 
for clean-up and the extract analysed by LC-MS/MS. The LC separation performed 
in a C18 column was achieved with a mobile phase consisting of water and a 
solution of methanol and acetonitrile with formic acid while detection was 
achieved in positive electrospray mode and MRM acquisition. The validation 
proved the applicability of the method with recoveries ranging from 90.4% to 
101.2%. Also, it was possible to detect compounds in concentrations between 5 
and 20 μg.L-1. The authors had also developed some stability tests and concluded 
that, in order to minimize the degradation of tetracyclines in their own epimers, 
the samples should be immediately injected into the LC-MS/MS system once 
prepared.  
Blasco et al. [174] optimized and validated a LC-MS/MS method capable of 
quantifying four tetracyclines used in veterinary medicine, as well as their epimers 
in muscle tissue of different species. The presented work consisted on an 
optimization of a previous one, [172], adding the use of hot water as an extractant 
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solvent to provide clean sample extracts in a pressurized liquid extraction. Other 
improvement is the employment of hydrophilic-lipophilic copolymer cartridges as 
SPE instead of the normal C18 reported first. For the chromatographic separation 
of tetracyclines from their respective epimers a C18 column was used and the 
mobile phase gradient was optimized with water and methanol both acidified with 
formic acid. The method was fully validated [17] showing average recoveries for all 
compounds, for the different species and at three levels of concentration (1, 100 
and 200 μg kg-1) always higher than 89% and precision lower than 17%. The limit 
of quantification was also calculated, ranging from 0.5 to 1 μg kg-1 while the CCα 
and CCβ ranged between 101–116 and 112–130 μg kg-1, respectively. 
 
MACROLIDES 
Macrolides are an important group of antibiotics, active against aerobic 
and anaerobic Gram-positive bacteria, used in veterinary medicine mainly to treat 
respiratory tract infections but also as growth promoter purposes. Their action is 
bacteriostatic through binding to the 50S subunit of the ribosome and inhibiting 
bacterial protein synthesis. The structures of all macrolides are based on a 
macrocyclic lactone ring to which sugars, including amino and deoxy sugars, are 
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attached. The therapeutically most relevant macrolides comprises 12-, 14-, 15- or 
16-membered ring. Some examples of macrolides are presented in figure 9. 
 
 
Figure 9: Molecular structure of some selected macrolides 
These molecules, as weak bases, are lipophilic, soluble in methanol and 
unstable in acids [62]. Another important fact is that their molecular structure 
contains chromophores, which makes possible their analysis by UV [62, 178, 179] and 
fluorometric detection [62, 180]. Recently, with improved sensitivity and specificity, 
mass spectrometry has replaced UV and fluorometric methods in detection and 
quantification of macrolides in different biological matrices [19, 20, 62, 181-190].  
Wang [182] presented an overview on the biological properties of 
macrolides and their analytical strategies, including extraction and liquid 
chromatography methods. The most commonly used techniques to extract 
eritromicina roxitromicina azithromycin 
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macrolides from biological matrices include SPE, usually with a C18 or a 
hidrophylic-lipophilic copolymer cartridge, and a liquid–liquid extraction with 
organic solvent or appropriated aqueous buffer. In terms of detection, triple 
quadrupole in MRM mode is the most used analytical tool. Recent developments 
in chromatography science have shown that UHPLC coupled with a mass 
spectrometer or time-of-flight mass spectrometer are emerging techniques for 
unequivocal identification and quantification of macrolides [62, 182].  
However, Berrada et al [189], published a study where results obtained with 
an LC-PDA are compared with those obtained in a LC-MS/MS system and, despite 
the higher detection capability of the mass detector, the authors concluded that 
the LC-PDA is a good alternative achieving a low-cost procedure and also a 
sensitive technique for the determination of macrolides in liver at residual 
concentrations. The extraction procedure presented has two steps: liquid 
extraction with EDTA–McIlvaine’s buffer and SPE clean-up with a hydrophilic-
lipophilic copolymer cartridge.  
On the other hand, Bogialli et al. [181], used the advantage of sensibility of 
an LC-MS/MS to develop a simple and rapid assay to determine three macrolides, 
erythromycin A, tylosin and tilmicosin, in eggs. The method was based on a single 
extraction step with acetonitrile without any further clean-up or purification. In 
terms of accuracy no matrix effects or ion stability were observed that could 
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compromise the detection and quantification of the target compounds. A C18 
column was used for chromatographic separation with acetonitrile and water 
acidified with formic acid as mobile phase. The method was validated fulfilling all 
regulated criteria [17]. 
Wang et al. [182] developed two liquid chromatography mass spectrometric 
techniques, UHPLC-ToF MS, and LC-MS/MS, for identification, quantification and 
confirmation of six macrolide antibiotic residues in eggs, raw milk, and honey. 
Authors concluded that, although LC-MS/MS had advantages in terms of lower 
limits of detection and better repeatability, UHPLC-ToF provided unequivocal 
confirmation and also allowed the identification of the possible degradation 
product. An example is given for tylosin that can be a mixture of tylosin A, as a 
major component, and tylosin B or desmycosin, tylosin C or macrocin, and tylosin 
D or relomycin. It is also suggested that the combination of the two techniques 
could be very beneficial or complementary in routine analysis of macrolide 
antibiotic residues when the identification of all the related products is required. 
 
MULTI-DETECTION MULTI-CLASS METHODS 
Multi-class and multi-detection methods are a challenge that is coming 
more and more embraced. In recent years it has been observed an increasing 
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interest in improving cost-effectiveness of analytical procedures [23, 30, 38, 54, 191-194]. 
One way of doing this is developing reliable screening methods, able to detect, at 
the same time and in a single run, the maximum number of analytes as possible. 
Although microbiological and bioassay techniques are still used for screening 
purposes, mainly because of their low cost and simplicity, more specific 
confirmatory methods are needed for unequivocal identification and for 
quantification. As a result and since a few years ago, the major concern was 
focused on the development of sensitive and specific confirmatory methods and 
few attentions were given to screening. Nowadays there is a growing concern on 
having efficient screening technologies that guarantee the absence of false-
positives and false-negative results. This efficiency is encountered in the multi-
detection methods based on liquid chromatography technology coupled with 
tandem mass spectrometry (MS/MS) and time of flight mass spectrometry (ToF). 
Also the use of UHPLC gives the possibility of having short running times together 
with higher resolution and sensitivity. The most reported methods are multi-
detection of related compounds, usually from the same family of antibiotics as 
described above for each class. Recently, some developments showed the 
increase of publications reporting analytical strategies to analyse, with the same 
method, unrelated compounds in multi-class procedures [20-23, 26-42, 45, 58, 61, 194-201].  
96 
Problems are still encountered in this sort of methods, mainly due to the 
difficulty in extraction and pre-treatment of samples, when analysing 
simultaneously different groups of compounds with different physic-chemical 
properties. Although some of the published works seemed to succeed on that 
task, many of the methods developed presented several steps in sample 
extraction for the different compounds depending on their properties [34, 42, 196, 202, 
203]. When this approach is used more than one LC run has to be performed. In 
some cases, even when just one extract is obtained, depending on the detector 
used and on the chromatographic conditions for retention and separation of 
analytes, more than one injection is needed. For mass detection some compounds 
are ionised in positive mode and others in negative and for some detectors that 
means two separate analyses. Also, chromatographic optimization can lead to 
differences, even slightly, in mobile phase and in the gradient depending on the 
compounds [202].  
The next paragraphs describe some of the methods recently developed for 
multi-detection multi-class methods in food producing animal matrixes, namely 
honey, milk, eggs and muscle.  
Honey is one of the target matrixes in the field of residues analysis mainly 
due to its popularity among consumers. The use of antibiotics in apiculture to 
prevent American Foulbrood diseases is known for a long time and both the 
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allowed and the banned compounds have to be controlled. Most of the methods 
developed are multi-residues analysis for compounds from the same group as it 
was already presented for each of the antibiotics families.  
A multi-screening approach for monitoring antibiotics in honey by LC-
MS/MS has been developed by Hammel et al. [42], in which a total of 37 from the 
42 initially intended veterinary drugs (5 tetracyclines, 7 macrolides, 3 
aminoglycosides, 8 β-lactams, 2 amphenicols and 17 sulphonamides) were 
confirmed and quantified at a concentration level of 20 μg kg-1. Appreciable 
performance was obtained for all analytes, except for five compounds (amoxicillin, 
ampicillin, desmycosin, penethamate and sulphanilamide). The sample 
preparation included four subsequent liquid/liquid extraction steps and in each 
one different compounds were extracted. It was decided not to optimize any solid 
phase extraction in order to have better recoveries at the end. The final extracts 
were analysed by LC-MS/MS in positive ionization with a TurboIonSpray source 
and acquisition in MRM mode. Chromatographic separation was fulfilled using a 
C18 column and mobile phases constituted of water containing 1mM NFPA 
(nonafluoropentanoic acid) mixed with 0.5% formic acid (v/v) and a mixture of 
acetonitrile/methanol (50/50, v/v) containing 0.5% formic acid (v/v). NFPA was 
used as an ion pairing agent to improve aminoglycosides retention in the column 
and only used in one of the mobile phase in order to minimize possible 
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suppression effects. Also, the gradient used was optimized to achieve separation 
of isomers (in this case tetracyclines and sulphonamides). The method was 
validated in accordance with EU directive 2002/657/EC [17] and, for screening 
purposes, was determined the limit of compliance that ranged from 23.4 μg kg-1 
(dihydrostreptomycin) and 31.4 μg kg-1 (tilmicosin).  
Furthermore, Lopez et al. [33], developed and validated a multi-class 
method for the determination of 17 antimicrobials by LC-MS/MS in honey. The 
compounds analysed were tetracyclines, fluoroquinolones, macrolides, 
lincosamides, aminoglycosides, sulphonamides, phenicols and fumagillin residues 
with chromatographic separations performed in a C18 column. For the 
determination of streptomycin an aliquot of honey diluted in water was 
centrifuged, filtered and analysed. The remaining supernatant was used for solid 
phase extraction with a polymeric sorbent able to retain both polar and non-polar 
compounds after filtration with a fine-mesh nylon fabric. At the end of sample 
treatment, three LC analyses could be performed: streptomycin extract, in 
positive mode; chloramphenicol, in negative mode and again in positive mode all 
the remaining compounds. One of the critical steps pointed by the authors 
concerned the fact that some antibiotics were sensitive to light. It was 
recommended that, once the samples were prepared must be immediately 
analysed, especially in the case of streptomycin extract that showed to be the 
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most unstable. After validation it was concluded that erythromycin could only be 
detected and confirmed but not quantified because of its low recovery. 
Repeatability was calculated and observed to be lower than 17% for almost all 
compounds. Recoveries ranged from 65 to 104%.  
A special emphasis is given to aminoglycosides detection in the multi-class 
method developed by Martos et al. [196]. Due to the high affinity of these 
compounds with polar surfaces such as glass, special attention had to be taken 
during all the procedure. The described method consisted on a semi quantitative 
screening of 39 compounds, in muscle, including amphenicols, beta-lactams, 
macrolides, sulphonamides, tetracyclines and quinolones. Some extra steps, with 
water as a polar solvent, had to be taken in order to guarantee aminoglycosides 
extraction. Also, the use of pure organic solvents was avoided, in opposition to 
water and buffer solvents, to improve recovery of beta-lactams. At the end the 
final extract was injected three times in the LC-MS/MS. In positive and in negative 
ionization the chromatographic separation was performed in a C18 column. For 
aminoglycosides a HILIC column had to be used. The accuracy ranged from 45%, 
for neomycin to 106%, for sulphanilamide. 
A completely validated method published in 2012 by Lopes and colleagues 
[40] with application in aquaculture fish samples, describes the advantages of using 
a UHPLC-MS/MS in combination with the sample extraction procedure QuEChERS 
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for the determination of 32 compounds belonging to several families (macrolides, 
penicillins, quinolones, sulphonamides, tetracyclines and anti-helminthes). Using 
UHPLC a reduction time in sample analysis and in the chromatographic separation 
could be achieved. The chromatography was enhanced to fulfil the resolution and 
optimal peak shape using 0.1% formic acid and acetonitrile as mobile phases. For 
mass spectrometry, a tandem quadrupole mass spectrometer with positive 
electrospray ionization (ESI+) and operating in MRM mode was used. QuEChERS 
has the main advantage of allowing a simple inexpensive extraction in few steps. 
With the aim of improving the recovery of tetracyclines and quinolones, the 
QuEChERS procedure was slightly changed by adding methanol to the extraction 
solution. However, the greater the amount of methanol added, the dirtier was the 
final extract, resulting from solvent matrix components. In the end, and in order 
to have satisfactory recoveries for all the compounds the authors selected a 
combination of acetonitrile:methanol (75:25, v/v). After validation the recoveries 
obtained ranged from 69% to 125%, and the expanded uncertainty evaluated at 
100 μg kg-1, was below 25% for all compounds with the exception of tetracycline 
(28%). For the inter-day precision the worse value was 30% for thiabendazole and 
marbofloxacin. Also, the LOD and LOQ were determined and obtained as 
maximum levels 7.5 μg kg-1 and 25 μg kg-1 respectively, except for danofloxacin, 
oxytetracycline and tetracycline. These compounds presented LOD of 15 μg kg-1 
and LOQ of 50 μg kg-1. The CCα and CCβ values were calculated according to the 
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corresponding MRLs. In conclusion, the authors claimed that 15 samples could be 
prepared in less than 1 hour and analysed in 2.5 hours. 
Recently and developed by the some authors [206] a similar multi-detection 
method targeting chicken muscle and covering 20 analytes from quinolones, 
sulphonamides, macrolides, anthelmintics, avermectins and also benzathine. This 
last compound is used to stabilize penicillins and was included to monitor their 
presence. The approach also used the same UHPLC-MS/MS equipment (also the 
same chromatographic and detection conditions) and QuEChERS for sample 
treatment. Having in mind that QuEChERS were first developed for pesticides 
analysis, the procedure had to be improved in order to extract all the target 
compounds from the sample. Originally the extraction solvent had a higher 
content of water. Authors concluded that the best recoveries were achieved when 
performing extraction with a mixture of acetonitrile:water (80:20, v/v) acidified 
with acetic acid. The method was fully validated according to the legislation [17]. In 
terms of recovery only benzathine with 65.6% at 20 μg kg-1 and sulfadimidine, with 
69% at 100 μg kg-1 presented the worst values. The stability of the method 
developed was proven with a precision study. For repeatability the maximum 
value obtained was for sulphachlorpyridazine (RSD=22.1% at 20 μg kg-1). The 
higher value determined for reproducibility was for benzathine (RSD=37.8% at 20 
μg kg-1) but all the other compounds presented values below 28%. LOD and LOQ 
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were determined with tylosin presenting the higher limits: 9.0 μg kg-1 and 30.0 μg 
kg-1 respectively. Critical concentrations, CCα and CCβ, were calculated according 
to EU commission decision [17], taking into account the MRLs, when established.  
The two methods [40, 206] described have the advantage of being used not 
only for screening, but also for confirmatory and quantification purposes. The 
detection was performed using two MRM transitions for each compound 
respecting the required points of identification for confirmatory methods 
demanded in the legislation. 
One of the most consumed foodstuffs from animal production is milk. 
Antibiotic residues are the most frequent inhibitory substances found in this 
matrix having undesirable effects on its quality. Their residues, along with adverse 
effects on consumer’s health, can slow or destroy the growth of the fermentation 
bacteria responsible for milk transformation in fermented products.  
The main problem concerning milk extraction for antibiotics determination 
is its high content of protein and fat. Traditionally, in this matrix, antibiotics 
extraction involved a step of precipitation of proteins [32, 34-39, 173] with organic 
solvent and a strong acid, such as trichloroacetic acid which can result in low 
recovery for unstable compounds. To overcome this difficulty Aguilera-Luíz et al. 
[36], developed a multi-detection method involving a single extraction technique 
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based on QuEChERS procedure combined with UHPLC-MS/MS analysis. The 
method was developed to determine 18 selected veterinary drugs 
(sulphonamides, macrolides, quinolones, anthelmintics and tetracyclines). 
Chromatographic separation was carried out with a C18 column with mobile phase 
consisting of methanol (eluent A) and 0.01% of formic acid in water (eluent B). The 
gradient profile was optimized in order to have fast, reliable separation and good 
shape peaks making possible the determination of all analytes in less than 10 
minutes. The applicability of the method was studied by validation. In terms of 
recovery it ranged between 70.6% (ivermectin) and 111.3% (erythromicyn). It was 
observed that repeatability and reproducibility were lower than 20.4% 
(albendazole). LOD and LOQ were determined resulting values from 1 to 4 μg kg-1 
and 3 to 10 μg kg-1 respectively, which were lower than the MRL established [16].  
A different approach in terms of detection is presented by Stolker et al. [38] 
for screening veterinary drugs in milk. UHPLC combined with ToF-MS has been 
used for screening and quantification of more than 100 veterinary drugs in which 
some groups of antibiotics were included (macrolides, penicillins, quinolones, 
sulphonamides, tetracyclines and amphenicols). A simple sample treatment starts 
with protein precipitation and follows to a polymer-based C18 solid phase 
extraction. The method was validated according to EU guidelines for quantitative 
screening [17]. At the MRL levels the repeatability obtained ranged up to 20% for 
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86% of the compounds analysed. For reproducibility the obtained value was lower 
than 40% for 96% of the compounds. The accuracy ranged from 80 to 120% for 
88% of the compounds. As the confirmation of identity of veterinary drugs by ToF-
MS is not yet included in EU guidelines it is mandatory to have a MS/MS 
confirmation method to process the suspected samples.  
Another publication by Ortelli and colleagues [35] presented the use of 
UHPLC coupled to orthogonal acceleration ToF mass spectrometry for the 
screening of 150 veterinary drugs residues in milk (antibiotics from beta-lactams, 
macrolides, quinolones, sulphonamides, tetracyclines among other veterinary 
drugs). The sample preparation was based on protein precipitation associated 
with ultra-filtration and appeared to be easy and fast. To control possible 
contamination problems, the authors advise the use of disposable material during 
all the process. The simplification of sample preparation was possible due the 
possibility of using UHPLC-ToF, described as a very high performance tool. The 
identification of contaminants is based on accurate mass measurement. The 
validation procedure was conducted based on EU directive 2002/657/EC [17]. In 
some cases it was observed that the obtained LOD was higher than the MRL (case 
of amoxicillin, betamethasone and dexamethasone). Also, in the case of 
amoxicillin, it was not possible to determine CCα and CCβ. The recovery and 
precision studies indicated possible matrix effects inducing suppression and 
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enhancement of signal. In the specific case of quinolones recoveries were up to 
807% (danofloxacin) confirming the presence of interferences due to the simple 
sample preparation.  
To improve recovery for as many compounds as possible, Gaugain-Juhel el 
al. [47] presented two separated and simple milk extractions followed by two LC-
MS/MS acquisitions to allow the screening of 58 antibiotics belonging to beta-
lactams, sulphonamides, macrolides, lincosamides, aminoglycosides, tetracyclines 
and quinolones. The first extraction route for beta-lactams, macrolides and 
sulphonamides consisted in a liquid extraction with acetonitrile, centrifugation 
and evaporation after which the extract was redissolved with ammonium acetate. 
The second route extracted tetracyclines, quinolones, aminoglycosides and 
lincomycin with a trichloroacetic solution that was, after centrifugation, directly 
analysed by LC-MS/MS. Chromatographic separation was reached with a C18 
column and two different gradients mixing 0.1% of pentafluoropropionic acid and 
acetonitrile to achieve the better shape and separation peak. The detector, a triple 
quadrupole was operated in positive ESI and in MRM conditions. Validation values 
of CCβ showed to be below or equal to MRL, except for amoxicillin, fulfilling the 
demanded requirements for a suitable screening method for all other compounds.  
Also covering a wide range of antibiotic families, Bohm et al [37] developed 
a single extraction procedure for milk analysis. The method is based on the protein 
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precipitation with trichloroacetic acid, a liquid extraction with McIlvaine buffer 
followed by solid phase extraction with hybrid polymeric columns and analysis by 
LC-MS/MS of 47 compounds (tetracyclines, quinolones, macrolides, 
sulphonamides, diamino-pyrimidine derivatives and lincosamides). 
Chromatographic separation was achieved with a C18 column and mobile phases 
composed by 0.2% formic acid and acetonitrile. The detection, with triple 
quadrupole, was performed with an electrospray ion source working in positive 
mode and in MRM conditions. The applicability of the method was proven by the 
validation study according to the EU commission decision 2002/657/EC [17] and 
with successful participation in proficiency tests. The recovery of the method 
ranged from 94% to 109% for all compounds and precision, in terms of 
repeatability and reproducibility was below 22% also for all compounds. 
Methods for the analysis of residues from several classes in eggs are still 
very few compared to the other target matrices. Heller et al. [28]; Frenich et al. [29]; 
Peters et al.[30]; Jiménez et al. [31] are some of authors that published the most 
relevant of them. The high lipid and protein content turns the eggs in a more 
complex matrix and consequently the extraction procedure becomes more 
difficult. Acetonitrile is the solvent of choice because it can precipitate proteins 
and also denatures enzymes that can depredate the analytes of interest during 
sample treatment. In spite of that problem this matrix is very important due to its 
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high consumption with eggs being present in all diets and also represents an 
inexpensive and very nutritious food item.  
Peters et al. [30] combined a sensitive full mass scan MS technique, ToF-MS, 
with a high resolution LC, UHPLC, for the determination of 100 veterinary drugs in 
three matrices: meat, fish and eggs. In the compounds analysed are included: 
macrolides, penicillins, quinolones, sulphonamides and tetracyclines. The 
chromatographic separation optimized uses a C18 column and a gradient mixing 
0.1% of formic acid and acetonitrile and the detection achieved in a ToF-MS 
equipped with an orthogonal ESI source operating in positive mode. The sample 
preparation starts with protein precipitation adding to the sample a mixture of 
acetonitrile:water (6:4, v/v) followed by SPE with polymer based C18 columns. The 
procedure was adapted from the previous described method developed for milk 
by Stolker et al. [38]. Although the method could be directly used for meat and fish, 
in the case of eggs the recovery for a high number of analytes was very poor. The 
use of a stronger eluent in the SPE clean-up is needed (methanol:ethyl acetate, 
1:1, v/v) probably due to protein binding of analytes to egg protein in SPE column. 
Proteins in eggs are smaller and more soluble in water than the proteins in meat 
and fish making the step of precipitation with acetonitrile less efficient and a 
higher protein concentration loading in SPE column, increasing interferences. The 
results obtained after validation are satisfactory to 70-90% of the analysed 
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compounds. The repeatability of the method, ranging from 8% to 15%, presented 
better values at higher concentrations and in meat samples. The reproducibility 
ranged from 15% to 20% showing insignificant differences between 
concentrations and matrices. Accuracy calculations indicated in some cases the 
presence of matrixes interferences since some values are higher than 100%. The 
authors concluded that the method performance is clearly influenced by the 
matrix as the performance criteria are fulfilled for >90% of the compounds in 
meat, >80% in fish and >70% in egg.  
Jiménez et al. [31] developed a multi-class method for the determination of 
several families of veterinary drugs in eggs. A total of 41 antimicrobials 
(sulphonamides, diaminopyridine derivates, quinolones, tetracyclines, 
macrolides, penicillins and lincosamides) were extracted adding a solution of EDTA 
and proceeding with a pressurized liquid extraction (PLE) with a mixture of 
acetonitrile: succinic acid buffer pH=6 (1:1, v/v). No further clean-up was 
necessary. The addition of EDTA has the main goal of improving tetracyclines 
recovery competing with them for the formation of metal complexes. The final 
extracts were analysed by LC-MS/MS using a C18 column for chromatographic 
separation and elution solvents composed by 0.02% of formic acid with 1mmol-1 
of succinic acid and acetonitrile. The electrospray ionization source was operated 
in the positive mode and the acquisition was performed in MRM mode. The 
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recovery of the method ranged from 60% to 118%. Satisfactory results were 
obtained in terms of precision and the calculation of CCα and CCβ confirmed that 
this method can be used for screening and confirmation purposes. 
The interest in developing multi-detection methods for determination of 
veterinary drugs in feed is also increasing [26, 204, 205].  
Cháfer-Pericás et al. [26], presented a multi-detection method for the 
determination of tetracyclines and sulphonamides in fish and feed. The 
determination, as screening, is performed applying immune-analytical assays 
after which a confirmatory LC-MS/MS is used. For feed samples treatment a 
metabolic solution containing EDTA was used and this procedure was the same 
for both screening and confirmatory methods which turned all the process rapid 
and simple.  
Borràs et al. [204] recently reported a multi-class method for the 
determination of 55 compounds belonging to 14 families, not just antibiotics, in 
animal feed. In this method the identification and quantification is performed with 
UHPLC-MS/MS and also a simple sample preparation was developed. Samples 
were extracted with a mixture of methanol, acetonitrile and McIlvaine buffer and 
diluted before injection in the UHPLC system. Authors concluded that SPE clean-
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up did not contribute to reduce any interference from the matrix and good 
recoveries were achieved with a simpler preparation. 
Table 6 presented below summarizes some of the most important and 
recent multi-detection and multi-class methods available in the literature for the 
determination of antibiotics in animal food producing. 
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Table 6: Multi-class methods for antibiotic residue analysis in edible tissues 
Class of antibiotic analysed Matrix 
Analytical 
technique 
Limits of performance 
(μg kg-1) 
Reference 
4 Tetracyclines; 4 Quinolones; 4 Macrolides; 3 β-lactams; 4 
Sulphonamides 
muscle 
kidney 
LC-MS/MS 
LOD between: 
2.0 – 15.0 
[195] 
4 Tetracyclines; 5 Quinolones; 1 Macrolide; 1 Lincosamid; 1 
Aminoglycoside; 1 Sulphonamide; 1 Amphenicol 
honey LC-MS/MS -- [33] 
3 Tetracyclines;11 Quinolones; 10 Macrolides ; 6 β-lactams; 6 
Aminoglycosides ; 15 Sulphonamides; 3 Amphenicols 
milk UHPLC-ToF-MS CCβ according MRL [38] 
6 Tetracyclines; 14 Quinolones; 9 Macrolides ; 12 β-lactams; 23 
Sulphonamides 
muscle 
liver 
kidney 
UHPLC-ToF-MS 
LOD < 5.0 
CCα according MRL 
[207] 
4 Tetracyclines; 9 Quinolones; 4 Macrolides ; 7 β-lactams; 14 
Sulphonamides 
muscle UHPLC-MS/MS CCα and CCβ according MRL [198] 
1 Tetracycline; 3 Quinolones; 4 Macrolides; 2 Sulphonamides milk UHPLC-MS/MS 
LOD between: 
1.0 – 4.0 
[36] 
6 Tetracyclines; 14 Quinolones; 10 Macrolides; 23 β-lactams; 24 
Sulphonamides 
milk UHPLC-ToF-MS 
LOD between: 
0.5 – 25.0 
[35] 
3 Tetracyclines; 10 Quinolones; 10 Macrolides; 15 β-lactams; 8 
Aminoglycosides ; 9 Sulphonamides 
milk LC-MS/MS LOD < 3.5 [34] 
7 Tetracyclines; 14 Quinolones; 10 Macrolides; 12 Sulphonamides milk LC-MS/MS CCα and CCβ according MRL [37] 
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Class of antibiotic analysed Matrix 
Analytical 
technique 
Limits of performance 
(μg kg-1) 
Reference 
12 Quinolones; 16 Sulphonamides muscle LC-MS/MS CCα according MRL [199] 
4 Tetracyclines; 10 Macrolides; 7 β-lactams; 11 Quinolones; 15 
Sulphonamides; 2 Amphenicols 
eggs 
fish 
muscle 
UHPLC-ToF-MS CCβ according MRL [30] 
3 Tetracyclines; 4 Quinolones; 9 Macrolides; 4 β-lactams; 6 
Aminoglycosides ; 8 Sulphonamides ; 2 Amphenicols 
muscle LC-MS/MS 
LOD ranging from 
1.0 – 41.0 
[196] 
8 β-lactams; 11 Quinolones milk 
LC-MS/MS 
UHPLC-MS/MS 
CCα and CCβ according MRL [201] 
4 Tetracyclines; 5 Macrolides; 7 Penicillins; 8 Quinolones; 12 
Sulphonamides 
eggs LC-MS/MS 
CCα ranging from 
0.5 – 3.8 
[31] 
4 Tetracyclines; 6 Quinolones; 2 Macrolides; 5 Β-lactams; 6 
Sulphonamides 
fish UHPLC-MS/MS 
LOD < 15.0 
LOQ < 50.0 
[40] 
2 Quinolones; 3 Macrolides; 6 Sulphonamides; Benzathine 
(biomarker of penicillin) 
muscle UHPLC-MS/MS 
LOD ranging from: 
3.0 – 6.0 
[206] 
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CONCLUSION 
It is possible to resume some conclusions regarding the state-of-the-art in the 
field of residues analyses, specifically in the case of antibiotics in food producing animals. 
The increasingly use of liquid chromatography, either HPLC or UHPLC, combined with 
tandem mass spectrometry detection is the preferred technique in the field of 
veterinary residues analysis in complex biological samples.  
Due to the demanded EU criteria [17] for quantitative and confirmatory 
determinations, triple quadrupole is still the tool of choice, even in the cases of multi-
detection analysis, mainly because of the possibility of unequivocal identification of 
trace concentrations in complex matrixes such as biological samples.  
As for multi-detection and multi-class screening, UHPLC–ToF is becoming one of 
the techniques of choice since the combination of these two instruments provides 
enough sensitivity and selectivity for detection of a wide range of compounds. One of 
the advantages when comparing triple quadrupole instruments is the possibility of 
extraction of any high-resolution MS traces even after acquiring data. 
  Regarding sample pre-treatment, the combination of liquid extraction with 
organic solvent or buffer solution is used. However liquid-solid extraction is the most 
popular approach and solid phase extraction, mainly with C18 or hydrophilic-lipophilic 
copolymer cartridges are the selected strategies for the purpose. Frequent problems are 
found in the area while simultaneously extracting and pre-treating groups of analytes 
with different physic-chemical properties. It is rather complicated to achieve equally 
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good recoveries in all compounds especially in multi-detection and multi-class methods 
and minimizing the loss of all analytes during sample preparation while providing 
enough sensibility at the target concentration. Same compounds can establish strong 
bounds with matrices components. The high concentration of proteins in the sample can 
also be a problem. Some procedures that include protein precipitation can lead to 
analyte losses as they can be adsorbed. During sample homogenization enzymes can be 
released by the cells and promote degradation of same unstable compounds. Problems 
in chemical stability are also an important issue to take in account. Some compounds, 
as β-lactams and macrolides, are easily degraded under certain conditions of 
temperature and pH.  
Another frequent problem mentioned is related with ion suppression or enhance 
of signal owing to interferences coming from the matrices. The legislation, that in some 
cases obliges the detection at trace levels, is an additional obstacle that makes the 
veterinary residues analysis a challenge. 
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Abstract 
A multi-residue screening method for 33 antibiotics from five different families 
was employed to simultaneously determine sulphonamide, tetracycline, macrolide, 
quinolone and chloramphenicol antibiotics using ultra high pressure liquid 
chromatography tandem mass spectrometry. A simple sample preparation method was 
developed using protein precipitation, centrifugation and solid phase extraction and was 
optimized to achieve the best recovery for all compounds. The methodology was 
validated for quantitative screening methods, by evaluating the detection capability 
(CCβ), specificity, selectivity, precision, applicability and ruggedness. Precision, in terms 
of relative standard deviation, was under 21% for all compounds. Because CCβ was 
determined for screening purposes and, according to maximum residue limit, the limit 
of detection of the method was also calculated and ranged from 0.010 μg kg-1 to 3.7 μg 
kg-1. This validation provided evidence that the method is suitable to be applied in 
routine analysis for the detection of antibiotics in bovine, caprine and ovine milk. 
 
Introduction 
Antibiotics in dairy cattle are mainly used to treat mastitis, diarrhoea and 
pulmonary diseases [1]. These treatments can result in the presence of antibiotic 
residues in milk. For the consumers, the presence of such residues can be responsible 
for toxic effects, allergic reactions in individuals with hypersensitivity and can result in 
the development of resistant strains of bacteria [2-5]. The presence of antibiotic residues 
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can also be responsible for undesirable effects on the dairy industry, especially 
concerning processed food by fermentation wherein the quality of the final products 
can be seriously compromised [4]. All these concerns make the analysis of antibiotic 
residues in milk an important field of food safety to study.  
To protect consumers, regulatory agencies in the European Union published 
several official documents regulating the control of veterinary drugs in food products 
from animal origin. Council Directive 96/23/EC [6] establishes the veterinary residue 
control in food producing animals. Tolerance levels, as described by European 
Commission Regulation 470/2009/EC [7], were set for compounds that can be used for 
therapeutic purposes. Regulation 37/2010 [8] lists the pharmacologically active 
substances and their maximum residue level (MRL) in foodstuffs of animal origin, as well 
as compounds for which no MRL has been set because no hazard for public health has 
been observed.  For some non-authorized substances a minimum required performance 
limit (MRPL) was set to harmonize the analytical performance of the methods [9, 10], 
meaning that MRPL is not a concentration obtained from toxicological data, but is only 
related to the general analytical performance. For antibiotics without an MRL or an 
MPRL, a validation level (VL) was defined based on the drug characteristics of the 
respective class of compounds (table 7). 
The requirements for performance and validation of the analytical methods 
employed in the official residues control for screening and confirmatory purposes are 
described in the European Decision 2002/657/EC [9]. Microbiological and bioassay 
techniques are still used for antibiotic qualitative screening purposes [3, 4, 11-14] mainly 
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because of their low cost and simplicity; however they lack sensitivity and specificity. To 
ensure unequivocal identification, there is growing need for efficient screening methods 
that guarantee a significantly reduced number of false-positives and false-negatives. 
This efficiency can be gathered in multi-detection methods based on liquid 
chromatography (LC) coupled with tandem mass spectrometry (MS/MS) [15-19]. The use 
of ultra-high pressure liquid chromatography (UHPLC) provides the possibility of having 
short run times together with higher resolution and sensitivity, important attributes 
when running several compounds at once [20-23]. 
Several methods can be found in literature for the determination of residues of 
different antibiotic families in milk. However, for the simultaneous analysis of 
compounds of different antibiotic classes in a multi-class residue analysis, only a 
restricted number of methods are reported in the literature, mainly due to the 
difficulties related to differences in physic-chemical properties between families of 
compounds [17, 18, 20-25].  
The present work describes the development and validation of a simple and 
effective quantitative screening method by UHPLC-MS/MS for the simultaneous 
detection of 33 antibiotic compounds from sulphonamides, tetracyclines, macrolides, 
quinolones and chloramphenicol in bovine, caprine and ovine milk samples for 
application in routine analyses. 
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Table 7: MRLs and MRPL levels set by EU for milk, VL values and MRM acquisition conditions for each antibiotic 
and internal standards 
 
 
MRL 
*MRPL   
(μg kg-1)  
VL  
(μg kg-1) 
ESI 
Precursor 
ion  
Product 
ion  
Cone 
voltage  
(eV) 
Collision 
energy  
(eV) 
Tetracyclines 
chlortetracycline 100 100 + 479.3 444.2 25 20 
oxytetracycline 100 100 + 461.5 426.3 25 20 
tetracycline 100 100 + 445.5 410.3 25 20 
doxycycline - 50 + 445.5 428.2 25 18 
demethyltetracycline (IS) + 465.2 448.3 25 17 
Quinolones 
ciprofloxacin 100 100 + 332.2 288.2 35 17 
enrofloxacin 100 100 + 360.3 316.3 31 19 
marbofloxacin 75 75 + 363.3 72.1 30 20 
oxolinic acid - 25 + 262.2 216.1 30 25 
flumequine 50 50 + 262.2 202.1 30 32 
norfloxacin - 25 + 320.3 276.2 20 17 
nalidixic acid - 25 + 233.2 215.1 40 14 
danofloxacin 30 30 + 358.3 96.1 33 21 
ofloxacin - 25 + 362.1 261.3 34 26 
enoxacin - 25 + 321.2 303.2 35 18 
cinoxacin - 25 + 263.2 217.1 30 23 
lomefloxacin  (IS) + 352.2 265.3 31 22 
Macrolides 
tylosin 50 50 + 917.1 174.3 35 35 
tilmicosin 50 50 + 869.3 174.2 35 45 
erythromycin 40 40 + 734.5 158.2 25 30 
spiramycin 200 200 + 843.5 174.0 35 35 
roxithromycin  (IS) + 837.7 679.5 30 30 
Sulfonamides 
sulfadiazine 100 100 + 251.2 156.2 30 15 
sulfamethoxazole 100 100 + 254.4 156.4 30 15 
sulfadimethoxine 100 100 + 311.4 156.2 30 20 
sulfametazine 100 100 + 279.4 156.3 30 15 
sulfathiazole 100 100 + 256.4 156.3 25 15 
sulfadoxine 100 100 + 311.4 156.4 30 18 
sulfamethizole 100 100 + 271.0 156.2 25 15 
sulfapyridine 100 100 + 250.3 156.3 30 15 
sulfisoxazole 100 100 + 268.3 156.2 25 15 
sulfisomidine 100 100 + 279.4 186.3 30 16 
sulfamethoxypyridazine 100 100 + 281.2 156.2 30 15 
sulfachloropyridazine 100 100 + 285.3 92.3 30 28 
sulfaquinoxaline 100 100 + 301.3 92.2 30 30 
sulfameter  (IS) + 281.3 92.2 25 30 
Amphenicol 
chloranphenicol 0.3* 0.3 - 320.9 151.9 30 25 
chloranphenicol_d5 (IS) - 326.0 157.0 30 25 
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Materials and Methods 
Reagents, solvents and standard solutions 
All reagents and solvents used were of analytical grade with the exception of 
chemicals used for the mobile phase, which were of HPLC grade. Methanol, acetonitrile 
and formic acid were supplied by Merck (Darmstadt, Germany). All standards of 
tetracyclines, quinolones, macrolides, sulphonamides and chloramphenicol were 
supplied by Sigma-Aldrich (Madrid, Spain). The individual standards are listed in table 1. 
One internal standard for each antibiotic family was used: demethyltetracycline for 
tetracyclines, lomefloxacin for quinolones, roxithromycin for macrolides, sulfameter for 
sulphonamides, and for chloramphenicol, the fifth-deuterated (d5) form; all the internal 
standards were provided by Sigma-Aldrich. For all substances, stock solutions of 1mg 
mL-1 were prepared by weighing the appropriate amount of standard, diluting in 
methanol, and storing at less than 5ºC. Suitable dilutions were also prepared to have 
convenient spiking solutions for both the validation process and routine analysis. 
Instrumentation 
The following equipment was used for sample preparation: Mettler Toledo 
PC200 and AE100 balances (Greifensee, Switzerland), Heidolph Reax 2 overhead mixer 
(Schwabach, Germany), Heraeus Megafuge 1.0 centrifuge (Hanau, Germany), Turbovap 
Zymark Evaporator (Hopkinton, MA, USA) and Whatman Mini-Uniprep PVDF 
(polyvinylidene fluoride) 0.45 µm filters (Clifton, NJ, USA). A Xevo TQ MS – Acquity 
UHPLC system coupled to a triple quadrupole tandem mass spectrometer from Waters 
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(Milford, MA, USA) was used for chromatographic separation and mass spectrometry. 
The electrospray ion source in positive (ESI+) and negative (ESI-) mode was used with 
data acquisition in multiple reaction monitoring (MRM) mode and analysed using 
Masslynx 4.1 software (Waters). The MRM optimized conditions are presented in table 
7.  
The UHPLC system consisted of a vacuum degasser, an autosampler and a binary pump 
equipped with an analytical reverse-phase column Acquity HSS T3 2.1x100 mm with 1.8 
μm particle size (Waters). The mobile phases used were: A, formic acid 0.1% (v/v) in 
water and B, formic acid 0.1% (v/v) in acetonitrile. The gradient program used, at a flow 
rate of 0.45 mL min-1, was: 0-5 minutes from 97% A to 40% A; 5-9 minutes from 40% to 
0% A; 9-10 minutes from 0% back to 97% A; 11-12 minutes 97% A.  The column was 
maintained at 40οC, the autosampler at 10οC and the injection volume was 20 µL. 
Sample preparation 
Homogenized raw milk samples (2g) were weighed into a 20 mL glass centrifuge 
tube, the internal standard solution was added, then vortexed and allowed to stand in 
the dark for at least 10 minutes. Proteins were precipitated and antibiotics extracted 
through shaking for 20 minutes with 10 mL of acetonitrile. Following centrifugation for 
15 minutes at 3100 x g, the supernatant was transferred into a new tube and evaporated 
to dryness under a gentle stream of nitrogen. The residue was re-dissolved with mobile 
phase A (400 μL), filtered through a 0.45 µm PVDF membrane, transferred to vials and 
injected into the UHPLC-MS/MS under MRM optimized conditions for each compound. 
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Validation procedure 
The method was validated as a quantitative screening method by assessing the 
following parameters for each compound: CCβ (detection capability), specificity, 
selectivity, precision, applicability and ruggedness. In addition the limit of detection 
(LOD) was also estimated in accordance with the observed signal-to-noise ratio in the 
spiked samples. The selectivity and specificity were evaluated by analysing 20 blank milk 
samples from each different species (bovine, ovine and caprine) and the same samples 
were spiked with all the compounds at the MRL/MRPL/VL level. Along with the species 
variation, the applicability and ruggedness were shown by carrying out the analysis on 
different days and by different technicians, which also allowed the evaluation of 
precision in terms of relative standard deviation (RSD). For the compounds where an 
MRL was established, CCβ evaluation was carried out to obtain a concentration that was 
less than or equal to the regulatory MRL, and for that reason, 20 blank samples from 
each animal species were spiked with half the value of the MRL. For drugs without a 
MRL or a MPRL recommended concentration levels, a VL was defined (table 2) and the 
calculation of the CCβ was in accordance with the Regulation 2002/657/EC decision [9] 
for unauthorized compounds. The peak areas of both the analyte and the respective 
internal standard were measured, and the analyte/internal standard ratios were used 
for all determinations.  
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Results and Discussion  
To fulfil the requirements of the legislated MRLs and the control of prohibited 
substances, methods have to be specific and sensitive enough to detect low levels, 
taking into account the complexity of obtaining good recovery of all compounds with 
distinct physic-chemical properties. The main problem associated with milk extraction 
for subsequent determination of antibiotics is the high protein content. In most 
methods reported in the literature, the preparation of milk samples for residue analysis 
involves protein precipitation followed by a solid-phase extraction (SPE) through the use 
of appropriate cartridges or dispersive SPE [16, 17, 20, 21, 23]. The precipitation of proteins is 
achieved in many cases by adding a strong acid, such as trichloroacetic acid, in 
combination with a miscible organic solvent. In the present method, acetonitrile was 
added to milk to promote the precipitation of proteins, and was also used as the 
extracting solvent. Protein precipitation was effective and a clean extract was obtained, 
which was demonstrated by the results obtained: no signal suppression or enhancement 
was observed and no interferences in the MS/MS detection that could compromise the 
determination. It can be assumed that the matrix components responsible for possible 
interferences were removed, such as proteins, fats, and carbohydrates. Although the 
use of SPE prior to MS/MS measurement can have the advantage of decreasing the 
effects of ion suppression caused by matrix interferences, it can also compromise the 
individual recoveries due the fact that each of the antibiotic classes, as well as antibiotics 
within each class, has different physic-chemical properties. All these aspects must be 
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taken into account when selecting the appropriate SPE cartridge, especially as it can be 
difficult to find one with multi-class selectivity.  
A procedure using a polymeric sorbent SPE cartridge, composed by an OASIS® 
(Waters) hydrophilic-lipophilic balance modified polymer, after protein precipitation 
and liquid-liquid extraction with acetonitrile was described previously [16, 17, 23]. Although 
this solid phase has very broad selectivity for polar compounds, after comparing the 
results with and without this step, it was considered unnecessary since better recoveries 
could be achieved with only liquid-liquid extraction. The principal advantage of the 
present method, when comparing with methods reported by Turnipseed et al. (2008), 
Bohm, et al. (2009) and Junza, et al. (2011) [16, 17, 23] is that the present extraction became 
easier to handle and, without the use of cartridges, the costs can be significantly 
reduced, which is a factor that must be taken into account when there are a large 
number of samples to be routinely analysed for screening purposes. The use of 
acetonitrile as both the agent of protein precipitation and also as the extracting solvent 
yields a process even more simple and cost effective. The celerity in obtaining results is 
one of the fundamental characteristics of screening methods. The use of equipment 
with good performance and high sensitivity, such as a UHPLC-MS/MS, enables sample 
preparation to be simplified without compromising the detection capability of the 
method. The high sensitivity of the equipment enables detection of compounds that are 
positively ionised, and chloramphenicol which is negatively ionised, in the same run. 
Chloramphenicol, being a banned substance, has to be detected at very low 
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concentrations, below its corresponding MRPL at 0.3 μg kg-1 which was successfully 
achieved (LOD = 0.06 μg kg-1: table 8). 
Table 8: The principal parameters of validation 
 LOD (μg kg-1) CCβ (μg kg-1) RSD (%) 
chlortetracycline 0.20 50.0 11 
oxytetracycline 0.20 50.0 9 
tetracycline 0.10 50.0 8 
doxycycline 0.30 1.5 14 
ciprofloxacin 0.20 50.0 21 
enrofloxacin 0.02 50.0 8 
marbofloxacin 0.10 35.0 19 
oxolinic acid 0.20 0.4 9 
flumequine 0.04 25.0 4 
norfloxacin 0.20 4.7 15 
nalidixic acid 0.30 0.4 9 
danofloxacin 0.05 15.0 14 
ofloxacin 3.70 4.1 17 
enoxacin 3.00 3.2 16 
cinoxacin 0.80 1.0 8 
tylosin 0.01 25.0 11 
tilmicosin 0.10 25.0 23 
erythromycin 0.10 20.0 4 
spiramycin 0.10 100.0 17 
sulfadiazine 2.00 50.0 15 
sulfamethoxazole 0.10 50.0 7 
sulfadimethoxine 0.20 50.0 13 
sulfametazine 0.10 50.0 5 
sulfathiazole 1.00 50.0 10 
sulfadoxine 0.20 50.0 5 
sulfamethizole 0.20 50.0 12 
sulfapyridine 1.00 50.0 12 
sulfisoxazole 0.10 50.0 7 
sulfisomidine 0.60 50.0 13 
sulfamethoxypyridazine 0.10 50.0 17 
sulfachloropyridazine 0.10 50.0 9 
sulfaquinoxaline 0.10 50.0 5 
chloranphenicol 0.06 0.1 15 
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To achieve maximum sensitivity for all compounds, MS/MS conditions (such as 
ion spray voltage, de-solvatation temperature, gas flow and collision conditions) were 
optimized by direct infusion into the detector of standard solutions and the principal ion 
transition was selected for each analyte. Table 7 presents the m/z ion transition 
monitored for screening and the associated collision energy. The use of an acidic mobile 
phase adjusted with 0.1% of formic acid promoted positive ionization, which improved 
the detection of most compounds since only chloramphenicol is negatively ionised.  
In terms of chromatographic optimization, several gradient profiles were studied 
to improve peak separation and minimize the run time. Acetonitrile was shown to be 
better that methanol because of maximized sensitivity and resolution, especially when 
acidified with formic acid. The gradient described above allows the determination of all 
compounds in 10 minutes. One of the advantages of working with UHPLC columns 
consisting of a smaller particle size is the possibility of having high efficiency in peak 
separation, sharp peaks, and also a reduction in run time when compared with a 
common HPLC column, in terms of particle size. Chromatograms obtained for a spiked 
sample with all compounds at the validation levels (VL) are shown in figure 10. Each peak 
is characteristic of the respective antibiotic, demonstrating the good performance of the 
method in terms of detection, as well as for optimal chromatographic separation. 
The main requisite for a reliable screening method is to detect unauthorized 
substances below the regulatory limits (MRL/MRPL) or at a level as low as possible, 
minimizing false-negative results. Therefore a method has to be fully validated in 
accordance with the legislation [8, 9]. At the expected retention time for all the target 
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compounds, no interfering peaks were observed in any of the analysed samples from 
the three different species. Additionally the identification of all compounds were 
effective in all samples from the different species, according the criteria of Regulation 
2002/657/EC decision [9], in all the 20 spiked samples at the VL. No false-negative results 
were observed since all analytes were detected at the expected retention time. The 
ruggedness of the method was assessed when carrying out analysis of both the blank 
and the spiked samples of milk from different animal species, using different technicians 
and with inter-day analysis. No significant variation was observed. 
The results for precision, quantified as RSD% (table 8), showed the precision of 
the method. No results were obtained above 21% which represents a significantly lower 
value when compared with the criteria value accepted by the Horwitz equation [9]. 
Although it is stated in Decision 2002/657/EC [9] that CCβ is the smallest content 
of the substance that may be detected, identified and/or quantified in a sample with an 
error probability of β=5%, it is considered to be the concentration above which the 
sample should be re-analysed by a confirmatory method. It is also stated that CCβ must 
be less than or equal to the regulatory limit (MRL/MRPL) for screening methods. For this 
reason, and for antibiotics with MRL legislated, ½ MRL was adopted as the CCβ value. 
For those without MRL, the calculation was carried out by a matrix-matched calibration 
curve according to Decision 2002/657/EC for unauthorized substances as described by 
Kaufmann (2009) [25]. The LOD was also evaluated to establish the sensitivity of this 
method and was defined as the lower concentration of the analyte, calculated by 
multiplying the mean value of the signal-to-noise ratio of 20 blank samples by three. All 
 168 
the LOD values for the measured compounds were found to be significantly lower than 
the MRL/MRPL/VL values. The validation values are presented in table 3. 
 
 
 
Figure 10: Liquid chromatography multiple reaction monitoring chromatograms of the antibiotics detected in a 
milk sample spiked at the corresponding validation level 
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Conclusions 
A rapid and reliable multi-residue and multi-class method for simultaneous 
detection of 33 antibiotics, from five different families was developed and validated for 
quantitative screening of milk samples. The validation results showed the applicability 
for routine analysis of bovine, caprine and ovine milk in accordance with the 
requirements established in Decision 2002/657/EC [9]. The optimized extraction 
procedure is a simple and efficient method without the need for an SPE step, thus 
reducing the handling time and associated costs, and allowing a larger the number of 
samples analysed in one day.  
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Abstract 
This paper describes a method for the determination of 41 antibiotics from 7 
different classes in gilthead sea bream (Sparus aurata) by ultra-high performance liquid 
chromatography with tandem mass spectrometry (UHPLC-MS/MS). Sulphonamides, 
trimethoprim, tetracyclines, macrolides, quinolones, penicillins and chloramphenicol 
were simultaneously determined. Fourteen procedures for sample treatment were 
tested and an extraction with acetonitrile and ethylenediaminetetraacetic acid was 
found to be the best option. The methodology was validated in accordance with 
Decision 2002/657/EC. Precision in terms of relative standard deviation (RSD) was under 
17% for all compounds, and the recoveries ranged from 92% to 111%. CCα and CCβ were 
determined according to the maximum residue limit or the minimum required 
performance limit, when necessary. The validation provided evidence that the method 
was suitable for application in routine analysis for the detection and confirmation of 
antibiotics in muscle of gilthead sea bream, an important and intensively produced fish 
in aquaculture. 
 
Introduction  
Aquaculture is described as the farming of marine or freshwater food (fish, 
molluscs, crustaceans and aquatic plants) under specific conditions, which include the 
use of controlled feed, medications and breeding [1, 2]. The changes in food habits in the 
last decades and the increasing demand for fish as one of the most consumed products 
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in the world made aquaculture an emergent industry [3 – 5]. According to Food and 
Agricultural Organization of the United Nations (2004) [6] this sector is continuously 
growing in many regions across the world since seafood products constitute an 
important food supply [7] and, consequently, are of huge economic importance. 
Although fisheries production is now a stabilized segment, it is expected that 
aquaculture will achieve the level of a fast-growing animal food-producing sector 
comparable to terrestrial farming [8]. 
One of the most significant constraints in aquaculture development is bacterial 
disease that can be responsible for serious economic losses and also compromise the 
welfare of the seafood [9, 10]. To treat and prevent possible infections, the use of 
antibiotics is widely implemented as medicated feed or by adding the drugs directly into 
the water, a process known as bath treatments [4, 5]. This last method is the most popular 
route of administration, but to achieve the same results as those obtained through oral 
administration of medicated feed, higher quantities of antibiotics are required. 
Moreover, it is known that the use of antibiotics is associated with the illegal practice of 
stimulating animal growth. For this purpose, the administration in low concentrations 
results in an increase of weight gain and enhancement of the feed conversion efficiency 
[1].  
The abusive use of these compounds and/or the disregard for the withdrawal 
period after drug administration may increase the presence of antibiotics in the aquatic 
environment and also of residues in edible tissues with associated health risks for 
consumers [11, 12]. Such residues can be responsible for toxic effects, allergic reactions in 
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individuals with hypersensitivity and can also result in the development of resistant 
strains of bacteria [1, 13, 14]. These concerns make the analysis of antibiotic residues in fish 
an important field in food safety [15, 16]. For these reasons and in order to control abusive 
situations, European regulatory agencies have published several official documents to 
keep these substances and their administration under control. Tolerance levels for 
permitted veterinary drugs were established as MRLs in foodstuff of animal origin and 
listed in the European Commission Regulation 37/2010 [17, 18]. For non-authorized 
substances no tolerance levels are set, but in some cases, in order to harmonize the 
analytical performance of the methods, a minimum required performance limit (MRPL) 
has been set [19, 20]. The MRPL level is not a concentration obtained from toxicological 
data but is only related with analytical method performance. The requirements 
concerning the performance and validation of the analytical methods employed in 
official residues control, for screening and confirmatory purposes, are described in 
Decision 2002/657/EC [19].  
Sensitive and specific analytical methodologies are required to perform the 
necessary control of the presence of antibiotic residues and ensure that the MRL levels 
are respected, and to estimate the presence of any non-authorized compound. Despite 
all these requirements, microbiological and bioassay techniques are still used for 
antibiotic qualitative screening, mainly due to their low cost and simplicity. On the other 
hand, such methods lack sensitivity and specificity, thus compromising the mandatory 
unequivocal identification [21, 22]. To avoid situations of false-positive and false-negative 
results, the concern with efficient screening methods is increasing and HPLC technology 
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coupled with tandem mass spectrometry (LC-MS/MS) is the technique of choice for 
veterinary residues analysis in biological samples [2, 4, 15, 16, 23, 24]. Recently, the use of 
ultra-high performance liquid chromatography (UHPLC) showed several advantages, 
when compared with HPLC in terms of resolution, sensitivity and also in minimizing the 
time of analysis which is an important feature when running numerous samples in 
routine laboratories [22]. It is also important to state that minimizing the time of analysis 
provides the possibility of reducing solvent consumption representing not only less 
solvent consumption and thus fewer costs, but also the reduction of laboratory 
environmental footprint concerned with the toxicity of mobile phases. 
Regarding the most frequently administrated and analysed antibiotics in 
biological samples originating in aquaculture, quinolones, amphenicols, tetracyclins, 
penicillins, sulphonamides, macrolides and aminoglycosides should be considered as 
target compounds [2, 5]. Overviews on the most efficient analytical strategies applied for 
the determinations of antibiotics in fish were summarized by several authors [2, 4], 
providing information on HPLC methods for each separate group of compounds. Only a 
limited number of publications are available that simultaneously present the 
determination of several classes of antibiotics in fish muscle, mainly due to constraints 
related to the differences in physic-chemical properties between families of compounds 
[23]. Some authors developed methods grouping a few compounds: Cháfer-Pericás et al. 
(2011) [16] developed an LC-MS/MS method to determine sulphonamides and 
tetracyclines; Schneider et al. (2007) [26] determined tetracyclines and quinolones by 
HPLC-Fluorescence; Romero-González, et al. (2007) [27] developed a method for 
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determination of five compounds from quinolones (oxilinic acid, flumequine), 
tetracyclines (oxytetracycline), sulphonamides (sulfadiazine) and trimethoprim in fish 
muscle and skin by LC-MS/MS; Dasenaki and Thomaidis (2010) [28] determined 
sulphonamides and tetracyclines by UHPLC-MS/MS; Evaggelopoulou and Samanidou 
(2013) [29] determined penicillins and amphenicols by HPLC- Photodiode Array Detector; 
Gbylik et al. (2013) [25] developed a method for the determination of 34 antibiotics in 
fish by LC-MS/MS; and Lopes et al., (2012) [22] presented a method that comprises 32 
compounds from which 25 antibiotics belonging to the macrolides, penicillins, 
sulphonamides and tetracyclines analysed by UHPLC-MS/MS, even though it does not 
include amphenicols and some quinolones determined in this paper. 
The present work describes the development and validation of a screening and 
confirmatory method by UHPLC-MS/MS for the simultaneous detection of 41 antibiotics 
from sulphonamides, tetracyclines, macrolides, quinolones, penicillins, chloramphenicol 
and trimethroprim in gilthead sea bream (Sparus aurata) from aquaculture production 
to be applied in routine analyses.  
 
Materials and Methods 
Chemicals and reagents 
All reagents used were of analytical grade with the exception of solvents used 
for mobile phase, which were HPLC grade. Methanol, acetonitrile and formic acid were 
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supplied by Merck (Darmstadt, Germany). Ethylenediaminetetraacetic acid (EDTA) was 
purchased from Sigma-Aldrich (Madrid, Spain). All standards of tetracyclines, 
quinolones, macrolides, sulphonamides, penicillins, chloramphenicol and trimethoprim 
were acquired from Sigma-Aldrich. The internal standards used were 
demethyltetracycline for tetracyclines, lomefloxacin for quinolones, roxithromycin for 
macrolides, sulfameter for sulphonamides and for trimethoprim, penicillin V for 
penicillins and for chloramphenicol, d5-chloramphenicol; all the internal standards were 
provided by Sigma-Aldrich.  
For all substances, stock solutions of 1 mg.mL-1 were prepared with an accurate 
amount of standard weighed, corrected for purity and presence of salt forms, and 
diluted in the appropriated solvent. Dilutions of 10 μg.mL-1, 1 μg.mL-1 (for all compounds 
and corresponding internal standards) and 0.02 μg.mL-1 (for chloramphenicol and its 
isotope), were prepared in order to have convenient spiking solutions for both the 
validation process and routine analyses depending on the tolerance concentration 
(MRL/MRPL) and the validation level (VL). All the standard solutions were stored at 
below 5°C during 1 month. Although no further experiences of stability were taken, it 
was observed that during 1 month the compounds were stable at below 5°C. 
 
Instrumentation 
During sample preparation the following equipment was used: Mettler Toledo 
PC200 and AE100 balances (Greifensee, Switzerland), Heidolph Reax 2 overhead mixer 
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(Schwabach, Germany), Heraeus Megafuge 1.0 centrifuge (Hanau, Germany), Turbovap 
Zymark Evaporator (Hopkinton, MA, USA) connected with a nitrogen generator (purity 
99.9995%) Peak Scientific (Frankfurt, Germany) and Whatman Mini-Uniprep PVDF 
(polyvinylidene fluoride) 0.45 µm filters (Clifton, NJ, USA).  
The analytical instrument used for chromatographic separation and MS 
detection consisted of an UHPLC system coupled to a triple quadrupole tandem mass 
spectrometer: Xevo TQ MS – Acquity UHPLC system (Waters, Milford, MA, USA). The 
UHPLC system consisted of a vacuum degasser, an autosampler and a binary pump 
equipped with an analytical reverse-phase column Acquity HSS T3 2.1x100 mm, 1.8 μm 
particle size. Chromatographic parameters were optimized starting with the choice of 
the best option for the mobile phase from basic to acidic solvents (ammonium format 
and formic acid solutions) at different concentrations and varying the flow rate between 
300 and 600 μL.min-1. The mobile phases selected were: (A) formic acid 0.1% in water 
and (B) acetonitrile. The gradient programme used, at a flow rate of 0.45 mL.min-1, was: 
0-5 minutes from 97% (A) to 40% (A); 5-9 minutes from 40% to 0% (A); 9-10 minutes 
from 0% back to 97% (A); 11-12 minutes 97% (A). The column was maintained at 40°C, 
after testing a range from 25 ºC to 45 ºC, the autosampler at 10°C, to keep samples 
refrigerated before injection and guarantee the stability of compounds in the extract, 
and an injection volume was 20 µL. The volume selected was previously studied for 
individual methods of related compounds.  The electrospray ion source in positive (ESI+) 
and negative (ESI-) mode was performed with data acquisition in MRM. Data acquisition 
was accomplished with Masslynx 4.1 software (Waters).  
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Sample preparation 
Homogenized gilthead sea bream muscle (2 g) taken from the dorsal area was 
weighed into a 20 mL glass centrifuge tube, the internal standard solutions were added 
in accordance with the VL of each class of compounds (50μL of d5-chloramphenicol 0.02 
μg.mL-1 solution and 20μL of each one of the other internal standards with 10 μg.mL-1), 
vortex mixed and allowed to stand in the dark for at least 10 minutes. Afterwards, 14 
different extractions were tested, some including an SPE step. The different extraction 
procedures tested and their numbers were as follow: 
1. Simple solvent extraction with 10 mL of acetonitrile; 
2. Simple solvent extraction with 10 mL of acetonitrile and 1 mL of 0.1M EDTA; 
3. Simple solvent extraction with 10 mL of methanol; 
4. Simple solvent extraction with 10 mL of methanol and 1 mL of 0.1M EDTA; 
5. Simple solvent extraction with 10 mL of acetonitrile:methanol (50:50, v/v); 
6. Simple solvent extraction with 10 mL of acetonitrile:methanol (50:50, v/v) and 1 
mL of 0.1M EDTA; 
7. Simple solvent extraction with 10 mL of water:acetonitrile (50:50, v/v), followed 
by SPE with HLB 200 mg; 
8. Simple solvent extraction with 10 mL of water:acetonitrile (50:50, v/v) and 1 mL 
of 0.1M EDTA, followed by SPE with HLB 200 mg; 
9. Simple solvent extraction with 10 mL of water:methanol (50:50, v/v), followed 
by SPE with HLB 200mg; 
10. Simple solvent extraction with 10 mL of water:methanol (50:50, v/v) and 1 mL of 
0.1M EDTA, followed by SPE with HLB 200 mg; 
11. Simple solvent extraction with 10 mL of water:acetonitrile (50:50, v/v), followed 
by SPE with C18 1 g; 
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12. Simple solvent extraction with 10 mL of water:acetonitrile (50:50, v/v) and 1 mL 
of 0.1M EDTA, followed by SPE with C18 1 g; 
13. Simple solvent extraction with 10 mL of water:methanol (50:50, v/v), followed 
by SPE with C18 1g; 
14. Simple solvent extraction with 10 mL of water:methanol (50:50, v/v) and 1 mL of 
0.1M EDTA, followed by SPE with C18 1 g. 
A simple solvent extraction was performed by shaking the sample with the solvent 
using a Reax shaker for 20 minutes followed by centrifugation for 15 minutes at 3100 g 
that was demonstrated to be sufficient in obtaining clear extracts. The supernatant was 
transferred into a new tube and, in cases when SPE was performed, applied to the 
preconditioned cartridges with methanol (3 mL) and water (3 mL). The elution of 
compounds was performed with acetonitrile (5 mL). The eluates and the supernatants 
of the remaining samples were evaporated to dryness under a gentle stream of nitrogen 
at 40οC. The residue was redissolved with mobile phase A (400 μL), filtered through a 
0.45 µm PVDF Mini-uniprep TM, transferred to vials and injected into the UHPLC-MS/MS 
under MRM optimized conditions for each compound (table 9). These conditions were 
obtained after tuning each analyte of interest by combined infusion of 10 μg.mL-1 of 
standards and mobile phase (composition of the first step of the gradient). 
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Table 9: MRM acquisition conditions for each antibiotic and for the internal standards (IS) used 
 
 
 
ESI 
Precursor 
ion (m/z) 
Product ions 
(m/z) 
Cone 
voltage 
(V) 
Collision 
energy 
(eV) 
Sulfonamides 
sulfapyridine + 250.3 156.3/92.3 30 15 
sulfadiazine + 251.2 156.2/92.2 30 15 
sulfamethoxazole + 254.4 156.4/92.2 30 20 
sulfathiazole + 256.4 156.3/92.3 25 15 
sulfisoxazole + 268.3 156.2/113.2 25 15 
sulfamethiazole + 271.0 156.2/108.1 25 15 
sulfisomidine + 279.4 186.3/124.4 30 16 
sulfamethazine + 279.4 156.3/124.5 30 15 
sulfamethoxypyridazine + 281.2 156.2/92.2 30 15 
sulfachloropyridazine + 285.3 92.3/156.3 30 28 
sulfadoxine + 311.4 156.4/92.3 30 18 
sulfadimethoxine + 311.4 156.4/92.3 30 20 
sulfanilamide + 173.2 92.1/156.2 30 25 
sulfaquinoxaline + 301.3 92.2/156.3 30 30 
sulfameter (IS) + 281.3 92.2 25 30 
 trimethoprim + 291.5 230.3/261.3 25 23 
Tetracyclines 
tetracycline + 445.5 410.3/427.3 25 20 
doxycycline + 445.5 428.2/410.3 25 18 
oxytetracycline + 461.5 426.3/443.3 25 20 
chlorotetracycline + 479.3 444.2/462.1 25 20 
demethyltetracycline (IS) + 465.2 448.3 25 17 
Macrolides 
erythromycin + 734.5 158.2/576.5 25 30 
spyriamicin + 843.5 174.0/540.3 35 35 
tilmicosin + 869.3 174.2/156.1 35 45 
tylosin + 917.1 174.3/772.5 35 35 
roxithromycin (IS) + 837.7 679.5 30 30 
Quinolones 
nalidixic acid + 233.2 215.1/187.1 40 14 
flumequine + 262.2 202.1/244.2 30 32 
oxolinic acid + 262.2 216.1/244.2 30 25 
cinoxacin + 263.2 217.1/245.2 30 23 
norfloxacin + 320.3 276.2233.2 20 17 
enoxacin + 321.2 303.2/234.2 35 18 
ciprofloxacin + 332.2 288.2/245.2 35 17 
danofloxacin + 358.3 96.1/314.3 33 21 
enrofloxacin + 360.3 316.3/245.2 31 19 
ofloxacin + 362.1 261.3/318.2 34 26 
marbofloxacin + 363.3 72.1/320.2 30 20 
lomefloxacin (IS) + 352.2 265.3 31 22 
Penicillins 
penicillin G + 335.1 176.0/160.0 30 25 
ampicillin + 350.4 106.3/160.4 25 20 
amoxicillin + 366.3 160.3/114.4 25 20 
oxacillin + 402.0 243.0/160.0 30 20 
nafcillin + 415.0 199.0/171.0 30 25 
dicloxacillin + 470.0 311.0/160.0 30 25 
penicillin V (IS) + 351.0 160.2 25 25 
Amphenicol 
chloramphenicol - 320.9 151.9/193.9 30 25 
chloramphenicol-d5 (IS) - 326.0 157.0 30 25 
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Validation 
The validation was based on the requirements of the EU regulation 2002/657 [19] 
which describes the performance criteria for analytical methods and also the 
parameters that might be evaluated during the validation process. According to these 
requirements, selectivity, specificity, recovery, repeatability, reproducibility, decision 
limit (CCα) and detection capability (CCβ) were determined. Selectivity and specificity 
were demonstrated by analysing 20 blank samples of gilthead sea bream from different 
origins to exclude the presence of any possible interference in the identification of the 
target antibiotics, and 20 blank samples of gilthead sea bream spiked at the VL in order 
to prove the identification capability of the method. Calibration curves were assembled 
with five concentration levels: 0.5 x VL, 1.0 x VL, 1.5 x VL, 2.0 x VL and 3.0 x VL and carried 
out in three different days and with different operators. In each day six replicates of the 
0.5 x VL, 1.0 x VL and 1.5 x VL were executed in order to calculate repeatability, 
reproducibility and recovery. CCα and CCβ were determined according to the following 
equations [19]: 
𝐶𝐶𝛼 = 𝜇𝑁 + 2.33 × 𝜎𝑁    (Equation 1, for compounds without MRLs) 
𝐶𝐶𝛼 = 𝑀𝑅𝐿 + 1.64 × 𝜎𝑀𝑅𝐿    (Equation 2, for compounds with established MRLs) 
𝐶𝐶𝛽 = 𝐶𝐶𝛼 + 1.64 × 𝜎𝑉𝐿  (Equation 3) 
Where μN is the mean of noise amplitude of 20 blank samples; σN is the standard 
deviation of the noise amplitude of 20 blank samples at the retention time of the target 
antibiotic; σMRL and σVL is the standard deviation at the MRL or VL level in the 20 spiked 
 187 
blank samples at that level. According to Decision 2002/657/EC [19], the use of internal 
standard in MS methods is mandatory to fulfil the criteria of identification that was 
based on the relative retention time related to the internal standard. For all calculations 
the peak areas of both the analytes and correspondent internal standard were 
measured and the analyte/internal standard area ratios determined. Internal standards 
were chosen in accordance with their similar physic-chemical behaviour with the 
antibiotics monitored and for that they were studied and selected before validation.  
 
Results and Discussion 
While developing a multi-detection and multi-class method, the sample 
preparation is often the most critical step as it is important to ensure good values for 
recovery for as many compounds as possible. For recovery correction and to control 
possible matrix effects, internal standards were selected for each group of compounds. 
The selection was based on their similarities with the compounds of interest, meaning 
that they should, as much as possible, be equally affected by the same fluctuations 
during extraction procedure, ionization efficiency, detection response and 
chromatographic behaviour. Thereby, quantification by matrix-based calibration curve 
using internal standards allows one to monitor the efficiency of the extraction procedure 
and also to correct possible matrix effects. Nevertheless, several procedures for sample 
treatment were tested, combining a simple solvent extraction and SPE with different 
extraction solvents and two solid phase sorbents: HLB (hydrophilic and lipophilic balance 
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modified polymer) and C18. The choice of these solvents and solid-phase sorbents was 
based on the affinities and polarities of the target compounds. In fact, HLB cartridges 
are considered to be of generically used for sample purification in the detection of 
veterinary drugs [30]. Kinsella et al., 2009 [39], also stated that acetonitrile, methanol and 
ethyl acetate are the preferred organic solvents in such methods. Table 10 presents the 
absolute recoveries (recoveries are not corrected by the internal standard and obtained 
with spiked blank samples) calculated for each compound in each procedure. The main 
purpose of these experiments was to evaluate the real impact/recovery that each 
procedure has in all compounds in order to select the best option possible. In table 5, 
absolute recoveries below 15% are highlighted (in bold) indicating that the extraction is 
not suitable for some compounds. Note that these cases are almost all related to 
procedures in the SPE step. Generally, this step is applied as a pre-concentration step of 
analytes and to obtain cleaner extracts due to the high efficiency of SPE. Two different 
SPE cartridges were tested in order to determine which provided the best specificity for 
the target compounds. Reverse phase C18 were compared with polymeric HLB, specific 
for compounds with high polarity. The use of hydrophilic and lipophilic balance-modified 
polymers grants the retention necessary to retain those analytes proving to be the 
better option when compared to the C18 cartridges. Nevertheless, for penicillins and 
tetracyclines, enhanced results were achieved without SPE step. The addition of a 
chelating agent (EDTA) gives a better performance for tetracyclines, macrolides and 
chloramphenicol. In the particular case of tetracyclines it is known that these 
compounds can form complexes with the bi- and trivalent cations present in the sample 
extraction solution which can lead to significant losses of compounds. According to 
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these results the extraction procedure that better fits all compounds was methodology 
number 2, simple solvent extraction with acetonitrile and EDTA, without the SPE step 
due to the overall better recoveries. Acetonitrile was showed to be more efficient for a 
higher number of compounds when compared with methanol or even a combination of 
both solvents. Nonetheless, for some compounds, the recoveries obtained are still very 
low including sulfanilamide with 15% and sulfaquinoxaline with 27%. Despite that, at 
the MRL concentrations and half of that amount the identification of these compounds 
was assured with the precision required in legislation, which was proved during 
validation. 
The elimination of SPE cartridges in the present methodology diminishes 
drastically the cost associated and allows a higher number of samples to be processed 
in a day. In conclusion, sample preparation included extraction of the sample with 10 
mL of acetonitrile and 1mL of a 0.1M EDTA solution during 20 minutes. After 
centrifugation the extract was evaporated under nitrogen at 40 ± 2oC. Dissolution with 
400 μL of the mobile phase is followed by UHPLC-MS/MS analysis. Additionally, several 
other parameters were optimized: the mobile phase, flow rate, gradient steps and 
ionization conditions. Basic and acidic mobile phases were tested (ammonium format 
and formic acid solutions) at different concentrations. It was observed that the 
ionization was more effective and reproducible in an acid medium and the optimal 
concentration of formic acid was adjusted to 0.1%. The flow rate was tested from 300 
to 600 μL.min-1 and also the temperature of the column from 25oC to 45oC.  
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Table 10: Absolute recoveries (expressed as %) of the target antibiotics for the 14 extractions procedures tested 
Method number  
 
Antibiotics 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
sulfapyridine 72 71 54 52 65 53 30 37 66 72 34 37 30 29 
sulfadiazine 73 73 51 49 65 51 15 22 57 48 18 22 15 15 
sulfamethoxazole 53 59 40 40 50 42 27 59 47 65 23 69 33 54 
sulfathiazole 62 61 42 44 56 43 27 39 62 68 27 33 25 24 
sulfisoxazole 48 55 22 43 53 42 3 40 21 58 12 48 24 39 
sulfamethiazole 57 62 39 40 55 42 8 32 44 54 12 32 23 30 
sulfisomidine 60 56 48 47 56 48 11 14 63 70 19 22 24 23 
sulfamethazine 70 74 59 61 74 59 41 60 79 81 57 67 54 54 
sulfamethoxypyridazine 69 73 57 57 69 55 41 65 69 71 56 65 47 52 
sulfachloropyridazine 46 54 39 40 49 38 22 58 52 59 29 56 28 41 
sulfadoxine 64 73 59 59 72 57 49 80 74 77 57 80 46 70 
sulfadimethoxine 38 48 30 32 39 29 51 53 57 62 69 82 73 67 
sulfanilamide 17 15 8 9 9 7 9 8 9 12 8 7 5 5 
sulfaquinoxaline 23 27 17 21 24 19 26 35 43 46 41 69 60 56 
trimethoprim 63 61 39 42 47 45 21 14 61 65 31 28 52 46 
tetracycline 55 84 23 80 56 79 6 13 13 99 1 1 5 12 
doxycycline 36 52 19 40 44 39 6 25 1 85 0 0 0 0 
oxytetracycline 36 66 20 52 42 55 5 10 12 83 6 5 8 17 
chlorotetracycline 30 55 9 42 28 39 3 20 0 75 1 0 0 2 
erythromycin 49 66 79 75 85 68 42 87 101 79 0 4 5 13 
spyriamicin 5 51 46 49 16 13 20 8 41 53 0 15 3 27 
tilmicosin 36 52 105 84 64 42 71 98 77 59 0 1 0 13 
tylosin 8 88 89 76 39 41 89 86 111 115 43 19 83 65 
nalidixic acid 51 72 56 66 60 59 40 63 67 71 8 16 9 18 
flumequine 34 48 32 43 37 39 50 56 67 71 15 27 17 29 
oxolinic acid 70 87 65 76 80 76 59 83 75 86 16 31 18 33 
cinoxacin 73 83 71 84 94 92 12 24 49 90 43 33 36 33 
norfloxacin 74 82 51 73 80 83 9 14 45 87 1 14 7 25 
enoxacin 70 74 45 65 73 76 8 11 38 71 0 11 5 22 
ciprofloxacin 65 72 43 62 71 67 8 14 36 74 0 10 4 20 
danofloxacin 104 104 68 94 96 99 18 23 71 112 0 7 1 21 
enrofloxacin 91 91 61 73 82 81 26 25 68 94 0 1 0 7 
ofloxacin 74 76 52 63 71 68 11 12 59 80 0 7 1 18 
marbofloxacin 79 78 56 68 75 74 10 12 63 86 0 12 3 22 
penicillin G 33 45 51 51 42 45 2 1 11 4 1 3 10 10 
ampicillin 47 51 50 50 61 53 4 4 21 9 11 10 41 34 
amoxicillin 35 40 52 57 48 58 1 5 15 7 11 10 19 13 
oxacillin 41 50 46 40 45 31 2 8 10 9 5 4 12 9 
nafcillin 30 45 32 36 41 30 6 11 9 10 3 6 8 11 
dicloxacillin 41 51 49 42 48 26 7 9 10 9 5 4 15 10 
chloramphenicol 67 108 52 109 114 107 35 113 38 130 104 191 118 97 
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The chromatographic conditions were optimized in order to have the better 
efficiency in peak separation (resolution between compounds), peak shape (in terms of 
symmetry) along with short run time. The conditions described above allowed the 
determination of all 41 compounds in less than 10 minutes. The ideal MS/MS conditions 
were obtained by direct infusion into the detector of each standard solution. To control 
possible interferences related with the presence of ionic bonds of antibiotics in salt 
form, the infusion was performed combined with the mobile phase in the composition 
of the first step of the gradient. Formic acid causes the cleavage of such bonds 
guaranteeing the necessary intensities of the molecular ion and consequently its total 
fragmentation. Thus, two ion transitions were selected for each compound (table 9) to 
fulfil the identification criteria demanded in the Decision 2002/657 [19]. The acidified 
mobile phase (0.1% of formic acid) promotes the positive ionization, which improved 
the detection of almost all compounds since only chloramphenicol is ionised in negative 
mode.  
The method was validated in accordance with the European Commission [19] 
which establishes performance criteria for the methods and the procedures for their 
validation. Selectivity and specificity were demonstrated as described above and the 
identification of all compounds were effective [19] in all spiked samples without any false-
negative result. 
The results for the precision, in terms of repeatability and reproducibility as the 
RSD, recovery, CCα and CCβ are summarized in table 11. Regarding repeatability, the 
higher value obtained was for sulfaquinoxaline with 15%, while the remaining 
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compounds were below that value. For reproducibility, the worst case was for 
dicloxacillin with 17% variation. All these values are below the limits defined in European 
Commission Decision [19]. Recovery was calculated as a ratio between the determined 
concentration and the real concentration. The range values obtained were between 92 
and 111% falling into the accepted range [19]. These sulphonamide-spiked recoveries 
presented the higher bias values when compared with the other antibiotic classes. 
However, the obtained values cannot exceed the level calculated by the Horwitz 
equation [19]. 
CCα and CCβ were determined according to the equations described above 
(equation 1, 2 and 3) depending on whether or not the MRL is established. As can be 
seen in table 3, compounds without tolerance level have their CCα and CCβ closer to the 
LOD of the method, although in the other cases these concentrations are always above 
MRL. 
One of the major improvements achieved by the current method relates to the 
large number of antibiotic families analysed and of monitored compounds. A limited 
number of publications reported methods for the simultaneous analysis of different 
antibiotics in fish samples. In comparison with the present method (41 compounds from 
seven different groups) the most recent method for screening and confirmation of 
antibiotics in fish was reported by Lopes et al. (2012) [22], where 32 compounds were 
monitored but only 25 corresponded to antibiotics. Aside from this, repeatability (< 20%) 
and reproducibility (< 30%) were in general similar or better that those currently 
reported, while recoveries were more scattered (69-125%). Other multi-detection 
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methods reported are mainly for the determination of a more limited number of 
compounds (fewer than 22) [15, 16, 26-29] with the majority contemplating only two 
families.  As described above, the most recent and comparable published methods in 
terms of number of compounds and analytical methodology were described by Lopes et 
al. (2012)[22] and Gbylik et al. (2013) [25].  Although the method described by Lopes et al. 
(2012) [22] is also by UHPLC-MS/MS, the number of antibiotics is lower and the sample 
preparation, although simple, involves the application of QuEChERS in substitution of 
SPE. Gbylik et al. (2013) [25] determines 34 antibiotics including aminoglycosides, but the 
extraction procedure is split into two parallel procedures, including in one SPE step, 
gathering together at the end for a single injection by LC-MS/MS. 
 
Conclusions 
The development of a sensitive and specific UHPLC-MS/MS method for the 
determination and quantification of 41 antibiotics in fish muscle was successfully 
achieved.  
An optimized extraction procedure with reduced handling time and associated 
lowering costs allows a higher number of samples to be analysed in one day which is a 
huge improvement in routine analyses. The speed with which results can be obtained is 
one of the fundamental characteristics in screening and confirmatory methods, which 
can be fulfilled using the proposed methodology. The UHPLC technology contributed to 
minimal analysis time while combining separation, sensitivity and high resolution 
chromatography.  
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Table 11: MRLs and MRPL set by European Union for fish muscle, VL and validation parameters: decision limit 
(ccα), detection capability (ccβ), repeatability, reproducibility and recovery 
 
MRL 
MRPL*  
(μg kg-1) 
VL 
(μg kg-1) 
CCα  
(μg kg-1) 
CCβ  
(μg kg-1) 
Repeatability 
(%RSD) 
Reproducibility 
(%RSD) 
Recovery  
(%) 
sulfapyridine 100 100 110.6 121.2 11 13 108 
sulfadiazine 100 100 115.4 130.8 9 9 106 
sulfamethoxazole 100 100 114.7 129.4 9 8 110 
sulfathiazole 100 100 116.9 133.8 8 8 107 
sulfisoxazole 100 100 114.7 129.4 9 9 109 
sulfamethiazole 100 100 116.5 133.0 13 14 105 
sulfisomidine 100 100 114.2 128.4 7 8 110 
sulfamethazine 100 100 111.2 122.4 3 5 107 
sulfamethoxypyridazine 100 100 118.7 137.5 8 10 108 
sulfachloropyridazine 100 100 126.9 153.7 8 12 111 
sulfadoxine 100 100 114.9 129.8 4 7 109 
sulfadimethoxine 100 100 110.6 121.2 5 5 110 
sulfanilamide 100 100 125.5 151.0 13 14 92 
sulfaquinoxaline 100 100 115.3 130.7 15 16 106 
trimethoprim 100 100 115.1 130.3 10 12 106 
tetracycline 100 100 116.5 133.1 9 10 102, 
doxycycline - 100 7.8 13.2 7 10 101 
oxytetracycline 100 100 117.2 134.4 8 9 102 
chlorotetracycline 100 100 124.2 148.4 12 16 104 
erythromycin 200 200 224.4 248.8 5 7 99 
spyriamicin - 50 12.4 21.1 7 9 95 
tilmicosin 50 50 59.4 68.9 9 13 99 
tylosin 100 100 114.0 128.1 10 10 93 
nalidixic acid - 100 10.5 17.9 5 8 94 
flumequine 600 600 628.9 657.7 11 8 107 
oxolinic acid 100 100 111.6 123.1 6 6 99 
cinoxacin - 100 5.8 9.8 6 7 99 
norfloxacin - 100 2.4 4.1 7 8 101 
enoxacin - 100 3.8 6.4 8 9 98 
ciprofloxacin 100 100 105.1 110.1 4 5 102 
danofloxacin 100 100 108.3 116.5 6 6 103 
enrofloxacin 100 100 106.1 112.2 4 6 102 
ofloxacin - 100 5.1 8.6 6 7 102 
marbofloxacin - 100 4.5 7.7 4 5 102 
penicillin G 50 50 65.7 81.4 13 13 99 
ampicillin 50 50 64.9 79.7 12 14 104 
amoxicillin 50 50 64.2 78.5 22 17 105 
oxacillin 300 300 356.8 413.6 14 14 103 
nafcillin 300 300 351.9 403.9 14 15 98 
dicloxacillin 300 300 364.1 380.7 12 17 97 
chloramphenicol 0.3* 0.3 0.1 0.2 14 16 103 
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In addition, the process of validation also demonstrated the good performance 
of the method, which can be an important contribution in food safety analysis. Although 
it was developed for gilthead sea bream muscle, the applicability of the presented 
method may be extended to other similar species commonly produced in aquaculture 
and widely consumed worldwide. 
The main advantage of the present method relies on the fact that it is a fast 
procedure that can be applied in routine analysis for the control of real samples from 
aquaculture production. Ensuring the safety of aquaculture products has never been 
more important, thus analyzing fish samples before commercialization is an important 
tool in terms of food safety. 
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Abstract 
A multi-residue quantitative screening method covering 41 antibiotics from 7 
different families, by Ultra-High-Pressure-Liquid-Chromatography tandem Mass 
Spectrometry (UHPLC-MS/MS), is described. Sulphonamides, trimethoprim, 
tetracyclines, macrolides, quinolones, penicillins and chloramphenicol are 
simultaneously detected after a simple sample preparation of bovine muscle optimized 
to achieve the best recovery for all compounds. A simple sample treatment was 
developed consisting in an extraction with a mixture of acetonitrile and 
ethylenediaminetetraacetic acid (EDTA), followed by a degreasing step with n-hexane. 
The methodology was validated, in accordance with Decision 2002/657/EC by evaluating 
the required parameters: decision limit (CCα), detection capability (CCβ), specificity, 
selectivity, repeatability and reproducibility. Precision in terms of relative standard 
deviation was under 20% for all compounds and the recoveries between 91% and 119%. 
CCα and CCβ were determined according the maximum residue limit (MRL) or the 
minimum required performance limit (MRPL), when required.  
 
Introduction 
In food producing animals, antibiotics are widely used and administrated as feed 
additives and in drinking water not only to treat and prevent diseases but also to illegally 
stimulate animal growth [1, 2]. 
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The continuous use of these drugs carries the risk of their presence in edible 
tissues which, for consumers, can be responsible for toxic effects and allergic reactions 
in hypersensitive individuals [3, 4]. It can also result in the development of resistant strains 
of bacteria that might compromise the efficiency of antibiotics used for treatment of 
animals [2]. When that occurs it became difficult to treat serious diseases, increasing the 
negative effects in animal welfare and consequently severe consequences for 
productivity and economy. Furthermore, the potential spread of resistant strains of 
bacteria from animals to humans can have the same effect when using antibiotics as 
human medicines [5]. These concerns make the analysis of antibiotic residues in food 
producing animals an important field in food safety. To control abusive situations, and 
because food safety is a key police priority for the European Commission [6], several 
official documents were settled down to regulate the control of veterinary drugs in 
products of animal origin. The Council Directive 96/23/EC [7] determines the measures 
to monitor certain substances and residues of veterinary medicines in living animals and 
in animal products. This directive foresees laboratorial control. For permitted veterinary 
drugs, tolerance levels were established as maximum residue limits (MRL) in foodstuff 
of animal origin and listed in the EU Commission Regulation 37/2010 [8, 9]. For non-
authorized substances there are no tolerance levels but, for some compounds, to 
harmonize the analytical performance of the methods, a minimum required 
performance limit (MRPL) had been set [10, 11]. The MRPL level is not a concentration 
obtained from toxicological data, but is only related with analytical performance. The 
European Decision 2002/657/EC [10] describes the requirements for the performance 
and validation of the analytical methods employed in the official residues control. To 
 206 
fulfil such requirements it is important to have sensitive and specific analytical 
methodologies capable of monitoring the use or potential abuse of these drugs in the 
field of animal husbandry, ensuring that MRL levels are respected. The concern about 
having efficient screening methods is increasing and also about the improvement of 
cost-effectiveness of analytical procedures [12-14]. Typically the methods used in 
laboratory are multi-detection of related compounds, usually from the same family of 
antibiotics. That means that a single sample, to be analysed for different groups of 
antibiotics, became part of a time consuming process that can last weeks.  The delayed 
final result is associated with high cost and turns to be questionable in terms of 
usefulness of the result. This efficiency can be gathered in multi-class and multi-
detection methods based on liquid chromatography coupled with tandem mass 
spectrometry (LC-MS/MS) being the tool of choice, providing the required degree of 
confidence for veterinary residue analysis in biological samples [3, 13]. Nowadays, the use 
of ultra-high performance liquid chromatography (UHPLC) provides numerous 
advantages in terms of resolution, sensitivity and also in minimizing time of analysis 
which is an important feature when running numerous samples in routine laboratories 
[15, 16]. Despite that, the simultaneous determination of antibiotics from different 
pharmacologic families in complex biological matrices, such as bovine muscle, has 
several constrains manly related with the differences in physic-chemical properties of 
the compounds [15, 17].  
In the literature, only few methods, combining multi-detection and multi-class in 
a quantitative screening method for bovine muscle, are available. Martos et al. (2010) 
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[14] describes a LC-MS/MS method for the screening of 39 compounds from 7 families of 
antibiotics, although not validated. Granelli, Elgerud, Lundström, Ohlsson & Sjöberg 
(2009) [18] presented an LC-MS/MS method for the determination of 19 compounds, 
from 5 classes. A group of US Department of Agricultural [19] described a qualitative 
screening method for the determination of more than 100 compounds in bovine muscle 
and/or in the kidney, by UHPLC-MS/MS including not only antibiotics, but also several 
other drugs, such as anthelmintics, thyreostatics, beta-agonists, hormones, NSAIDS and 
tranquilizers. Although proved to be efficient for screening purposes, the validation 
presented is not based on European Commission requirements [10]. Recently, multi-
detection methods for the analysis of veterinary drugs using liquid chromatography 
coupled with time-of-flight mass spectrometry (LC-ToF-MS) have been published [20] and 
UHPLC-ToF-MS [21]. One of the main advantages is the possibility of analysing an 
unlimited number of analytes in a single run, since the detection by ToF-MS is not limited 
by dwell time [22]. Nevertheless, although it can be applied for screening and 
quantification purposes it cannot be used as confirmatory methods due to the 
requirements of legislation [10] and always obliges the confirmation of positive findings 
using a MS/MS detector. 
The present paper describes the development and validation of a simple and 
effective quantitative screening method by UHPLC-MS/MS for the simultaneous 
detection of 41 antibiotic compounds from sulphonamides, tetracyclines, penicillins, 
macrolides, quinolones, trimethoprim and chloramphenicol in bovine muscle. Validation 
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procedure followed the requirements from the European Commission Decision 
2002/657/EC [10] in order to apply the method in routine analysis. 
Table 12: MRM acquisition conditions for each antibiotic and for the internal standards (IS) used 
 
 
ESI 
Precursor 
ion (m/z) 
Product ion 
(m/z) 
Cone 
voltage 
(V) 
Collision 
energy (eV) 
Retention 
time 
(minutes) 
Sulfonamides 
sulfapyridine + 250.3 156.3 30 15 3.27 
sulfadiazine + 251.2 156.2 30 15 3.24 
sulfamethoxazole + 254.4 156.4 30 20 4.26 
sulfathiazole + 256.4 156.3 25 15 3.35 
sulfisoxazole + 268.3 156.2 25 15 4.37 
sulfamethiazole + 271.0 156.2 25 15 3.86 
sulfisomidine + 279.4 186.3 30 16 3.74 
sulfamethazine + 279.4 156.3 30 15 3.77 
sulfamethoxypyridazine + 281.2 156.2 30 15 3.84 
sulfachloropyridazine + 285.3 92.3 30 28 4.15 
sulfadoxine + 311.4 156.4 30 18 4.25 
sulfadimethoxine + 311.4 156.4 30 20 4.65 
sulfanilamide + 173.2 92.1 30 25 1.07 
sulfaquinoxaline + 301.3 92.2 30 30 4.70 
sulfameter (IS) + 281.3 92.2 25 30 3.86 
 trimethoprim + 291.5 230.3 25 23 3.29 
Tetracyclines 
tetracycline + 445.5 410.3 25 20 3.91 
doxycycline + 445.5 428.2 25 18 3.96 
oxytetracycline + 461.5 426.3 25 20 3.46 
chlorotetracycline + 479.3 444.2 25 20 3.86 
demethyltetracycline (IS) + 465.2 448.3 25 17 3.69 
Macrolides 
erythromycin + 734.5 158.2 25 30 4.22 
spyriamicin + 843.5 174.0 35 35 3.71 
tilmicosin + 869.3 174.2 35 45 3.94 
tylosin + 917.1 174.3 35 35 4.73 
roxithromycin (IS) + 837.7 679.5 30 30 5.43 
Quinolones 
nalidixic acid + 233.2 215.1 40 14 3.81 
flumequine + 262.2 202.1 30 32 5.19 
oxolinic acid + 262.2 216.1 30 25 4.44 
cinoxacin + 263.2 217.1 30 23 4.25 
norfloxacin + 320.3 276.2 20 17 3.45 
enoxacin + 321.2 303.2 35 18 3.40 
ciprofloxacin + 332.2 288.2 35 17 3.48 
danofloxacin + 358.3 96.1 33 21 3.52 
enrofloxacin + 360.3 316.3 31 19 3.58 
ofloxacin + 362.1 261.3 34 26 3.44 
marbofloxacin + 363.3 72.1 30 20 3.36 
lomefloxacin (IS) + 352.2 265.3 31 22 3.54 
Penicillins 
penicillin G + 335.1 176.0 30 25 3.81 
ampicillin + 350.4 106.3 25 20 3.34 
amoxicillin + 366.3 160.3 25 20 4.21 
oxacillin + 402.0 243.0 30 20 5.24 
nafcillin + 415.0 199.0 30 25 5.47 
dicloxacillin + 470.0 311.0 30 25 5.65 
penicillin V (IS) + 351.0 160.2 25 25 5.07 
Amphenicol 
chloramphenicol - 320.9 151.9 30 25 4.25 
chloramphenicol_d5 (IS) - 326.0 157.0 30 25 4.24 
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Material and Methods 
Reagents, Solvents and Standard Solutions 
All reagents and solvents used were of analytical grade with the exception of 
chemicals used for the mobile phase, which were of HPLC grade. Methanol, acetonitrile 
and formic acid were supplied by Merck (Darmstadt, Germany). 
Ethylenediaminetetraacetic acid (EDTA) was purchased from Sigma-Aldrich (Madrid, 
Spain). All standards of sulphonamides, tetracyclines, penicillins, macrolides, 
quinolones, trimethoprim and chloramphenicol were supplied by Sigma-Aldrich 
(Madrid, Spain). The individual standards are listed in table 12. Six internal standards 
were used: demethyltetracycline for tetracyclines, penicillin V for penicillins, 
lomefloxacin for quinolones, roxithromycin for macrolides, sulfameter for 
sulphonamides and for trimethoprim and chloramphenicol- d5 for chloramphenicol. All 
the internal standards were provided by Sigma-Aldrich. For all substances, stock 
solutions of 1 mg mL-1 were prepared by weighing the appropriate amount of standard, 
diluted in methanol, and storing at -20οC. Suitable dilutions were also prepared to have 
convenient spiking solutions for both the validation process and the routine analysis. 
Instrumentation 
For the sample preparation, the following equipment was used: Mettler Toledo 
PC200 and AE100 balances (Greifensee, Switzerland), Heidolph Reax 2 overhead mixer 
(Schwabach, Germany), Heraeus Megafuge 1.0 centrifuge (Hanau, Germany), Turbovap 
Zymark Evaporator (Hopkinton, MA, USA) and Whatman Mini-Uniprep PVDF 0.45 µm 
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filters (Clifton, NJ, USA). Chromatographic separation and mass spectrometry detection 
were performed with a Xevo TQ MS – Acquity UHPLC system coupled to a triple 
quadrupole tandem mass spectrometer from Waters (Milford, MA, USA). The 
electrospray ion source in positive (ESI+) and negative (ESI-) modes was used with data 
acquisition in multiple reaction monitoring (MRM) mode and analysed using Masslynx 
4.1 software (Waters). The MRM optimized conditions are presented in table 12. The 
UHPLC system consisted of a vacuum degasser, an autosampler and a binary pump 
equipped with an analytical reverse-phase column Acquity HSS T3 2.1x100 mm with 1.8 
μm particle size (Waters). The mobile phases used were: [A] formic acid 0.1% (v/v) in 
water and [B] acetonitrile. The gradient program used, at a flow rate of 0.45 mL min-1, 
was: 0-5 minutes from 97% [A] to 40% [A]; 5-9 minutes from 40% to 0% [A]; 9-10 minutes 
from 0% back to 97% [A]; 11-12 minutes 97% [A].  The column was maintained at 40οC, 
the autosampler at 10οC and the injection volume was 20 µL. 
Sample preparation 
A portion of 2.0 ± 0.05 g of minced and mixed bovine muscle sample was weighed 
into a 20 mL glass centrifuge tube. The internal standard solution was added, then 
vortexed for 30 s and allowed to stand in the dark for at least 10 minutes.  
Afterwards, twelve different extractions procedures were tested; the list of them 
and the main steps are presented in table 13. 
The liquid extraction was performed by shaking the sample with the solvent 
using a Reax shaker for 20 minutes followed by centrifugation for 15 minutes at 3100 g. 
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The supernatant was transferred into a new tube and, for extractions ADry, MDry and 
EaDry evaporated to dryness under a gentle stream of nitrogen, at 40ºC. For the extract 
samples A, M and Ea the evaporation were just until 0.5 mL. Procedures AHxDry, 
MHxDry, EaHxDry, AHx, MHx and EaHx followed a defat step by adding 3 mL of n-hexane 
to the supernatant obtained after centrifugation. The extracts were vortexed for 30 s 
and centrifuged for 15 minutes at 3100 g. The n-hexane layer were discarded and, for 
extractions AHxDry, MHxDry and EaHxDry they were evaporated to dryness under a 
gentle stream of nitrogen, at 40ºC. For extract samples AHx, MHx and EaHx the 
evaporation were just until 0.5 mL. In all procedures, the residue was redissolved with 
mobile phase A (400 μL) or added to the 0.5mL of final extract, filtered through a 0.45 
µm PVDF Mini-uniprep TM, transferred to vials and injected into the UHPLC-MS/MS 
under MRM optimized conditions for each compound (table 12). 
Table 13: Schematic description of the twelve extraction procedures tested 
Procedure 
Solvent extraction (10 mL) with    
1 mL 0.1M EDTA 
Deffating    
(2 mL) 
Concentration 
ADry acetonitrile 
 
evaporate 
until dryness 
MDry methanol 
EaDry ethyl acetate 
AHxDry acetonitrile 
n-hexane MHxDry methanol 
EaHxDry ethyl acetate 
A acetonitrile 
 
evaporate 
until 0.5 mL 
M methanol 
Ea ethyl acetate 
AHx acetonitrile 
n-hexane MHx methanol 
EaHx ethyl acetate 
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Validation procedure 
The validation procedure followed the described by the EU Commission Decision 
2002/657/EEC [10]. According to those requirements, specificity, recovery, repeatability, 
reproducibility, decision limit (CCα) and detection capability (CCβ) were determined.  
The specificity was assessed by analysing 20 bovine muscle samples from 
different origins to find possible peaks that could interfere with the detection of the 
analytes of interest. The same samples were spiked with all the compounds at the level 
of interest (VL) that, for most of them, corresponds to their MRL/MRPL level, in order to 
prove the identification capability of the method. Calibration curves were assembled 
with five concentration levels: 0.5 x VL, 1.0 x VL, 1.5 x VL, 2.0 x VL and 3.0 x VL and carried 
out in three different days and with different operators. In each day six replicates of the 
0.5 x VL, 1.0 x VL and 1.5 x VL were executed in order to calculate repeatability, 
reproducibility and recovery. Recovery determined in the validation process was 
estimated as a ratio between the determined concentration and the real concentration. 
CCα and CCβ were determined according to the following equations [10]: 
𝐶𝐶𝛼 = 𝜇𝑁 + 2.33 × 𝜎𝑁    (Equation 1, for compounds without MRLs) 
𝐶𝐶𝛼 = 𝑀𝑅𝐿 + 1.64 × 𝜎𝑀𝑅𝐿    (Equation 2, for compounds with established MRLs) 
𝐶𝐶𝛽 = 𝐶𝐶𝛼 + 1.64 × 𝜎𝑉𝐿  (Equation 3) 
In which: μN is the mean of noise amplitude of twenty blank samples; σN is the 
standard deviation of the noise amplitude of twenty blank samples at the retention time 
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of the target antibiotic; and σMRL or σVL is the standard deviation at the MRL or VL level 
in the twenty spiked blank samples at that level. For all the determinations, with the 
exception for the studies of absolute recoveries during sample preparation 
development, the peak areas of both the analytes and the correspondent internal 
standard were measured, and the analyte/internal standard area ratios were 
determined. Internal standards were chosen in accordance with their similar physic-
chemical behaviour with the antibiotics monitored and for that they were studied and 
selected before validation.   
 
Results and Discussion 
The principal limitation found while developing multi-detection and multi-class 
methods is related with the sample preparation, mainly due to the difficulty in achieving 
an efficient and generic procedure to extract simultaneously several compounds from 
diverse families with different physic-chemical properties. It is difficult to reach equally 
good recoveries in such methods and minimize the loss of all analytes during sample 
preparation. Multi-step and complex sample clean-up can result in total loss of some 
target compounds and simplifying the procedure can be an improvement. Therefore and 
considering that the high selectivity of solid-phase-extraction (SPE) can be a problem in 
multi-class methods, a simple liquid extraction was tested and optimized.  
Twelve procedures were experienced and final results, in terms of individual 
absolute recovery, are presented in table 14. The main purpose of these experiments 
was to evaluate the real impact/recovery that each procedure has in all compounds in 
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order to select the best option possible. For that reason, absolute recoveries presented 
for each method did not take into account the presence of the internal standard, in 
opposition to the recovery obtained during validation. 
 
Table 14: Absolute recoveries (expressed as %) of the target antibiotics for the twelve extractions procedures 
tested. Absolute recoveries below 15% are in bold and underlined 
Method  
Antibiotics ADry  MDry EaDry AHxDry MHxDry EaHxDry A M EA AHx MHx EaHx 
sulfapyridine 88 72 38 76 16 18 99 16 81 99 61 9 
sulfadiazine 46 33 19 38 11 18 95 17 48 104 29 13 
sulfamethoxazole 36 28 2 23 19 16 57 41 6 46 47 14 
sulfathiazole 50 26 5 46 6 8 91 12 18 109 15 6 
sulfisoxazole 36 27 0 13 12 3 53 10 2 45 42 5 
sulfamethiazole 43 25 6 35 6 14 72 19 15 80 20 11 
sulfisomidine 42 38 17 37 21 15 72 18 43 90 54 13 
sulfamethazine 72 62 31 65 41 27 94 37 96 108 96 23 
sulfamethoxypyridazine 28 22 9 24 15 11 60 11 24 64 42 10 
sulfachloropyridazine 66 50 10 50 27 32 83 18 18 102 63 19 
sulfadoxine 54 41 7 46 28 19 80 53 14 104 67 16 
sulfadimethoxine 46 43 12 36 22 14 76 52 31 106 69 17 
sulfanilamide 3 1 3 5 0 10 18 1 3 22 1 9 
sulfaquinoxaline 27 30 5 23 18 8 35 36 14 56 47 9 
trimethoprim 54 36 16 35 15 2 74 19 23 57 47 4 
tetracycline 62 11 17 53 8 23 99 10 36 101 17 19 
doxycycline 57 22 21 53 16 50 92 38 44 106 40 26 
oxytetracycline 35 4 9 26 5 20 54 7 15 72 5 14 
chlorotetracycline 35 9 15 37 8 49 85 11 42 90 15 46 
erythromycin 64 59 9 45 42 5 93 61 17 98 62 16 
spyriamicin 48 50 5 54 35 0 94 58 14 111 77 0 
tilmicosin 27 30 5 25 19 0 69 40 25 81 56 0 
tylosin 49 75 3 40 55 0 74 102 6 98 113 0 
nalidixic acid 81 67 38 72 46 73 92 46 48 105 66 46 
flumequine 46 42 37 42 29 59 75 50 62 107 69 50 
oxolinic acid 62 48 46 56 34 66 87 47 58 106 65 48 
cinoxacin 59 43 21 54 7 76 95 18 34 102 50 60 
norfloxacin 67 45 13 60 27 5 92 40 35 95 56 3 
enoxacin 57 35 14 40 18 6 96 19 33 100 47 6 
ciprofloxacin 60 39 15 52 24 6 67 35 28 100 43 3 
danofloxacin 58 37 14 43 23 0 97 41 30 98 52 1 
enrofloxacin 51 37 16 37 22 8 83 33 36 84 47 13 
ofloxacin 49 27 9 36 18 1 76 31 21 78 39 2 
marbofloxacin 77 53 26 62 29 1 72 23 42 98 67 2 
penicillin G 86 62 12 77 27 0 94 31 34 100 84 0 
ampicillin 50 28 2 21 11 0 87 57 0 65 48 0 
amoxicillin 45 33 22 34 18 0 51 0 0 52 0 0 
oxacillin 39 32 7 39 27 11 101 50 24 101 87 10 
nafcillin 34 23 12 44 17 17 60 36 30 85 40 11 
dicloxacillin 18 22 2 31 16 3 46 31 7 57 33 3 
chloramphenicol 57 77 9 24 30 12 56 6 10 113 9 50 
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Three organic solvents were tested for sample extraction: acetonitrile, methanol 
and ethyl acetate. The addition of a quelating agent was also performed, EDTA, 
especially to compete with antibiotics as tetracyclines and macrolides.  It is known that 
these compounds can form complexes with the bi- and trivalent cations present in the 
sample extraction solution which can lead to significant losses of those compounds 
during the procedure. The presence of another compound, as EDTA, which has similar 
behaviour, is responsible for the improvement of performance of these antibiotics 
avoiding drastically those losses. 
In some of the experiments a defatting step of the organic layer was introduced, 
with n-hexane, to minimize the lipid content from the muscle and thus the potential 
interferences during analysis. Also, because some compounds have better affinity with 
aqueous phase, the same assays were performed without total dryness at the end of the 
extraction (until 0.5 mL).  
Absolute recoveries were calculated for each compound and each methodology 
in order to understand the effects of all variants. The results are presented in table 8 
and, graphically compared in figure 11, by the representation of the minimum and 
maximum absolute recoveries obtained. In a first analysis of table 14 and figure 11 it can 
be seen that worse results were achieved when using ethyl acetate as extracting solvent, 
followed by methanol, being the acetonitrile the organic solvent of choice for the most 
compounds. Comparing the performance of the methods that involved evaporation 
until dryness or until 0.5 mL, it can be easily concluded that the second option gives 
better results. There are two reasons that can justify these data. First of all, the higher 
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affinity of polar compounds with aqueous phase can be responsible for a significant 
amount of antibiotics concentrated in the aqueous content of the sample, turned 
miscible in the acetonitrile during homogenization. Also the well-known instability of 
antibiotics [23] can be a problem during a longer evaporation process of the remaining 
aqueous layer. Being the acetonitrile the chosen organic solvent the next step was to 
compare between methods A and AHx. It can be observed that the recovery is 
significantly higher when the lipid content is reduced from the matrix. The possibility of 
diminishing the interferences coming from the matrix can be responsible for reducing 
effects like ion suppression or enhancement of signal [13, 17], a common problem in the 
detection system when working with less specific methods such as multi-detection and 
multi-class and biological samples. 
 
Figure 11: Minimum and maximum absolute recoveries obtained for the twelve extraction procedures for all the 
antibiotics tested at the concentration of the VL (see table 9 for the respective values) 
Nonetheless a compromise had to be adopted selecting the most suitable 
method, although, for some compounds, the recoveries obtained are still significantly 
low, being the worse result the obtained for sulfanilamide with 22%. Briefly, the selected 
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method listed with the code AHx above in the sample preparation, in the table 13 and 
figure 11,  was determinate to be as follow: 2g of homogenized bovine muscle extracted 
with 10mL of acetonitrile with 1mL of 0.1M EDTA; after centrifugation the supernatant 
was defatted with n-hexane; centrifuged and evaporated until 0.5 mL of final extract.  
For recovery correction and to control possible matrix effects, internal standards 
were selected for each group of compounds. The selection was based on their 
similarities with the target compounds, meaning that they should, as much as possible, 
be equally affected by the same fluctuations during extraction procedure, ionization 
efficiency, detection response and chromatographic behaviour. Thereby, quantification 
by matrix based calibration curve using internal standards allows to monitor the 
efficiency of the extraction procedure and also to correct possible matrix effects.  
Chromatographic and detection parameters were optimized: mobile phase, flow 
rate, gradient steps and ionization conditions. The conditions described above allow the 
determination of all 41 compounds in less than 10 minutes, one of the huge advantages 
of UHPLC and for that, chromatographic conditions were tested with the purpose of 
achieving the better efficiency in peak separation and peak shape along with a short run 
time.  
In terms of detection, the ideal MRM conditions were obtained by direct infusion 
into the detector of each standard solution at the concentration of 10 μg mL-1. The use 
of an acidified mobile phase, 0.1% of formic acid, promotes the positive ionization, 
which improved the detection of almost all compounds since only chloramphenicol is 
ionized in negative mode. To fulfil the identification criteria demanded in the Decision 
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2002/657 [10], two ion transitions were selected for each compound (table 7). In figure 2 
a representative chromatogram of a spiked bovine muscle sample, at the corresponding 
validation level (VL) is presented. As an example, individual MRM of one compound per 
family of monitored antibiotic is also presented in figure 12. 
 
Figure 12: Chromatogram of individual MRM of one compound per class of antibiotic for a spiked bovine muscle 
sample at the corresponding validation level (VL) 
The method was validated in accordance with the European Commission 
Decision 2002/657 [10] that establishes performance criteria for the methods and the 
procedures for their validation.  
The absence of interfering peaks, in the 20 blank bovine muscle analysed 
samples, above a signal-to-noise ratio of 3, was confirmed in all blank samples. 
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Furthermore, after spiking the same blank samples, the identification of all compounds 
was effective without any false negative result. The results for precision, in terms of 
repeatability and reproducibility as relative standard deviation (RSD %), recovery, CCα 
and CCβ are summarized in table 15. Values presented for precision and recovery were 
calculated for the VL that, for most of the compounds are the MRL. To prove the 
robustness of the method, precision is an important parameter that must be analysed 
during validation since it measures the variability during the analytical process. In terms 
of repeatability, the higher value obtained was for sulfanilamide, with 17%. All the other 
compounds were under that RSD. Regarding reproducibility, the worse value, 22%, was 
also for sulfanilamide while the remaining compounds were below 20%. All these values 
are in accordance with the acceptance criteria, according to the Decision 657/2002 [10]. 
The calculated RSD cannot exceed the level calculated by the Horwitz equation that 
depends on the concentration level. The recovery determined during validation was 
calculated as a ratio between the determined concentration and the real concentration. 
The range values obtained were between 86 and 109% falling into the accepted range 
[10].  It is important to note that such values are different from the ones obtained during 
the development of sample preparation. In these cases the recoveries were calculated 
as absolute values, without having the correction of the internal standard addition, and 
for that reason values presented in table 14, for method AHx, are different from the 
ones calculated during validation and described in table 15.  
CCα and CCβ were calculated according to the equations described above 
(equation 1, 2 and 3) depending if the MRL is established or not. As can be seen in table 
10, compounds without tolerance level have lower CCα and CCβ, closer to the limit of 
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detection of the method although in the other cases these concentrations are always 
above MRL. 
 
Table 15: MRLs and MPRL set by EU for bovine muscle, validation level (VL) and validation parameters: decision 
limit (ccα), detection capability (ccβ), repeatability, reproducibility and recovery 
 
MRL 
*MRPL 
(μg kg-1) 
VL 
(μg kg-1) 
CCα   (μg 
kg-1) 
CCβ (μg 
kg-1) 
Repeatability 
(%RSD) 
Reproducibility 
(%RSD) 
Recovery (%) 
sulfapyridine 100 100 132 164 8 12 109 
sulfadiazine 100 100 113 125 5 8 93 
sulfamethoxazole 100 100 108 117 7 10 108 
sulfathiazole 100 100 107 115 6 8 105 
sulfisoxazole 100 100 111 121 6 9 104 
sulfamethiazole 100 100 110 120 3 5 101 
sulfisomidine 100 100 104 108 3 4 93 
sulfamethazine 100 100 105 110 6 9 100 
sulfamethoxypyridazine 100 100 108 116 2 4 91 
sulfachloropyridazine 100 100 104 108 7 11 103 
sulfadoxine 100 100 110 121 3 5 91 
sulfadimethoxine 100 100 107 114 4 5 93 
sulfanilamide 100 100 105 111 17 22 102 
sulfaquinoxaline 100 100 106 112 5 7 102 
trimethoprim 100 100 108 116 5 7 98 
tetracycline 100 100 125 149 13 20 109 
doxycycline 100 100 123 147 13 20 103 
oxytetracycline 100 100 124 148 13 19 102 
chlorotetracycline 100 100 121 143 12 17 100 
erythromycin 100 100 116 131 9 14 101 
spyriamicin 200 200 226 252 15 20 101 
tilmicosin 50 50 60 71 7 10 93 
tylosin 100 100 116 133 9 14 116 
nalidixic acid - 100 0.01 0.02 8 13 102 
flumequine 200 200 214 229 8 12 104 
oxolinic acid 100 100 114 127 8 12 105 
cinoxacin - 100 0.02 0.04 10 14 108 
norfloxacin - 100 0.02 0.04 9 13 86 
enoxacin - 100 0.04 0.06 10 15 98 
ciprofloxacin - 100 0.09 0.12 9 14 95 
danofloxacin 200 200 229 258 15 20 106 
enrofloxacin 100 100 121 142 12 17 105 
ofloxacin - 100 0.01 0.02 10 15 105 
marbofloxacin - 100 163 176 7 11 100 
penicillin G 50 50 69 87 11 17 94 
ampicillin 50 50 61 73 7 10 97 
amoxicillin 50 50 65 79 8 12 106 
oxacillin 300 300 315 330. 9 13 101 
nafcillin 300 300 307 315 4 6 103 
dicloxacillin 300 300 310 319 6 9 96 
chloramphenicol 0.3* 0.3 0.07 0.10 13 19 105 
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The results of the validation clearly demonstrated the suitability of this method 
for the detection and identification of all tested antibiotics. 
 
Conclusions 
A reliable multi-detection and multi-class method for the determination of 41 
antibiotics from 7 different classes in bovine muscle was developed. The sample 
preparation has the main advantage of being inexpensive and low time consuming. Also 
the use of UHPLC-MS/MS provided the possibility of analysing a wide number of samples 
in short period of time. By replacing the methods currently applied in the laboratory 
(one screening method for each class of compounds) the total time from sampling to 
the final result will be reduced in a very significant period of time.  
The method developed was completely validated in order to be used in routine 
analysis of official control for quantitative screening purposes with the possibility of 
extending the method for confirmation. For a laboratory involved in food safety control 
with a large number of antibiotic residues and samples to analyse, the present method 
is a huge improvement. 
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Abstract 
  A multi-residue quantitative screening method covering 39 antibiotics from 7 
different families by ultra-high-pressure-liquid-chromatography tandem mass 
spectrometry (UHPLC-MS/MS) is described. Sulphonamides, trimethoprim, 
tetracyclines, macrolides, quinolones, penicillins and chloramphenicol are 
simultaneously detected in liver tissue. A simple sample treatment method consisting of 
extraction with a mixture of acetonitrile and ethylenediaminetetraacetic acid (EDTA) 
followed by solid-phase extraction (SPE) with a hydrophilic-lipophilic balanced (HLB) 
cartridge was developed. 
  The methodology was validated, in accordance with Decision 2002/657/EC, by 
evaluating the following required parameters: decision limit (CCα), detection capability 
(CCβ), specificity, repeatability and reproducibility. The precision, in terms of the relative 
standard deviation, was under 22% for all of the compounds, and the recoveries were 
between 80% and 110%. The CCα and CCβ were determined according to the maximum 
residue limit (MRL) or the minimum required performance limit (MRPL), when 
established.  
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Introduction  
  Antibiotics are widely used for therapeutic and prophylactic purposes in food-
producing animals and to promote animal growth [1]. The use of antibiotics as growth 
promoters is considered fraudulent in Europe because it can lead to residues of these 
compounds persisting in edible matrices. These antibiotic residues can result in allergic 
reactions in some hypersensitive individuals and in the appearance of bacterial strains 
that are resistant to drugs that are used in both veterinary and human medicine [2], 
which are currently considered a huge worldwide concern. 
  For that reason, the European Community determined the need for the 
mandatory control of the veterinary drugs in food from animal origin designated for 
human consumption [3]. For permitted veterinary drugs, the maximum residue limits 
(MRL) in foodstuff of animal origin were established and are listed in the EU Commission 
Regulation 37/2010 [4, 5].  Food products containing concentrations of antibiotics 
exceeding the established MRL are inappropriate for human consumption. In the case 
of some non-authorized substances, a minimum required performance limit (MRPL) has 
been set to harmonize the analytical performance of the methods used in different 
laboratories [6, 7]. 
  A wide variety of edible matrices must be monitored for the presence of 
veterinary residues, including muscle, liver, kidney, fat, milk, eggs, fish and honey. 
Nevertheless, there are relatively few multi-detection and multi-class methods for the 
determination of antibiotics in liver tissue.  There are still very few methods describing 
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approaches for analysing different classes of compounds, particularly for their 
determination in liver tissue [8, 9]. To our knowledge, the only available method for the 
determination of an extensive number of antibiotics from several classes in such a 
matrix was published by Kaufmann et al [8], who detected 100 veterinary drugs in 
muscle, liver and kidney tissues using UHPLC-ToF-MS. The main constraint with using 
ToF-MS methodologies is related to the fact that it is impossible to use them for 
confirmation purposes because ToF-MS is not yet included in the regulations [6].  
  There are also some methods that group a few families of compounds, such as 
the one presented by Shao et al. [9], who developed a multi-class confirmatory method 
for tetracyclines and quinolones in muscle, liver and kidney tissues using UHPLC-MS/MS. 
However, the common procedures described in the literature for the determination of 
antibiotics in liver tissue only include groups of related compounds [10-14].  
  When working with liver tissue and developing the sample preparation 
methodology, one of the principal obstacles is related to the complexity associated with 
the high protein and fat contents in this matrix, which often interfere in the analytical 
performance. Additionally, the high enzymatic activity in liver tissue can be responsible 
for the fast degradation of labile compounds, which leads to significant losses during 
sample preparation. Another issue to be considered is that the simultaneous 
determination of antibiotics from different pharmacologic families in complex biological 
matrices is constrained by differences in the physicochemical properties of the 
compounds [15, 16], a fact that makes developing the sample extraction method a 
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challenge that can only be overcome by reaching a compromise that better fits the 
purpose of the multi-class method. 
  The lack of methodologies for screening of antibiotics in liver demanded for new 
developments in order to fulfil the requirements of the control program and, 
consequently, improve food safety. Considering all of these aspects and the need for a 
reliable and efficient method for the determination of antibiotics in liver tissue while 
improving the time of analysis for several groups of compounds and the cost-
effectiveness, the aim of this work was to develop a multi-class and multi-detection 
method using UHPLC-MS/MS for the detection of antibiotics from seven families 
(sulphonamides, trimethoprim, tetracyclines, macrolides, quinolones, penicillins and 
chloramphenicol). To use the method in routine analysis and official control, it was 
validated according the requirements described in the European Commission Decision 
2002/657/EC [6]. 
 
 
Material and Methods 
Reagents, Solvents and Standard Solutions 
All of the reagents and solvents used were of analytical grade, with the exception 
of the chemicals used for the mobile phase, which were of HPLC grade. Methanol, 
acetonitrile, n-hexane and formic acid were supplied by Merck (Darmstadt, Germany). 
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Ethylenediaminetetraacetic acid (EDTA) was purchased from Sigma-Aldrich (Madrid, 
Spain). All of the standards of the sulphonamides, tetracyclines, penicillins, macrolides, 
quinolones, trimethoprim and chloramphenicol were supplied by Sigma-Aldrich 
(Madrid, Spain). The individual standards are listed in table 16. The following six internal 
standards were used: demethyltetracycline for the tetracyclines; penicillin V for the 
penicillins; lomefloxacin for the quinolones; roxithromycin for the macrolides; 
sulfameter for the sulphonamides and trimethoprim; and chloramphenicol-fifth-
deuterated (d5) for chloramphenicol. All of the internal standards were provided by 
Sigma-Aldrich. For all of the substances, stock solutions of 1 mg mL-1 were prepared by 
weighing the appropriate amount of standard, diluting it in methanol, and storing it at -
20°C for one year. Suitable dilutions were also prepared to have convenient spiking 
solutions for both the validation process and the routine analyses. Working solutions 
were stored at -20ºC for one month. 
 
Instrumentation 
For the sample preparation, the following equipment was used: Mettler Toledo 
PC200 and AE100 balances (Greifensee, Switzerland), a Heidolph Reax 2 overhead mixer 
(Schwabach, Germany), a Heraeus Megafuge 1.0 centrifuge (Hanau, Germany), a 
Turbovap Zymark Evaporator (Hopkinton, MA, USA) and Whatman Mini-Uniprep PVDF 
0.45 µm filters (Clifton, NJ, USA). A vacuum manifold was used for the solid phase 
extraction (SPE) with an Oasis HLB polymeric sorbent cartridge (3 mL, 200 mg) (Waters, 
Milford, MA, USA). Chromatographic separation and mass spectrometry detection were 
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performed using a Xevo TQ MS–Acquity UHPLC system coupled to a triple quadrupole 
tandem mass spectrometer from Waters (Milford, MA, USA). The electrospray ion 
source (ESI) was used both in positive and negative modes with data acquisition in the 
multiple reaction monitoring mode (MRM), and the Masslynx 4.1 software (Waters) was 
used for data processing. The MRM optimized conditions are presented in table 16. The 
UHPLC system consisted of a vacuum degasser, an autosampler and a binary pump 
equipped with an analytical reverse-phase column (Acquity HSS T3 2.1 x 100 mm with 
1.8 μm particle size, Waters). A flow rate of 0.45 mL min-1 was used with the following 
mobile phases: [A] formic acid 0.1% (v/v) in water and [B] acetonitrile. The following 
gradient program was used: 0-5 minutes from 97% to 40% [A]; 5-9 minutes from 40% to 
0% [A]; 9-10 minutes from 0% back to 97% [A]; 11-12 minutes 97% [A].  Column and 
autosampler were maintained at 40οC and 10οC, respectively. A 20 µL aliquot (full loop) 
was injected onto the analytical column. 
 
Sample preparation 
Two grams of minced and mixed liver tissue was weighed into a 20 mL glass 
centrifuge tube. The internal standard solution was added, and the sample was vortexed 
for 30 s and allowed to stand in the dark for at least 10 minutes. The sample was 
extracted by shaking using a Reax shaker for 10 minutes with 10 mL of acetonitrile and 
1 mL of 0.1 M EDTA. After that, the sample was left in the ultrasound bath for 20 
minutes. Following centrifugation for 10 minutes at 4000×g, the supernatant was 
transferred into a new tube and evaporated to near dryness (1 mL). Water (5 mL) was 
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added, and the solution was vortexed for 15 s. The solutions were then submitted to a 
clean-up step using SPE Oasis HLB cartridges, which were preconditioned with 
acetonitrile (10 mL) and water (10 mL). After passing the aqueous extract through the 
columns using gravity, the cartridges were washed with water (5 mL) and then dried 
under reduced pressure for approximately 5 minutes. The elution was performed with 
acetonitrile (10 mL). The eluate was evaporated to near dryness (0.5 mL) under a gentle 
stream of nitrogen and 400 μL of mobile phase [A] was added. To this extract n-hexane 
(2 mL) was added and the solution vortexed for 30 s. After centrifugation for 10 minutes 
at 4000×g, the n-hexane layer was removed. The final extract was filtered through a 0.45 
µm PVDF Mini-uniprep TM, transferred to vials and analysed by UHPLC-MS/MS under the 
MRM optimized conditions described in table 16. 
 
Validation procedure 
In-house validation was performed following the method described by the EU 
Commission Decision 2002/657/EEC [6] that requires the evaluation of the method in 
terms of the specificity, recovery, repeatability, reproducibility, decision limit (CCα) and 
detection capability (CCβ).  
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Table 16: MRM acquisition conditions for each antibiotic and for the internal standards (IS) used 
By analysing 20 blank liver samples from different animal species (bovine, swine, 
ovine, and poultry) to find possible peaks that could interfere with the detection of the 
target analytes, the specificity of the method was assessed. Afterwards, the same 20 
samples were spiked with all of the compounds of interest at the validation level (VL) 
 
 
ESI 
Precursor 
ion (m/z) 
Product 
ions (m/z) 
Cone 
voltage (V) 
Collision 
energy (eV) 
Sulfonamides 
sulfapyridine + 250.3 156.3/92.3 30 15 
sulfadiazine + 251.2 156.2/92.2 30 15 
sulfamethoxazole + 254.4 156.4/92.2 30 20 
sulfathiazole + 256.4 156.3/92.3 25 15 
sulfisoxazole + 268.3 156.2/113.2 25 15 
sulfamethiazole + 271.0 156.2/108.1 25 15 
sulfisomidine + 279.4 186.3/124.4 30 16 
sulfamethazine + 279.4 156.3/124.5 30 15 
sulfamethoxypyridazine + 281.2 156.2/92.2 30 15 
sulfachloropyridazine + 285.3 92.3/156.3 30 28 
sulfadoxine + 311.4 156.4/92.3 30 18 
sulfadimethoxine + 311.4 156.4/92.3 30 20 
sulfanilamide + 173.2 92.1/156.2 30 25 
sulfaquinoxaline + 301.3 92.2/156.3 30 30 
sulfameter (IS) + 281.3 92.2 25 30 
 trimethoprim + 291.5 230.3/261.3 25 23 
Tetracyclines 
tetracycline + 445.5 410.3/427.3 25 20 
doxycycline + 445.5 428.2/410.3 25 18 
oxytetracycline + 461.5 426.3/443.3 25 20 
chlorotetracycline + 479.3 444.2/462.1 25 20 
demethyltetracycline (IS) + 465.2 448.3 25 17 
Macrolides 
erythromycin + 734.5 158.2/576.5 25 30 
spyriamicin + 843.5 174.0/540.3 35 35 
tilmicosin + 869.3 174.2/156.1 35 45 
tylosin + 917.1 174.3/772.5 35 35 
roxithromycin (IS) + 837.7 679.5 30 30 
Quinolones 
nalidixic acid + 233.2 215.1/187.1 40 14 
flumequine + 262.2 202.1/244.2 30 32 
oxolinic acid + 262.2 216.1/244.2 30 25 
cinoxacin + 263.2 217.1/245.2 30 23 
norfloxacin + 320.3 276.2233.2 20 17 
enoxacin + 321.2 303.2/234.2 35 18 
ciprofloxacin + 332.2 288.2/245.2 35 17 
danofloxacin + 358.3 96.1/314.3 33 21 
enrofloxacin + 360.3 316.3/245.2 31 19 
ofloxacin + 362.1 261.3/318.2 34 26 
marbofloxacin + 363.3 72.1/320.2 30 20 
lomefloxacin (IS) + 352.2 265.3 31 22 
Penicillins 
amoxicillin + 366.3 160.3/114.4 25 20 
oxacillin + 402.0 243.0/160.0 30 20 
nafcillin + 415.0 199.0/171.0 30 25 
dicloxacillin + 470.0 311.0/160.0 30 25 
penicillin V (IS) + 351.0 160.2 25 25 
Amphenicol 
chloramphenicol - 320.9 151.9/193.9 30 25 
chloramphenicol-d5 (IS) - 326.0 157.0 30 25 
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(table 12) to prove the identification capability of the method and once again its 
specificity. Calibration curves using spiked samples were assembled using the following 
five concentration levels, 0.5 x VL, 1.0 x VL, 1.5 x VL, 2.0 x VL and 3.0 x VL, and the 
analyses were carried out on three different days with different operators. Six replicates 
of the 0.5 x VL, 1.0 x VL and 1.5 x VL concentration levels were performed each day to 
determine the precision of the method (in terms of the repeatability and reproducibility) 
and the recovery. The recovery was estimated as a ratio between the obtained 
concentration and the real concentration. 
The critical concentrations, CCα and CCβ, were calculated according to the 
following equations [6]: 
 
𝐶𝐶𝛼 = 𝜇𝑁 + 2.33 × 𝜎𝑁    (Equation 1, for compounds without MRLs) 
𝐶𝐶𝛼 = 𝑀𝑅𝐿 + 1.64 × 𝜎𝑀𝑅𝐿    (Equation 2, for compounds with established MRLs) 
𝐶𝐶𝛽 = 𝐶𝐶𝛼 + 1.64 × 𝜎𝑉𝐿  (Equation 3) 
 
where μN is the mean of the noise amplitude of 20 blank samples; σN is the standard 
deviation of the noise amplitude of 20 blank samples at the retention time of the target 
analyte; and σMRL or σVL is the standard deviation at the MRL or VL level in the 20 spiked 
blank samples at that level. For all of the determinations, the peak areas of both the 
analytes and the corresponding internal standards were measured, and the 
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analyte/internal standard area ratios were determined. Internal standards were chosen 
for their similar physicochemical behaviours to those of the antibiotics being monitored 
[17]. 
 
 
Results and Discussion 
The major challenge in the determination of veterinary drugs in biological 
samples, usually in residual concentrations, lies in sample preparation. Our knowledge 
and experience from previously developed multi-class methods in milk, fish and bovine 
muscle [17-19] was the starting point for the present method. In these previously work, 
the appropriated solvents, for the extraction of the target compound, were already 
studied and, starting from that knowledge, a new method, to be used in liver, was 
developed.  Thus, the best option for use as the extraction solvent, in terms of the 
recovery, is an organic extractant, specifically acetonitrile. Aqueous solvents failed to 
extract the less polar compounds. The same conclusion is expressed in other available 
publications, though those extractions were performed on different matrices [8, 20], 
where acetonitrile is preferred over methanol and ethyl acetate, because these last two 
solvents can be responsible for extracting matrix components that can interfere in the 
detection. Additionally, it is important to add that acetonitrile, aside from being an 
efficient extraction solvent, promotes the precipitation of proteins, thereby turning this 
step into one that is important for obtaining a clean extract. Some of the target 
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antibiotics, such as tetracyclines, quinolones and macrolides, can easily form chelate 
complexes with bi- and trivalent metal cations present in the sample extraction solution. 
These can lead to lower recoveries; to prevent their formation, a chelate agent with a 
similar behaviour should be used to control the problem and increase the recoveries. 
For that reason, EDTA is often used during the liquid extraction, and it has been 
determined to improve the extraction efficiencies of tetracyclines, quinolones and 
macrolides. 
Compared with muscle tissue, liver tissue is a much more complex matrix 
because of its high protein content, enzymatic activity and fat content. Therefore, to 
prevent possible chromatographic interferences and ion suppression or enhancement, 
further clean-up steps during the sample preparation were optimized.  
The use of solid-phase extraction prior to mass spectrometric detection can be a 
huge advantage to decrease the effects of ion suppression caused by components of 
liver tissue. To control the possible losses of target antibiotics, the best option is to use 
a multi-class selectivity cartridge that can fit the diverse physicochemical properties of 
all of the target antibiotics. The best option, in terms of selectivity, is to use a sorbent 
composed of a hydrophilic-lipophilic balance modified polymer (OASIS HLB), which is 
known to have a very broad selectivity for polar compounds [8, 21]. The solid-phase 
extraction is followed by concentration through evaporation under a gentle stream of 
nitrogen, without evaporation to total dryness, to avoid a long evaporation process. The 
instability of antibiotics along with the higher affinity of some polar compounds for 
aqueous phase possibly remaining present in the cartridge and being eluted together 
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with the acetonitrile are the main reasons for this procedure [22]. After reconstitution 
with the mobile phase, a thin lipidic layer was observed. To remove that layer and 
prevent such interference in the mass spectrometric detection, a defatting step was 
performed via the addition of n-hexane. After discarding the n-hexane layer, the final 
extract was injected and analysed using UHPLC-MS/MS. 
The UHPLC-MS/MS parameters, in terms of chromatography and detection, were 
previously optimized. The mobile phase, flow rate and gradient steps were selected to 
achieve the best chromatographic separation and peak shape, along with a short run 
time. The conditions described above allowed the determination of the 39 compounds 
in less than 10 minutes. To fulfil the identification criteria described in Decision 
2002/657 [6], two ion transitions must be controlled for each compound. The ideal MRM 
conditions (table 16) were achieved through the direct infusion into the detector of each 
individual standard solution at a concentration of 10 μg mL-1. For positive ionization, 
which is the case for all of the compounds except chloramphenicol, the use of formic 
acid in the mobile phase works as a promoter of positive ionization and consequently 
improves the detection. In figure 13, individual MRM chromatograms of one compound 
per family of monitored antibiotics obtained from a spiked bovine liver sample at the 
corresponding validation level (VL) are presented.  
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Table 17: MRLs and MRPL set by European Union for liver, VL and validation parameters: decision limit (ccα), 
detection capability (ccβ), repeatability, reproducibility and recovery 
 
MRL     
(μg kg-1) 
VL       
(μg kg-1) 
CCα       
(μg kg-1) 
CCβ        
(μg kg-1) 
Repeatability 
(%RSD) 
Reproducibility 
(%RSD) 
Recovery (%) 
sulfapyridine 100 100 124 149 15 22 101 
sulfadiazine 100 100 125 150 15 22 105 
sulfamethoxazole 100 100 121 142 15 23 85 
sulfathiazole 100 100 115 129 8 12 109 
sulfisoxazole 100 100 123 146 16 24 88 
sulfamethiazole 100 100 111 122 6 9 108 
sulfisomidine 100 100 123 146 13 19 108 
sulfamethazine 100 100 115 129 8 12 110 
sulfamethoxypyridazine 100 100 114 129 8 12 110 
sulfachloropyridazine 100 100 118 135 10 15 107 
sulfadoxine 100 100 111 123 7 11 97 
sulfadimethoxine 100 100 123 147 13 19 110 
sulfanilamide 100 100 125 150 15 22 105 
sulfaquinoxaline 100 100 118 137 11 17 98 
trimethoprim 50 50 65 81 11 16 88 
tetracycline 300 300 322 343 12 18 109 
doxycycline 300 300 325 351 14 22 108 
oxytetracycline 300 300 313 326 7 11 110 
chlorotetracycline 300 300 321 343 15 22 88 
erythromycin 200 200 219 237 10 16 109 
spyriamicin 300 300 317 333 10 15 102 
tilmicosin 1000 1000 1024 1048 13 20 110 
tylosin 100 100 111 122 7 10 101 
nalidixic acid - 100 5.81 16.0 15 23 110 
flumequine 500 500 528 555 15 23 110 
oxolinic acid 150 150 166 182 9 13 109 
cinoxacin - 100 3.10 7.60 15 22 100 
norfloxacin - 100 0.32 0.94 13 19 108 
enoxacin - 100 1.72 3.87 15 22 88 
ciprofloxacin 300 300 316 331 11 17 87 
danofloxacin 400 400 418 437 12 18 94 
enrofloxacin 300 300 325 349 15 22 103 
ofloxacin - 100 0.22 0.65 8 13 81 
marbofloxacin 150 150 174 198 14 21 107 
amoxicillin 50 50 74 97 15 22 98 
oxacillin 300 300 320 339 14 22 83 
nafcillin 300 300 321 341 12 17 109 
dicloxacillin 300 300 325 349 14 21 109 
chloramphenicol - 0.3 0.28 0.48 11 17 109 
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The method was validated in accordance with the European Commission 
Decision 2002/657/EC [6], and the following parameters were evaluated: specificity, 
recovery, precision (as repeatability and reproducibility) decision limit (CCα) and 
detection capability (CCβ).  
The specificity of the method was assessed by analysing 20 blank samples of liver 
tissue of different species (bovine, swine, ovine, and poultry) to verify the absence of 
interference above a signal-to-noise ratio of 3 at the retention time of the target 
compounds that could compromise their detection and identification. Additionally, in 
the spiked blank samples, all of the identification criteria [6] were fulfilled without any 
false negative results, again proving the specificity of the method for the species 
analysed. Considering the proved specificity and that no major differences were found 
between the 20 blank and spiked samples, only one animal species (bovine) was used 
for the next validation steps. This choice was based on the fact that bovine liver tissue 
is a matrix that is very often consumed. 
The results obtained for the precision (repeatability and reproducibility) as the 
relative standard deviation (RSD), recovery, CCα and CCβ are summarized in table 17. 
The precision and recovery were calculated at the VL that corresponds to the MRL for 
those compounds that had it. For repeatability and reproducibility, the highest RSDs of 
16% and 24%, respectively, were obtained for sulfisoxazole. All of the other compounds 
had RSDs under these values. The recovery was calculated as a ratio between the 
determined concentration in a spiked sample and the real concentration. The range of 
values obtained were between 81 and 110%, thus falling into the acceptable range [6].  
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Figure 13: Individual MRM of one antibiotic per family is given as example from a spiked liver sample at the 
corresponding validation level (100 µg kg-1 for sulfanilamide and tylosin; 50 µg kg-1 for trimethoprim and 
amoxicillin; 300 µg kg-1 for oxitetracycline; 0.3 µg kg-1 for chloramphenicol and 500 µg kg-1 for flumequine). 
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Both the precision and recovery are mandatory parameters in validation because 
they measure the variability during the analytical process and can be used to analyse 
and prove the robustness of the method.  
The two critical concentrations, CCα and CCβ, were determined from the 
calibration curves obtained from the bovine blank liver samples spiked at five 
concentration levels (0.5, 1, 1.5, 2  and 3 x VL) and the application of the equations 
described above (equations 1, 2 and 3), keeping in mind that not all of the compounds 
had an established MRL. Antibiotics without a tolerance level (MRL) had lower CCα and 
CCβ values that were closer to the limit of detection of the method, although in the 
other cases, these concentrations were always above the MRL. 
 
Conclusions 
An analytical method is proposed for the simultaneous determination of 39 
antibiotics from 7 different classes in liver tissue. The developed method is able to 
determine the presence of compounds from the sulphonamides, tetracyclines, 
macrolides, quinolones, chloramphenicol, penicillins and trimethoprim in a single run 
using UHPLC-MS/MS, providing a possible way to significantly reduce the time required 
to analyse one sample. The developed method was fully validated and fulfilled all of the 
criteria specified by the European Union Decision 2002/657/EC [6], proving that it is 
suitable for routine analysis and quantitative screening purposes for official control, with 
the possibility of extending the method for antibiotic confirmation. Although the main 
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part of the validation procedure was performed only for bovine samples, its specificity 
proved that the method can be used for swine, ovine and poultry liver tissue. 
Because there are a limited number of publications reporting methods for the 
simultaneous analysis of antibiotics in liver tissue, the present method is a huge 
improvement for laboratories that are involved in food safety control and have a large 
number of samples and antibiotics to analyse.  
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ABSTRACT 
The efficiency of multi-detection screening methods, based on liquid 
chromatography coupled with tandem mass spectrometry, has been proven in recent 
years. However, when simultaneously analysing different groups of compounds with 
different physic-chemical properties, the specificity of sample preparation has to be 
minimized. In mass spectrometry, this situation can lead to ion suppression or 
enhancement of signals due to interferences coming from the matrices. This 
phenomenon was studied to understand the real impact in routine analysis. Matrix 
interferences were monitored in extracts of milk, muscle, liver and fish for 40 antibiotics 
using recently developed and validated multi-detection methods with Ultra-High 
Performance Liquid Chromatography tandem Mass Spectrometry (UHPLC-MS/MS). 
Although a significant dispersion in the results was observed, for most of compounds, 
ion suppression is the major problem that, although it does not compromise the 
screening methods, can prevent the use of multi-detection for confirmation and 
quantification of antibiotic residues in food matrices. 
 
INTRODUCTION 
In recent years, improving the cost-effectiveness and efficiency of analytical 
screening procedures has increasingly become a concern in the determination of 
veterinary drugs in food products with animal origins. Versatile and reliable screening 
methodologies can provide rapid results by reducing the number of samples to be 
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confirmed and decreasing the cost associated with a more laborious method. This 
efficiency can be found in multi-detection methods based on liquid chromatography 
coupled with tandem mass spectrometry, surpassing the traditional screening 
microbiological and immunoassays methodologies. Due to the criteria demanded by the 
European Commission [1], either high performance liquid chromatography (HPLC) or 
ultra-high performance liquid chromatography (UHPLC), combined with triple 
quadrupole mass spectrometry detection is the tool of choice in the field of veterinary 
residue analysis, mainly because of the possibility of unequivocal identification of trace 
concentrations in complex matrixes, such as biological samples [2, 3]. The advances 
achieved in analytical detection in recent decades combined sensitive equipment, 
simplification of sample preparation and the possibility of analysing a large number of 
compounds at simultaneously [3-5]. However, the simultaneous determination of 
compounds from different pharmacologic families in complex matrices has constraints 
due to the differences in the physicochemical properties of the target drugs. This fact 
makes the development of sample extraction methods a challenge that can only be 
overcome by reaching a compromise that better fits the purpose of the multiclass 
methods, in most cases, minimizing the specificity of the sample preparation. The lack 
of specificity in sample treatment can result in the presence of endogenous compounds 
from the sample that co-elute with the analytes of interest, which are responsible for 
changes in the intensity of the detected signal [6]. These interferences are usually called 
matrix effects and can also have other sources, such as compounds released during the 
sample preparation or from reagents added to the mobile phases [4-10]. Matrix effects, 
despite being a frequent problem for all instrumental techniques, can be more 
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significant when working with mass spectrometry because they can result in ion 
suppression or signal enhancement [11]. The interferences present in the sample extract, 
even if they are not observed in the chromatogram, can cause modifications to the spray 
droplet solution, decreasing the evaporation efficiency and changing the mechanism of 
ionization, resulting in either decreases or increases in the detected signals. Because it 
is less specific, the positive ionization mode is more affected by these phenomena, and 
these interferences should be completely studied to understand their real impact on 
routine analysis [12]. From this information, we can determine the factors that can be 
modified or improved to minimize the impact. Considering these aspects, matrix 
interferences were monitored in extracts of milk, fish, bovine muscle and liver for the 
determination of 40 antibiotics (sulphonamides, trimethoprim, tetracyclines, 
macrolides, quinolones and penicillins), using the recently, and previously published, 
developed and validated multi-detection methods using UHPLC-MS/MS [13-16]. The 
present publication summarizes the observed and calculated matrix effects in terms of 
suppression or enhancement of the signal. 
 
MATERIALS AND METHODS 
Chemicals, Reagents and Standard Solutions 
All reagents used were of analytical grade with the exception of solvents used 
for the mobile phase, which were of UHPLC grade. Methanol, acetonitrile, n-hexane and 
formic acid were supplied by Merck (Darmstadt, Germany). Ethylenediaminetetraacetic 
acid (EDTA) was purchased from Sigma-Aldrich (Madrid, Spain). Tetracyclines, 
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quinolones, macrolides, sulphonamides, penicillins, and trimethoprim (listed in table 18) 
were acquired from Sigma-Aldrich. Stock solutions of 1 mg mL-1 were prepared with an 
accurate amount of standard weighed, diluted in methanol and stored at -20°C for one 
year. Suitable dilutions, also in methanol, were prepared to have convenient spiking 
solutions for all of the matrix effect assays [13-16]. The working solutions were stored at -
20°C for one month. 
Table 18: MRM acquisition conditions, in positive ionization mode, for each antibiotic 
  
Precursor 
ion (m/z) 
Product 
ion (m/z) 
Cone 
voltage (eV) 
Collision energy 
(eV) 
Sulfonamides 
Sulfapyridine 250.3 156.3 30 15 
Sulfadiazine 251.2 156.2 30 15 
Sulfamethoxazole 254.4 156.4 30 20 
Sulfathiazole 256.4 156.3 25 15 
Sulfisoxazole 268.3 156.2 25 15 
Sulfamethiazole 271.0 156.2 25 15 
Sulfisomidine 279.4 186.3 30 16 
Sulfamethazine 279.4 156.3 30 15 
Sulfamethoxypyridazine 281.2 156.2 30 15 
Sulfachloropyridazine 285.3 92.3 30 28 
Sulfadoxine 311.4 156.4 30 18 
Sulfadimethoxine 311.4 156.4 30 20 
Sulfanilamide 173.2 92.1 30 25 
Sulfaquinoxaline 301.3 92.2 30 30 
Trimethoprim 291.5 230.3 25 23 
Tetracyclines 
Tetracycline 445.5 410.3 25 20 
Doxycycline 445.5 428.2 25 18 
Oxytetracycline 461.5 426.3 25 20 
Chlorotetracycline 479.3 444.2 25 20 
Macrolides 
Erythromycin 734.5 158.2 25 30 
Spyriamicin 843.5 174.0 35 35 
Tilmicosin 869.3 174.2 35 45 
Tylosin 917.1 174.3 35 35 
Quinolones 
Nalidixic Acid 233.2 215.1 40 14 
Flumequine 262.2 202.1 30 32 
Oxolinic Acid 262.2 216.1 30 25 
Cinoxacin 263.2 217.1 30 23 
Norfloxacin 320.3 276.2 20 17 
Enoxacin 321.2 303.2 35 18 
Ciprofloxacin 332.2 288.2 35 17 
Danofloxacin 358.3 96.1 33 21 
Enrofloxacin 360.3 316.3 31 19 
Ofloxacin 362.1 261.3 34 26 
Marbofloxacin 363.3 72.1 30 20 
Penicillins 
Penicillin G 335.1 176.0 30 25 
Ampicillin 350.4 106.3 25 20 
Amoxicillin 366.3 160.3 25 20 
Oxacillin 402.0 243.0 30 20 
Nafcillin 415.0 199.0 30 25 
Dicloxacillin 470.0 311.0 30 25 
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Instrumentation 
During sample preparation the following equipment was used: Mettler Toledo 
PC200 and AE100 balances (Greifensee, Switzerland), Heidolph Reax 2 overhead mixer 
(Schwabach, Germany), Heraeus Megafuge 1.0 centrifuge (Hanau, Germany), Turbovap 
Zymark Evaporator (Hopkinton, MA, USA) and Whatman Mini-Uniprep PVDF 
(polyvinylidene fluoride) 0.45-µm filters (Clifton, NJ, USA). A vacuum manifold was used 
for the solid phase extraction (SPE) with an Oasis HLB polymeric sorbent cartridge (3 mL, 
200 mg) (Waters, Milford, MA, USA). 
The analytical instrument used for chromatographic separation and mass 
spectrometry detection consisted of an UHPLC system coupled to a triple quadrupole 
tandem mass spectrometer: Xevo TQ MS – Acquity UHPLC system, Waters (Milford, MA, 
USA). The UHPLC system consisted of a vacuum degasser, an autosampler and a binary 
pump equipped with an analytical reverse-phase column Acquity HSS T3 2.1x100 mm, 
1.8-μm particle size. The mobile phases used were (A) formic acid 0.1% in water and (B) 
acetonitrile. The gradient program used, at a flow rate of 0.45 mL min-1, was 0-5 minutes 
from 97% (A) to 40% (A); 5-9 minutes from 40% to 0% (A); 9-10 minutes from 0% back 
to 97% (A); 11-12 minutes 97% (A). The column and autosampler were maintained at 
40°C and 10°C, respectively, and 20-µL aliquot (full loop) was injected. 
The electrospray ion source in positive (ESI+) mode was performed with data 
acquisition in multiple reactions monitoring mode (MRM). Data acquisition and 
processing were accomplished using the Masslynx 4.1 software, Waters (Milford, MA, 
USA).  
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Sample preparation 
The sample preparation was performed as already developed, validated and 
described in previous publications [13-16]. However, brief descriptions of the methods are 
shown below. In all cases the final extract was filtered through a 0.45-µm PVDF Mini-
Uniprep TM, transferred to vials and analysed using UHPLC-MS/MS under the MRM 
optimized conditions described in table 18. 
Milk:  The extraction of antibiotics and precipitation of proteins from two grams 
of raw milk were performed by homogenizing the sample with 10 mL of acetonitrile (10 
minutes). After centrifugation, 15 minutes at 3100 x g, the supernatant was evaporated 
to dryness. The residue was redissolved with 400 μL of mobile phase (A) [13]. 
Fish muscle: Two grams of homogenized gilthead sea bream muscle were 
extracted using 10 mL of acetonitrile and 1 mL of a 0.1 M EDTA solution (20 minutes). 
After centrifugation, 15 minutes at 3100 x g, the organic layer was evaporated to dryness 
and redissolved in 400 μL of mobile phase (A) [14]. 
Bovine Muscle: Two grams of minced bovine muscle were extracted with 10 mL 
of acetonitrile and 1 mL of 0.1 M EDTA (10 minutes). After centrifugation, 15 minutes at 
3100 × g, the supernatant was defatted with 3 mL of n-hexane. Centrifugation was 
performed again for 15 minutes at 3100 x g, and the n-hexane layer was discarded. The 
final extract was evaporated to 0.5 mL [15]. 
Bovine Liver: Two grams of minced liver were extracted with 10 mL of 
acetonitrile and 1 mL of 0.1 M EDTA (10 minutes) followed by ultrasound bath (20 
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minutes). After centrifugation for 10 minutes at 4000 × g, the supernatant was 
evaporated to near dryness (1 mL). Water (5 mL) was added, and the extract solution 
was submitted to a cleanup step using SPE Oasis HLB cartridges (preconditioned with 10 
mL of acetonitrile and 10 mL of water). The cartridges were washed with 5 mL of water 
and dried under reduced pressure (5 minutes). The elution was performed using 
acetonitrile (10 mL) followed by evaporation to nearly dryness (0.5 mL). Redissolution 
was made with 400 μL of mobile phase (A) followed by a defatting step with 2 mL of n-
hexane. After centrifugation, 10 minutes at 4000 × g, the n-hexane layer was removed 
[16].  
Matrix Effects 
The matrix effects were evaluated by analysing parallel standard solutions of all 
target analytes in the mobile phase and in the blank sample extract (matrix-matched 
solutions) at the concentration of 100 μg kg-1. These experiments were performed ten 
times in each matrix: milk, fish muscle, bovine muscle and liver. The matrix effects can 
be measured using the following equation [10]: 
𝑀𝐸 (%) =  
𝐴𝑚𝑎𝑡𝑟𝑖𝑥
𝐴𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑
× 100  (Equation 1) 
Where Amatrix is the average signal, in absolute area, obtained in the blank extract 
spiked after extraction (the analyte was added to the matrix extract) and Astandard is the 
average signal for the compound in the standard solution (prepared in the mobile 
phase). The suppression or enhancement of the absolute area of the signal, ASE, can be 
expressed by  
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𝐴𝑆𝐸 (%) = 100 − 𝑀𝐸  (Equation 2) 
where the result can be interpreted as: 
𝐴𝑆𝐸 (%) = 1  𝑛𝑜 𝑚𝑎𝑡𝑟𝑖𝑥 𝑒𝑓𝑓𝑒𝑐𝑡 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 
𝐴𝑆𝐸 (%) > 1 𝑠𝑖𝑔𝑛𝑎𝑙 𝑒𝑛ℎ𝑎𝑛𝑐𝑒𝑚𝑒𝑛𝑡 
𝐴𝑆𝐸 (%) < 1 𝑖𝑜𝑛 𝑠𝑢𝑝𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 (𝑙𝑜𝑠𝑠 𝑜𝑓 𝑠𝑖𝑔𝑛𝑎𝑙) 
 
RESULTS AND DISCUSSION 
The major limitation found when developing multi-detection methods is related 
to the sample preparation due to the difficulty in achieving an efficient and generic 
procedure to simultaneously extract multiple compounds from diverse families with 
different physicochemical properties. Multi-step and complex sample clean up 
procedures can result in significant loss of some target compounds, and for that reason, 
less specific procedures are the only solution for the screening of several different 
compounds in one analysis [17, 18]. 
Previously developed methods for the multi-detection determination of 40 
antibiotics in food products with animal origins were validated to be in agreement with 
the European Commission Decision 2002/657/EC [1]. One important parameter that 
should be evaluated to complement the validation and better understand any possible 
fluctuations is the matrix effect and how this parameter can interfere with the final 
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result in the analysis of real samples. Even though mass spectrometry can surpass 
microbiological and immunological assays due to its high sensitivity and selectivity, ion 
suppression and enhancement can be drawbacks for this detection tool if they are not 
well understood.  
Table 19: Summary of mean results obtained for the signal suppression/enhancement (ASE).  In cases where 
enhancement is observed, the result is presented in bold and underlined the suppression higher than 50% 
  ASE (%) 
  Milk Fish muscle Bovine muscle Bovine liver 
Sulfonamides 
Sulfapyridine -46.6 -26.6 -52.5 -25.2 
Sulfadiazine -53.1 -25.6 -67.3 -43.0 
Sulfamethoxazole -59.3 -76.6 -67.1 -44.1 
Sulfathiazole -35.7 -27.8 -65.3 -41.6 
Sulfisoxazole -57.3 -69.4 -65.9 -46.9 
Sulfamethiazole -14.0 -30.5 -52.9 -12.3 
Sulfisomidine -58.4 3.9 -87.5 -75.6 
Sulfamethazine -34.8 -53.2 -47.6 -28.3 
Sulfamethoxypyridazine -33.8 -4.9 47.0 -28.2 
Sulfachloropyridazine -49.6 -8.6 -47.6 -19.9 
Sulfadoxine -34.3 -60.0 -54.0 -24.6 
Sulfadimethoxine -31.8 23.9 -17.8 -14.5 
Sulfanilamide -78.1 -58.0 -76.0 -77.5 
Sulfaquinoxaline -21.0 -9.7 -10.1 3.4 
Trimethoprim -31.6 -46.3 -66.3 -22.8 
Tetracyclines 
Tetracycline -35.0 -57.7 -39.5 -10.2 
Doxycycline -25.3 -44.1 -7.1 -12.1 
Oxytetracycline -46.9 -54.5 -45.7 -30.2 
Chlorotetracycline -33.6 -44.7 -35.0 -15.6 
Macrolides 
Erythromycin -57.9 -57.2 17.0 52.9 
Spyriamicin -11.8 -54.2 -43.9 10.1 
Tilmicosin -14.3 -44.7 34.3 54.0 
Tylosin -30.0 -6.7 -35.6 -20.9 
Quinolones 
Nalidixic acid -48.5 4.1 -39.4 0.8 
Flumequine -20.5 -15.5 -8.7 1.7 
Oxolinic acid -33.2 12.1 -18.2 -19.1 
Cinoxacin -14.2 9.1 -10.4 7.7 
Norfloxacin -37.9 -35.7 -65.2 -17.4 
Enoxacin -27.4 -23.4 -14.1 -33.8 
Ciprofloxacin -34.7 -52.9 -15.7 -37.9 
Danofloxacin -4.7 -7.8 -58.2 -18.6 
Enrofloxacin -46.6 -36.8 -52.5 -25.2 
Ofloxacin -25.4 -49.7 -25.9 -42.3 
Marbofloxacin -28.1 -6.7 -27.5 -36.6 
Penicillins 
Penicillin G -16.5 -11.1 -36.2 -42.8 
Ampicillin -12.7 -48.3 -40.7 -38.7 
Amoxicillin -33.9 -39.9 -66.7 -44.1 
Oxacillin 3.9 9.0 -23.6 -7.6 
Nafcillin -6.5 -4.0 -4.0 1.2 
Dicloxacillin 14.9 25.0 -15.9 -24.2 
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In the present study, 10 blank samples of each target matrix (milk, fish, bovine 
muscle and liver) were extracted using the developed sample preparation and spiked 
right before analysis in the UHPLC-MS/MS. Ten standard solutions were prepared in the 
mobile phase at the same concentration and analysed in parallel. The resulting signals 
were compared by applying equations 1 and 2; the real effects were measured and are 
shown in table 19 as ASE (%), where ASE >1% indicated the occurrence of a matrix 
enhancement effect and ASE<1% indicated the occurrence of a suppression effect. In the 
table, these values are underlined when the suppression is greater than 50% and shown 
in bold when they are enhanced.  
 
Figure 14: Matrix effects observed in milk, fish muscle, bovine muscle and liver represented as ASE (%), calculated 
with equation 2 
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Although a significant dispersion in the results was observed, a loss of signal was 
obtained for the majority of compounds and matrices; 20% of the results have more 
than 50% suppression. In contrast, enhancement, ASE>1%, only represents 11% of the 
total calculated data. All of the results for the four matrices with all compounds are 
represented graphically in figure 14. 
The worst results, i.e., signal losses of more than 50%, were obtained for the 
bovine muscle. In this matrix, the observed matrix effect was ASE<-50% for 13 
compounds as shown in table 19. In fish muscle, 10 compounds showed ASE<-50%; in 
milk, only 6 analytes had ASE<-50%; and finally, in bovine liver, only 2 antibiotics had 
ASE<-50%.   
Compared with milk, fish and bovine muscle, liver is the most complex matrix 
analysed (higher protein, enzymatic activity and fat content). To minimize the possible 
and expected interferences, more clean-up steps were introduced when the method 
was developed via the introduction of solid-phase extraction, which generally resulted 
in a lower suppression (figure 14), showing the large impact that sample preparation 
can have. Minimizing the specificity of extraction can definitely lead to major 
interferences in the results and alter the method sensitivity. To guarantee the detection 
of the compounds of interest in multi-detection methods where the sample extraction 
cannot be specific, even when large suppression occurs, highly sensitive and specific 
equipment is needed. The significantly lower limits of detection achieved during the 
validation assures the detection of all compounds even in the worst cases of suppression 
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observed in this study. This fact is important to avoid the possibility of false negative 
results. 
The highest enhancement results were observed for macrolides in liver tissue, 
especially for erythromycin, which had an increase of 52.9%, and tilmicosin, which 
increased 54%. The interesting case of erythromycin is represented in figure 2, where 
the opposite impact of the milk matrix resulted in a 57.9% suppression of the signal 
compared with the liver tissue. Additionally, as shown in figure 15, the blank samples 
did not present any visible interferences that could lead to false positives, and even 
when almost 60% of the signal is lost, the detection is still not compromised.  
 
Figure 15: Example of a significant matrix effect observed in the analysis of erythromicin: A – 58% of ion 
suppression observed in milk; B – 53% of signal enhancement in liver 
Based on these matrix interferences, it can be assumed that quantification can 
be compromised, which is an important fact when Maximum Residue Levels [19, 20] are 
being analysed. An error in the quantification process can jeopardize the validity of the 
result. 
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 More selective sample preparation should be applied for confirmation and 
quantification purposes, meaning multi-detection methods should only be used for 
screening. Specific methods are required for each matrix and analyte and their 
combinations. Improving chromatographic separation when performing confirmation 
methods for a single compound or family of antibiotics should also be taken in 
consideration as a step to minimize the expected matrix effect. Modifying the mobile 
phase strength, stationary phase and gradient conditions can prevent analyte peaks 
from co-eluting in regions where more interferences are observed. 
 
CONCLUSIONS 
Despite all of the conclusions regarding the pitfalls of multi-detection methods, 
the described methods are still the best options for successfully screening a large 
number of antibiotics. The detection capabilities achieved using UHPLC-MS/MS, the 
cost-effectiveness, the time required for analysis, and the specificity for antibiotics 
present in the sample are the features that make these screening methods useful tools 
for Food Safety. 
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GENERAL DISCUSSION 
Despite the fact that antibiotics play an important role in protecting human and 
veterinary health, their inappropriate use is nowadays threatening their effectiveness 
by compromising its ability to fight infections when facing resistant bacteria. The 
increasing awareness of the consumers for food safety issues [1] and the fact that this 
subject is one of the main priorities to the European Commission [2], results in a high 
pressure on official laboratories to guarantee that this concern is being effectively 
monitored. An efficient control of veterinary drug residues is essential and when official 
methods are applied it has to be ensured that MRLs are not exceeded and that the 
banned compounds are not present in the samples [3]. 
Considering the different classes of antibiotics used in veterinary medicine and 
the diverse kind of foodstuff matrices that has to be controlled, laboratories have to 
consistently manage a considerable volume of samples and analyze a large number of 
compounds. As a consequence of that situation, in the last decade, a major concern has 
been focused on improving time of analysis, cost-effectiveness aside with developing 
sensitive and specific screening technologies able to detect in a single assay the 
maximum number of compounds as possible [4-6]. Those characteristics were achieved 
in the methods developed during the present project, as initially proposed. The methods 
developed are intended to be applied in the official routine analysis, in the national plan 
of residues control in Portugal, and with them, improve the performance of the 
laboratory by minimizing the time between the sample collection and the final result in 
a controlled cost. The individual methods for each family of antibiotics will be replaced 
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by one unique method per matrix saving weeks of laborious work, mainly in sample 
preparation. 
Through this Dissertation it is presented the development of four multi-detection 
and multi-class methodologies intended to be implemented in the routine analysis for 
the official control, in Portugal, of antibiotics in highly consumed foodstuff of animal 
origin: milk, fish muscle, bovine muscle and liver. These methods are intended to speed 
up the routine analysis and reduce the respective costs. 
While developing a multi-detection and multi-class method the sample 
preparation was the most critical step as it is important to ensure the desirable recovery 
for as many compounds as possible. To control possible fluctuations during the process, 
suitable internal standards were selected for each group of compounds, based on their 
physic-chemical similarities.  
The analytical tool of choice used to guarantee the unequivocal identification of 
the target antibiotics and to fulfill the European Commission performance and validation 
criteria [3] was the UHPLC-MS/MS. 
The first method presented is a quantitative screening of 33 antibiotics 
(tetracyclines, quinolones, macrolides, sulphonamides and chloramphenicol) in milk, 
one of the most consumed food of animal origin [7]. A simple sample preparation was 
optimized, in order to achieve the best recovery possible for the target compounds, 
including LLE and protein precipitation with an organic solvent, acetonitrile. This solvent 
is preferred over methanol and ethyl acetate, since both of them can be responsible for 
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extracting matrix components that would interfere in the detection. Another reason is 
that the acetonitrile can promote the precipitation of proteins, an important step to 
obtain a cleaner extract. Furthermore, aqueous solvents failed to extract the less polar 
compounds. Along with the required parameters monitored in the validation process, 
and being milk a very important matrix in terms of food habits, it was considered to be 
interesting to know the LOD associated to each target molecule, and with that proving 
the ability to determine the presence of the compounds of interest at low 
concentrations. The calculated LOD ranged from 0.010 µg. kg-1 (tylosin) to 3.7 µg kg-1 
(ofloxacin). Comparing those results with the MRLs/MRPL established in the legislation 
they are significantly lower and it can be concluded that the method has the necessary 
sensitivity to guarantee that no false negative results will be obtained. The applicability 
of the method was studied and the validation provided evidence that it is suitable to be 
used in routine analysis for the detection of antibiotics in bovine, caprine and ovine milk. 
The second multi-class method was developed for fish muscle, more specifically 
gilthead sea bream, one of the most consumed fish in Portugal. With the increase of fish 
consumption in the last decades [8, 9], aquaculture became an important economic 
activity in which antibiotics are widely used whether for prevention or for treatment of 
bacterial diseases [10]. For those reasons fish muscle should be one of the target edible 
tissues controlled for the presence of veterinary drug residues. The multi-class method 
developed determines simultaneously the presence of 41 antibiotics from 
sulphonamides, trimethoprim, tetracyclines, macrolides, quinolones, penicillins and 
chloramphenicol. An efficient sample preparation was optimized after testing fourteen 
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different methods using LLE and SPE steps. The optimal method, considering the 
absolute recoveries for all antibiotics, was an extraction with acetonitrile and EDTA, a 
chelating agent. The recovery of compounds able to form complexes with cations 
present in the sample extraction solution can be compromised and, by adding a 
molecule that competes for those cations, EDTA, those losses can be minimized. The 
method was fully validated providing the evidence that it is suitable to be applied in 
routine analysis for the determination of the target antibiotics in muscle of gilthead sea 
bream. The critical concentrations CCα and CCβ were determined, in accordance with 
the established by the Commission Decision 2002/657/EC [3], depending if the MRL or 
MRPL is established or not. For compounds without a tolerance level established, the 
critical concentrations were calculated closer to de detection limit of the method, being 
the lower value achieved for norfloxacin with a CCα of 2.4 µg kg-1. Even though, the 
lowest value was obtained for chloramphenicol, which MRPL is defined as 0.3 µg kg-1, 
and the CCα calculated is 0.1 µg kg-1. Once again the reduced handling time and 
associated low costs will allow a higher number of samples to be analysed in one day 
improving routine analyses.  
Another matrix that is equally highly consumed worldwide, bovine muscle, the 
developed method allows the determination of 41 antibiotics from sulphonamides, 
trimethoprim, tetracyclines, macrolides, quinolones, penicillins and chloramphenicol. 
Until now only few methods, combining multi-detection and multi-class in a quantitative 
screening method for bovine muscle, are available in the literature. Twelve procedures 
for sample preparations were tested and it was concluded, once again, that the high 
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selectivity of the SPE step is a concern in multi-class methods. The optimized method 
has many similarities with the one described for fish muscle only adding a defatting step, 
n-hexane, to minimize the lipid content  presented in the bovine muscle in higher 
concentration than in fish muscle. The addition of this step is responsible for the 
achievement of higher recoveries as it eliminates potential interferences that could 
compromise the detection. The results obtained during validation clearly demonstrated 
that the method is suitable for the quantitative identification of all tested antibiotics in 
bovine muscle. The validation was performed having in mind the existing MRL and MRPL 
concentrations and also in the cases where no tolerance limit was established. For those 
cases, the critical concentrations obtained were closer to de detection limit being the 
lowest value achieved for nalidixic acid and ofloxacin with a CCα of 0.11 µg kg-1. 
The lack of methodologies for screening of antibiotics in liver was the main reason 
to choose it as one of the target matrices in the present work. The proposed method 
simultaneously determines 39 antibiotics from 7 different classes in liver tissue: 
sulphonamides, trimethoprim, tetracyclines, macrolides, quinolones, penicillins and 
chloramphenicol. There are very few methods described for analysing antibiotics in liver 
tissue and there are even less for multi-detection and multi-class determination. This 
situation triggered the interest for new developments to fulfil the requirements of the 
control program and, consequently, improve food safety tools. One of the principal 
obstacles faced when working with liver tissue and optimizing sample preparation is 
related with the complexity of the sample. The high protein and fat contents and the 
significant enzymatic activity in liver tissues can represent more interference in the 
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analytical performance as well as can cause fast degradation of labile compounds 
leading to low recoveries in the sample preparation. That reason can justify the fact that 
a more complex sample extraction was needed in order to prevent possible 
chromatographic interferences and ion suppression or signal enhancement effects. The 
starting point was based on the previously developed methods; the appropriated 
extraction solvents for the target compounds were already tested. The developed 
procedure consists of an extraction with a mixture of acetonitrile and EDTA followed by 
a SPE step with a hydrophilic–lipophilic balanced (HLB) sorbent, known to have a very 
broad selectivity for polar compounds. A complete validation of the method was 
performed, fulfilling all the demanded criteria and providing evidence that it is suitable 
to be applied in routine analysis for quantitative screening purposes. For liver tissue the 
lowest value obtained for CCα was 0.22 µg kg-1 for ofloxacin, an antibiotic with no MRL 
defined for liver. Despite the fact that the method was developed for bovine liver, during 
the validation process, the specificity was also studied for swine, ovine and poultry liver 
tissues leading to the conclusion that the method is suitable for those liver tissues. The 
present method represents an important improvement for laboratories involved in food 
safety control since a limited number of publications are available for the determination 
of such huge number of antibiotics in liver tissue. 
The advances achieved in the analytical methods developed, combining sensitive 
equipment, simplification of sample preparation and the detection of a large number of 
compounds simultaneously, has however some constrains. The lack of specificity in 
sample preparation can result in the presence of endogenous compounds from the 
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sample that co-elute with the antibiotics, causing changes in the intensity of the 
detected signal: suppression or enhancement of the signal [11]. To better understand this 
phenomenon, matrix interferences were monitored in extracts of milk, fish, bovine 
muscle and liver for the determination of antibiotics by UHPLC-MS/MS. The evaluation 
of the matrix effects was made by analysing in parallel standard solutions of all target 
analytes in the mobile phase and in the blank sample extract (matrix-matched solutions) 
at adequate concentrations. It was observed that the variability of signal suppression 
and enhancement effects are compound and matrix dependent. For the majority of 
compounds a loss of signal was observed (ion suppression); being 20% of the analysed 
samples with more than 50% of suppression. In contrast, enhancement effects, only 
represents 11% of the total calculated data. In comparison with the other matrices, liver 
is the most complex matrix analysed due to the higher protein, enzymatic activity and 
fat content and, for that reason, it was expected a higher signal interference. To prevent 
the referred expected effect a SPE step was introduced. This approach resulted in a 
decrease of the signal suppression, confirming that the specificity of the extraction 
procedure couldn't be minimized in order to avoid major interferences that can alter the 
sensitivity of the methods.   
When intense signal suppression occurs it is important to guarantee the detection 
of compounds, avoiding false negative results, by using highly sensitive and specific 
equipment. However it was observed that quantification can be affected by those 
effects leading to the conclusion that it is mandatory to use more specific sample 
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preparation in case of confirmation and quantification purposes, meaning that multi-
detection methods should be mainly used for screening. 
Despite all of the conclusions regarding the pitfalls of multi-detection and multi-
class methods, the described ones are still the best options for successfully screening a 
large number of antibiotics on a short period of time. Currently, the strategy that was 
applied until now involved the application of several methods, most of them multi-
residue of related compounds (same class) resulting in a time-consuming process 
leading to several weeks of laboratorial work before achieving the final result. The 
celerity in obtaining results is one of the fundamental characteristics and advantages of 
the multi-residue and multi-class screening methods. The possibility of analysing, in one 
single procedure, a large number of compounds per sample reducing the handling time 
and the associated costs, allowing a large number of samples to be monitored in one 
day, is the main feature of the present work. It is also important to emphasize that the 
UHPLC-MS/MS technology contributed to achieve minimal analysis time combining 
separation, sensitivity and high resolution chromatography along with high detection 
capabilities [12]. 
The main feature of the proposed methodologies, as important tools for 
improving consumer confidence in foodstuff of animal origin, is the benefit that they 
add to food safety risk analysis. 
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FUTURE TRENDS 
For the official control of the presence of antibiotics in foodstuff of animal origin a 
wide range of edible tissues has to be monitored [13]. In the present work, four 
methodologies are presented and the knowledge achieved during their development 
should be applied to other matrices such as kidney, fat, eggs and honey. Nevertheless, 
the analysis of animal feeds and of drinking water by this kind of multi-detection and 
multi-class methods will be also an important improvement to control the fraudulent 
use of antibiotics more efficiently. 
The increasing relevance of aquaculture in Portugal and the influence that 
antibiotics have in fish farming demands a more careful attitude. The method developed 
for gilthead sea bream fish muscle should work as a starting point to be optimized in 
order to be applied to another similar species commonly produced in Portuguese 
aquaculture, such as sea bass, turbot, sole, white bream or trout.  
Last but not least, the development of new multi-detection and multi-class 
methods for other antibiotics, such as aminoglycosides, cephalosporins and polimixins 
(with different chemical properties), or their inclusion in the previous related methods 
should be another challenge to reach in this field.  
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